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Tropane alkaloids are a group of nitrogenous compounds that have a role in the 
treatment of multiple medical conditions. Many members of the Solanaceae produce 
these high valued compounds, such as the commercial source Duboisia. However, 
potato (Solanum tuberosum) does not produce tropane alkaloids. High levels of 
compounds which share tropane alkaloid precursors do accumulate in potato tissues (the 
nortropane alkaloids). The aim of this project is to investigate whether the range of 
alkaloids synthesised in potato can be enhanced by utilising biotechnological 
approaches to re-engineer the biochemical pathways, overcoming lesion points within 
potato.  
 
Transgenic lines have been developed to investigate whether metabolic flux can 
be diverted away from the nortropane alkaloids and towards the precursors of the high 
value tropane alkaloids. Transgenic lines which over-express tropinone reductase I, 
have been shown to accumulate the precursor tropine, after the application of exogenous 
tropinone, and within leaf disc assays tropine accumulation reached 161.00 ± 3.61 μg/g 
FW in transgenic lines compared to 0.63 ± 0.05 μg/g FW in Désirée controls. Similarly, 
tropinone reductase II down-regulating lines have shown a decrease in the 
accumulation of pseudotropine, a nortropane alkaloid precursor; however, there was no 
statistically significant increase in tropine accumulation. Pseudotropine accumulation in 
down-regulating transgenic lines reached 1.64 ± 0.27 μg/g FW, compared to 5.24 ± 0.44 
μg/g FW in Désirée controls.  Other regions of the biosynthetic pathway were 
investigated through recombinant protein expression assays to generate a more in-depth 
understanding and identify further lesions in this pathway within potato. These assays 
showed that the annotated hyoscyamine-6β-hydroxylase within the potato genome 
browsers were not able to convert hyosycamine to the downstream tropane alkaloids, 





















I would like to dedicate this to my friends and family who have supported me through-

























Firstly, I would like to acknowledge the support I have received from my supervisors. 
Dr. Raymond Campbell being there to bounce ideas off and offer advice when things 
were not going to plan with cloning issues that were encountered. Dr. Mark Taylor and 
Professor Derek Stewart for offering continued guidance and advice throughout this 
process and ensuring that I was on top of everything. 
 
It would be remiss of me to not acknowledge my parents Martin and Jackie whom have 
taken an interest in this and asked questions to try and lead me down other trains of 
thought. My best pals Tilly and Duncan whom have offered an ear when I have needed 
to let loose and talk through things which were causing stress and have helped me 
change my lifestyle massively over the last 2 years. I would also like to thank the new 
friends I have made at the Dundee Roadrunners whom have opened my eyes to a new 
activity which has been extremely beneficial in relieving the stress that this project has 
bought on and the last few years certainly would not have been as fun without them.   
 
I’d also like to thank and acknowledge the help and support received from the rest of the 
Taylor Group as well as the staff in the LC-MS facility at The James Hutton Institute 
for their ability to listen to my issues and offer advice as well as offer help with 
harvesting and tissue culture. So, my sincerest thank-you to: Dr. Laurence Ducreux, Dr. 
Wayne Morris, Dr. Almudena Trapero-Mozos, Dr. William Allwood, Dr. Alexandre 
Foito and Dr. Sabine Freitag.  
 
I could go on, but there are too many people to name – sincerely to everyone who has 




















Version: (i.e. First, 
Resubmission, Final) 





In accordance with the appropriate regulations I hereby submit my thesis and I declare that: 
 
1) the thesis embodies the results of my own work and has been composed by myself 
2) where appropriate, I have made acknowledgement of the work of others and have made 
reference to work carried out in collaboration with other persons 
3) the thesis is the correct version of the thesis for submission and is the same version as 
any electronic versions submitted*.  
4) my thesis for the award referred to, deposited in the Heriot-Watt University Library, should 
be made available for loan or photocopying and be available via the Institutional 
Repository, subject to such conditions as the Librarian may require 
5) I understand that as a student of the University I am required to abide by the Regulations 
of the University and to conform to its discipline. 
6) I confirm that the thesis has been verified against plagiarism via an approved plagiarism 
detection application e.g. Turnitin. 
 
* Please note that it is the responsibility of the candidate to ensure that the correct version 











Submitted By (name in capitals):  





For Completion in the Student Service Centre (SSC) 
 
Received in the SSC by (name in 
capitals): 
 
Method of Submission  




E-thesis Submitted (mandatory 









                                                    
vi 
Table of contents 
 
Title page          i 
Abstract           ii 
Dedication          iii 
Acknowledgements         iv 
Declaration          v 
Table of contents         vi 
List of tables          xii 
List of figures         xiv 
Abbreviations         xxi
            
Chapter 1: Introduction        1 
 
 
1.1  Natural products from potato      2 
1.2 Definition and occurrence of tropane alkaloids    3 
1.3 History          4 
1.4 Recent uses         5 
1.5 Biosynthetic Pathway       7 
1.5.1 The shared pathway within the Solanaceae    8 
1.5.2 The tropane alkaloid arm      10 
1.5.3 The nortropane alkaloid arm      12 
1.6  Production in the Solanaceae         14 
1.7 Evolution in Plants        20 
1.8  The short-chain dehydrogenase/reductase superfamily    20 
1.9 Solanum tuberosum: the potato      21 
1.10 Manipulation of the potato genome and tropane alkaloid biosynthesis 
pathway          23 
1.11 Modular cloning methodology      24 
1.12 Methods used for the detection of tropane alkaloids   30 
 1.12.1 Thin Layer Chromatography      30 
 1.12.2 HPLC-UV        31 
 1.12.3 Gas Chromatography Mass Spectroscopy (GC-MS)   31 
 1.12.4 QqQ-LC-MS        32 
1.13 Extraction method differences      33 
1.14 Objectives         35 
                                                    
vii 
Chapter 2: Materials and Methods       36
  
2.1.   Media, antibiotics and buffers       37
 2.1.1 Bacterial culture media      37 
 2.1.2 Tissue culture media       37 
 2.1.3 Antibiotics        38 
 2.1.4 Buffers        38 
2.2   Plasmids          41 
 2.2.1 pGEM®-T Easy       41 
 2.2.2 pET-28a(+) (Novagen®, Germany)     42 
 2.2.3 GoldenBraid        43 
  pUPD2        43 
pDGB1_α1R        44 
pDGB3_α series       45 
pDGB3_Ω series       46 
2.3 Bacterial Strains         47 
2.3.1 Escherichia coli DH5a       47 
2.3.2 Escherichia coli BL21 (DE3)      47 
2.3.3 Agrobacterium tumefaciens AGL1     47 
2.4 Plant material         47 
2.4.1 Growth and maintenance of Brugmansia aurea, Withania somnifera and 
Hyoscyamus niger         48 
2.4.2 Maintenance of stock and transgenic potato material    48 
2.4.3 Harvesting of plant material       49 
2.5. Molecular Protocols         49 
2.5.1 Nucleic acid extraction      49 
Isolation of RNA        49 
Isolation of DNA        49 
Extraction of DNA from bacterial preparations using Promega Miniprep 49 
2.5.2 Analysis of nucleic acids      50 
Quantification of nucleic acids by spectrophotometry   50 
Gel electrophoresis          50 
DNA and RNA quality determination by gel electrophoresis      50
 DNA recovery from agarose gels      51 
 
                                                    
viii 
2.5.3 Enzymatic manipulation of nucleic acids     51 
Polymerase Chain Reaction (PCR)      51 
Restriction endonuclease digestion reactions     52 
cDNA synthesis         52 
2.5.3.1 Ligation reactions        53 
pGEM®-T Easy (Promega, USA)      53 
pET-28a(+)(Novagen)       53 
  Ligations in the GoldenBraid system     54 
 2.5.3.2 Design of primers        54 
2.5.3.3 RT-qPCR (Universal Probe Library)     54 
2.5.3.4 Sequencing of DNA       55 
2.5.3.5 Recombinant protein induction     55 
2.5.3.6 Protein extraction and Western Blot      56 
2.5.4 Bacterial Protocols        58 
2.5.4.1 Heat shock transformation of competent E.coli (strains DH5α and BL21 
(DE3))          58 
2.5.4.2 Transformation of electro-competent Agrobacterium   58 
2.5.4.3 Preservation of bacterial cultures     59 
2.5.4.4 Generation of bacterial cultures for transient and stable inoculation 59                                                                                                      
2.5.4.5 Tissue culture of generated transgenic lines    59 
2.6 Biochemical Analysis        60 
2.6.1 Chlorophyll and Carotenoid extraction     60 
2.6.2 Extraction of tropane alkaloids from plant tissue   61 
2.6.3 Extraction of tropane alkaloids from media    61 
2.6.4 HPLC          62 
      2.6.5 ThermoFisher Scientific’s OrbiTrap™ LC-MS system.     62 
2.6.6 QqQ-LC/MS        63 








                                                    
ix 
Chapter 3: Detection method development     64 
 
3.1 Introduction          65 
 3.1.1 Composition of alkaloids and extraction from plant material  65 
 3.1.2 A new LC-MS system for detection of tropane alkaloids  66 
            3.1.3 ThermoFisher Scientific’s OrbiTrap™ LC-MS system.    66 
3.1.4 Agilent Triple-Quadrupole (QqQ) LC-MS/MS tropane alkaloids 
fragmentation patterns in literature       67 
3.2 Materials and Methods        69 
 3.2.1 Extraction methods       69 
3.3 Results          70 
3.3.1 Thin Layer Chromatography (TLC)      70 
3.3.2 HPLC-UV         70 
3.3.3 ThermoFisher Scientific’s OrbiTrap™ LC-MS system  72 
3.3.3.1 Comparison of extraction methods.     73 
3.3.4 Agilent QqQ-LC-MS/MS      77 
3.4 Discussion          83 
3.5 Moving Forward         88 
 
Chapter 4: Functional characterisation of a candidate gene encoding    
hyoscyamine-6β-hydroxylase from potato.                  89 
 
4.1 Introduction         90 
4.2 Materials and Methods        94 
 4.2.1 Generation and characterization of h6h recombinant plasmids 94 
 4.2.2 Biological replication        94 
4.3 Results          97 
4.4 Discussion         107 
 
Chapter 5:  Over-expression of Withania somnifera tropinone reductase I in 
Solanum tuberosum cultivar Désirée.       111 
         
5.1 Introduction         112 
5.2 Materials and Methods        115 
 5.2.1 Production of transformation vectors     115 
 5.2.2 Biological replication       118 
5.3 Results          119 
                                                    
x 
 5.3.1 Transgene characterization       125 
 5.3.2 Growth and Phenotypic Characterisation               126
 5.3.3 Tuber and Root alkaloid content     128 
 5.3.4 Exogeneous tropinone leaf disc assays              131
 5.3.5 Exogeneous tropinone tuber sprout feeding assays   134 
5.4 Discussion         138 
5.4.1 Expression of trI       138 
5.4.2 Phylogenetic analysis of tropinone reductases    139 
5.4.3 Detectable endogenous tropane and associated alkaloid content  139 
5.4.4 Tropinone feeding assays        141 
5.4.4.1 Use of elicitors to potentially enhance tropine production 142 
5.4.5 Presence of high value tropane alkaloids     143 
5.5 Summary          145
       
Chapter 6: Effects of tropinone reductase II down-regulation and the simultaneous 
effects of tropinone reductase II down-regulation and WstrI overexpression in 
Solanum tuberosum.          146 
 
6.1 Introduction         147 
6.2 Materials and Methods        149 
 6.2.1 Production of plasmids and transgenics    149 
 6.2.2 Biological replication       149 
6.3 Results          152 
 6.3.1 Transgenic Characterisation      153 
 6.3.2 Growth and Phenotypic Characterisation    156 
 6.3.3 Tuber and Root alkaloid content     159 
 6.3.4 Exogeneous tropinone leaf disc assays     162 
 6.3.5 Exogeneous tropinone tuber sprout feeding assays   168







                                                    
xi 
6.3 Discussion         173 
 6.3.1 Expression patterns of trII       173 
 6.3.2 Phenotypic differences        174 
 6.3.3 The detectable endogenous nortropane and tropane alkaloid content  174 
6.3.4 Tropinone feeding assays      176 
6.3.4.1 The potential enhancement of transgene expression through the 
application of an elicitor       178 
6.3.5 The detectability of the high valued tropane alkaloids    179 
6.4 Summary          180
     
Chapter 7: General discussion       181
  
References          187 
          





















                                                    
xii 
List of tables 
 
1.1                    18 
Tropane alkaloid yield during differnet light regimes 
1.2            18        
Tropane alkaloid content in six tissues at different altitudes 
2.1           62 
HPLC running conditions  
2.2            63 
LC-MS/MS running conditions 
3.1.1           68 
Known tropane alkaloid fragmentation patterns 
3.3.1           72 
Column retention times for tropane alkaloids 
3.3.2            78 
Tropane alkaloid ions optimised for the QqQ-LC-MS/MS 
3.3.3            79 
Generated standard curve data for metabolites under investigation 
5.2.1            118 
















                                                    
xiii 
Tables in the Appendix: 
 
A.3.1           204 
Average relative abundance and Standard deviation of compounds used in the  
development of the detection method.  
A.3.2            205 
Data for metabolites associated with the tropane and nortropane alkaloid biosynthesis  
pathway used in the generation of the detection method used.  
A.3.3            206 
Numerical representation of metabolites detected in samples 
A.4.2.1           206 
Primers used in the synthesis and sequencing of recombinant protein vectors 
A.5.2.1           207 
Primer sequences and location of primer binding upon WstrI coding sequence used in 
this study.  
A.6.2.1           208 
Primers used in the production of down-regulation vector, sequencing and 
characterisation of transgenics within this study  
                                                    
xiv 
 
List of figures 
 
1.1            3 
Tropane alkaloid backbone. 
1.2                    7 
Tropane and nortropane alkaloid biosynthetic pathway in the Solanaceae.  
1.3           8 
Chemical structure of N-methyl-Δ1-pyrrolinium.  
1.4           8 
The first steps in the formation of tropinone 
1.5           9 
The tropinone branch point 
1.6           11 
The two proposed routes for the formation of hyoscyamine from littorine   
1.7           11 
Representation of the biosynthesis of scopolamine from hyoscyamine 
1.8            13 
Calystegine content from eight potato cultivars. 
1.9           13 
Calystegine content from thirteen potato cultivars. 
1.10           14 
Tribes within the Solanaceae   
1.11            15 
Movement of tropane alkaloid metabolites during biosynthesis 
1.12           17 
Represenation of pyridine alkaloids 
1.13           20 
Chemical structure of Cocaine 
1.14           25 
Type II and Type IIS restriction endonuclease cut sites 
1.15           25 
GoldenBraid methodology.  
1.16           27 
Domestication within the GoldenBraid 3.0 system.  
 
                                                    
xv 
 
1.17           28 
Generation of transcriptional units 
1.18           29 
Assembly of multiple units.  
1.19           32 
Representation of metabolite fragmentation and detection through the three different 
quadrupoles of the QqQ-LC-MS.  
2.1            41 
pGEM®-T Easy vector.  
2.2            42 
pET-28a(+) vector.  
2.3            43 
pUPD2 vector.  
2.4            44 
pDGB1_α1R vector. 
2.5            45 
pDGB3_α vector.  
2.6            46 
pDGB3_Ω vector. 
2.7            57 
Schematic representation of the completed protein transfer cell.   
3.1.1            66 
OrbiTrap™ electrode field scheme. 
3.3.1            70 
Alkaloid detection by TLC 
3.3.2            71 
HPLC chromatogram using tropane alkaloid standards 
3.3.3            71 
HPLC chromatogram of media spiked with tropane alkaloids 
3.3.4            73 
Tropane alkaloid chromatogram generated during method development on the 
OrbiTrap™.  
3.3.5            75 
Extraction methods differneces on tropane alkaloid recovery.  
 
                                                    
xvi 
 
3.3.6            76 
Chromatogram and detailed peak analysis from an extract analysed on the OrbiTrap™ 
3.3.7            79 
Fragmentation of scopolamine 
3.3.8            80 
Multiple Reaction Monitoring metabolite detection 
3.3.9            82 
Effects of LLE on metabolite recovery      
4.1.1            91 
Conversion of hyoscyamine to scopolamine by h6h 
4.2.1            94 
Translated Sth6h_A amino acid sequence in pET28a+ 
4.2.2           95 
Diagram of completed pET28a+_Sth6h_A vector 
4.2.3            95 
Diagnostic virtual and restriction endonuclease digestion images 
4.3.1            98 
Phlyogenetic relationships between h6h from potato and tropane alkaloid producers.  
4.3.2           100 
h6h amino acid alignments between species within the Solanaceae 
4.3.3            101 
qRT-PCR time course analysis of h6h in potato tissues 
4.3.4            102 
Western blot analysis of histidine tagges recombinant h6h 
4.3.5            104 
Tropane alkaloid biotransformation by Dsh6h and Sth6h at 16oC 
4.3.6            105 
Tropane alkaloid biotransformation by Dsh6h and Sth6h at 28oC 
4.3.7            106 
Functional assay to determine in planta h6h activity 
5.1.1            112 
Conversion of tropinone to tropine  
5.1.2            113 
trI protein sequence alignment.  
 
                                                    
xvii 
 
5.2.1            116 
Manufactured plasmid vectors and expected enzymatic digestion patterns.  
5.2.2            117 
gDNA electrophoresis for characterisation of transgenics 
5.2.3            117 
Characterisation by PCR for positive WstrI transgenic lines 
5.2.4            118 
RNA extraction and cDNA characterisation prior to qRT-PCR analysis 
5.3.1            119 
trI time course expression data from four tissues  
5.3.2            121 
Phylogenetic tree detailing tropinone reductase clusters across species which exhibit 
reductase activity 
5.3.3           122 
Amino acid sequence alignment of Solanaceous trI 
5.3.4            124 
Withania somnifera and potato trI amino acid sequence alignment                           
5.3.5            125 
WstrI transgenic characterisation. 
5.3.6            126 
Plant height measurements during growth of WstrI transgenics 
5.3.7            127 
Harvested fresh weight potato organ data 
5.3.8             128 
Analysis of growth characterics  
5.3.9            129 
Tuber metabolite analysis of selected transgenic lines 
5.3.10            130 
Root metabolite analysis of selected transgenic lines 
5.3.11            132 
Pseudotropine and tropine content from transgenic lines during leaf disc assays.  
5.3.12            133 
Tropinone reductase activity from transgenic lines during leaf disc assays 
 
 
                                                    
xviii 
 
5.3.13            135 
Detection of tropine alkaloids in sprouts from exogeneous feeding assays 
5.3.14            136 
Detection of tropane alklaoids in plantlets grown in the presence of methyl jasmonate 
and tropinone 
5.3.15            137 
WstrI and trII expression data from methyl jasmonate application assays. 
6.1.1            147 
The tropinone branch point.  
6.2.1            150 
Diagrammatic representation of vectors for the production of transgenics 
6.2.2             151 
Predicted and actual enzymatic digests of produced transformation vectors. 
6.2.3            151 
Electrophoresis gel of transgenic cassette 
6.3.1           152 
trII time course expression data from four tissues 
6.3.2            154 
Transgene expression data from characterisation of initial transgenics 
6.3.3            156 
Height measurements during growth of AstrII and WstrI/AstrII transgenics 
6.3.4           157 
Growth characteristics  
6.3.5                                 158 
Biomass of tissues from harvested transgenic lines 
6.3.6            159 
Tuber tropane and nortropane alkaloid metabolite content 
6.3.7            161 
Root tropane and nortropane alkaloid metabolite content 
6.3.8            163 
Pseudotropine and tropne content from Désirée leaf disc assays 
6.3.9            164 
Tropinone reductase gene expression during Désirée leaf disc assays 
 
 
                                                    
xix 
 
6.3.10           166 
Metabolite content from Bintje AstrII leaf disc assays. 
6.3.11           167 
trII gene expression during Bintje leaf disc assays 
6.3.12            169 
Alkaloid metabolite content in transgenic tuber sprouts during feeding assays 
6.3.13           170 
Detected tropane alklaoids in transgenic plantlets grown in the presence of methyl 
jasmonate and tropinone 
6.3.14            171 
WstrI and trII expression data from AstrII and WstrI/AstrII methyl jasmonate 
























                                                    
xx 
 
Figures in the appendix: 
 
A.5.2.1          207 
WstrI/ef-1α expression ratios for all plant lines characterised prior to the best performers 
being grown out in the glasshouse.  
A.6.2.1            208 
RT-qPCR analysis for all SttrII down-regulating lines prior to the best lines being 

































<     Less than 
>   More than 
µg/g    microgram/gram 
35s CaMV   35s Cauliflower Mosaic Virus 
B.C     Before Christ  
BRIC   Brazil, Russia, India and China 
CDS    Coding Sequence 
cDNA    complementary DNA  
CID   Collision Induced Dissociaton 
DAO   Diamine Oxidase 
ddH2O   double distilled water 
Ds    Datura stromonium 
DNA    Deoxyribonucleic acid  
DW    Dry Weight 
ef-Iα    elongation-factor-Iα 
FW    Fresh Weight  
gadph   Glyceraldehyde 3-phosphate dehydrogenase 
GCMS   Gas Chromatography Mass Spectrometry 
h6h    hyoscyamine-6β-hydroxylase 
HPLC-UV   High Performance Liquid Chromotography Ultra Violet 
IPTG    Isopropyl β-D-1-thiogalactopyranoside 
KCl   Potassium chloride    
LLE    Liquid-Liquid Extraction 
LB    Lysogeny Broth  
LOD   Limit Of Detection 
LOQ   Limit of Quantification 
mg/kg    milligrams/kilogram 
MRM    Multiple Reaction Monitoring 
MS 20   Murashige Skoog 20 
m/z    mass/charge ratio 
NADP(H)   Nicotinamide Adenine Dinucleotide Phosphate 
nptII    Neomycin phosphotransferase II gene 
PAV    Presence Absence Varients 
                                                    
xxii 
 
PCR    Polymerase Chain Reaction 
PDA   Photo-Diode Array 
pmt    putrescine-N-methyltransferase  
QqQ-LC-MS/MS        Triple Quadrupole Liquid Chromatography Mass Spectrometer 
RNA    Ribonucleic acid 
RT-qPCR   Real Time quantitative Polymerase Chain Reaction 
SAM    S-adenosylhomocysteine 
SASA    Science and Advice for Scottish Agriculture 
SDR    Short chain dehydrogenase/reductase 
SnRKI    sucrose-non-fermenting-I related protein kinase 
SOC    Super Optimal broth with Catabolite supression 
SPE    Solid-Phase Extraction 
St    Solanum tuberosum 
TBS-T   Tris-Buffered Saline with Tween 
t/ha    tons/hectare  
TLC    Thin Layer Chromotography  
trI    tropinone reductase I  
trII    tropinone reductase II 
TRL    Tropinone Reductase Like 
USA    United States of America 
VIGS   Virus Induced Gene Silencing 
WHO    World Health Organisation 
Ws    Withania somnifera 
           
 
       




































1.1 Natural products from plants 
 
Natural products are broadly defined as ‘chemical compounds produced by 
living organisms’ (Abdel-lateif et al, 2016). Natural products have a role in an 
organism’s physiology and can provide secondary benefits to the organism. Within 
plants, many natural products are secondary metabolites; these are chemical compounds 
which are not involved in the regular maintenance of the life cycles of the plants which 
synthesise them (Oksman-Caldentey and Inzé, 2004).  
 
During the early 1900s, plant-derived medicines from the root, leaves and bark 
accounted for 80% of medicines used. It is also estimated that currently 60% of 
anticancer compounds are produced from natural products (Abdel-lateif et al, 2016). 
There continues to be great emphasis on elucidating the pathways for the production of 
plant natural products as some synthetic drugs, in particular antimicrobials cause a 
number of negative side effects (Abdel-lateif et al, 2016). The World Health 
Organisation (WHO) have generated a list of 252 essential drugs, of these 11% are 
produced from natural products of flowering plants, which in 2002 were valued at 
US$30 billion just in the USA (Oksman-Caldentey and Inzé, 2004).   
 
More than 200,000 natural plant products have been discovered, and these can 
be divided into groups dependent on their chemical composition (Springob and 
Kutchan, 2009). One of the diverse groups is the alkaloids, and all the groups are 
produced through complex biosynthetic routes. A simple definition of an alkaloid was 
offered by Pelletier in 1983: ‘a cyclic compound containing nitrogen in a negative 
oxidation state which is of limited distribution in living organisms’ (Roberts and Wink, 
1998). The alkaloids are one of the most diverse groups of natural products, with 
humans having exploited these plant natural products for centuries (see section 1.3). 
Alkaloid diversity begins with the amino acid they are derived from; for example, the 
benzylisoquinoline alkaloids are derived from two tyrosine molecules whilst the 
pyrrollzidine alkaloids are composed of a necine base (hydroxymethylpyrrilizadine) 









1.2 Definition and occurrence of tropane alkaloids. 
 
Since 1983 the definition of tropane alkaloids has been refined to include the 
presence of two or more hydroxyl groups (Molyneux et al, 2002) along with the tropane 
ring which is the defining feature of these compounds (Figure 1.1, Philipov and 
Doncheva, 2013). The tropane alkaloids are a group of secondary metabolites produced 
by some members of the plant families Solanaceae, Erythroxylaceae, Convolvulaceae, 
Proteaceae and Rhizophoraceae (Jirschitzka et al, 2012; Philipov and Doncheva, 2013). 
Erythroxylum, more commonly known as the coca plant belongs to the family 
Erythroxylaceae and has been found to contain hygrine and cocaine. The plant family 
Convolvulaceae which includes Calystegia sepium is a source of nortropane alkaloids, 
known as the calystegines (Christen, 2000). Triunia montana (a member of the 
proteaceae) have been found to contain tropane alkaloids with side chains connected at 
either C2 or C4, such as darlingine (Yang et al, 2017) and Bruguiera sexangula 
(Rhizophoraceae) contain the alkaloid brugine (Griffin and Lin, 2000). In 2003 it was 
reported that there were over 12,000 known chemical alkaloid structures (Hashimoto 
and Yamada, 2003), but this figure increased to just over 27,000 by 2014, although 
there is uncertainty as to the validity of some of these compounds (Amirkia and 
Heinrich, 2014). Of these, over 200 are known to belong to the tropane alkaloids 











Figure 1.1: Tropane alkaloid backbone.  










Tropane alkaloids have been used for their inherent pharmaceutical properties 
throughout history, having been first used for their hallucinogenic properties, but now 
more for their action as anticholinergics or stimulants (Griffin and Lin, 2000).  
 
Some of the earliest evidence that indicates that humans were using plants which 
produced tropane alkaloids is from 4000 year old Assyrian clay tablets, where Atropa 
belladonna and other plants are mentioned (Wink, 1998). In both India and China, the 
use of alkaloid producing plants in medicine has been described as far back as 900 B.C 
and 3000 B.C respectively (Wink, 1998). Tropane alkaloids were first introduced into 
European medical practices by Romany immigrants with references being made in the 
17th Century (Griffin and Lin, 2000), but it was not until 1819 when the term alkaloid 
was used to describe these compounds by the German chemist, Carl Meiβner.  
 
Methods for extracting purified alkaloids became available from 1830 onwards 
with hyoscyamine amongst the first to be extracted (Grynkiewicz and Gadzikowska, 
2008). Around 1860 Western Civilisation first experienced specific tropane alkaloid 
preparations. These were preparations of scopolamine and hyoscyamine made by 
Australian Aborigines using the leaves and twigs of Duboisia hopwoodii, and was 
known as ‘pituri’ (Bernard, 1952), which during expeditions by Western botanists to 
Australia in the early to mid-1800s, were collected. This allowed investigations into the 
physiological effects of tropane alkaloids to occur.  
 
During World War II, the leaf of the current commercial tropane alkaloid 
producing plants was first studied for its alkaloid composition. Duboisia myoporoides 
and Duboisia leichhardtii were found to contain scopolamine and hyoscyamine in 
higher concentrations than the sources being used at the time (Atropa belladonna and 
Hyoscyamus spp.) (Barnard, 1952), this resulted in them being adopted as an industrial 










1.4 Recent uses. 
 
More recently, the use of plant derived drugs is on the increase, particularly 
those based on the tropane alkaloid skeleton such as scopolamine which has been shown 
to help in the treatment of motion sickness and hyoscyamine in the treatment of 
gastrointestinal disorders (Hashimoto et al, 1993; Oksman-Caldentey, 2007).  
 
Atropine, a tropane alkaloid which is formed by the racemization of (-)-
hyoscyamine, has uses in both ophthalmology and cardiology, where it is used for its 
analgesic and antispasmodic properties on the parasympathetic nervous system 
(Khanam et al, 2001; Palazon et al, 2003). Dependent on the dose administered, 
atropine can be used to treat both bradycardia and tachycardia. For the treatment of 
bradycardia, which is when an individual has a low regular heart rate, atropine is 
administered in low concentrations where it increases the firing of the sino-ventricular 
node. In cases of tachycardia, where a patient’s resting heart rate is over 100 beats per 
minute, atropine treatment at higher doses inhibits the sino-atrial node and reduces the 
heart rate. In both cases, and to varying degrees, atropine blocks the acetylcholine 
receptors within the heart muscular walls and can slow the heartbeat. The effects 
between both scopolamine and atropine have upon the central nervous system differ 
greatly, and this is thought to be due to the enhanced permeability of scopolamine to 
cross the blood-brain barrier.   
 
Scopolamine can cause drowsiness and fatigue making it effective as a motion 
sickness medication (Christen, 2000). According to Kumar et al (2010), the use of 
scopolamine through transdermal delivery systems for motion sickness was expected to 
have a market value of US$31.5 billion in 2015. In contrast the nortropane arm of the 
biosynthesis pathway, which leads to the production of the calystegines, which display 
strong glycosidase inhibition (Kaiser et al, 2006), is much less valued compared to the 
tropane alkaloids. The Brazil, Russia, India and China (BRIC) Diabetes Drugs Market 
report (Markets and Markets, 2018) indicated that diabetes mediation was worth US$8.7 
billion in 2014. This value is solely for diabetes medication and includes both the oral 








Glycosidase inhibitors can be used in the treatment of diabetes, as they block the 
breakdown of glucosides, reducing glucose release. Molyneux et al, (1993) 
demonstrated that a complex of Calystegine B1 (27%) and B2 (73%) from extracts of 
Calystegia sepium displayed potent inhibitory characteristics against β–glucosidase, 
with 50% inhibition being seen at a calystegine complex concentration of 0.6 µg/ml. 
Currently the nortropane alkaloids are not extracted for use as glycosidase inhibitors. 
However, due to the inhibition exhibited above, there is interest in utilising these 
compounds as antiviral or anticancer medication which could see their economic value 






























1.5 Biosynthetic Pathway. 
Figure 1.2: Tropane and nortropane alkaloid biosynthetic pathway in the Solanaceae.    
The tropane alkaloid pathway can be seen with the formation of tropine catalysed by the trI (EC 
1.1.1.206) enzyme, with subsequent catlysisation by the enzymes cyp80F1 (Q1A1B0-1) and h6h (EC 
1.14.11.11) (A). Whereas, the nortropane arm can be seen from tropinone and the action of trII (EC 
1.1.1.236), leading to pseudotropine formation (B). In both cases pmt (EC 2.1.1.53) is responsible for the 
formation of tropinone from ornithine.    
   A      B 
Calystegine A3 
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1.5.1 The shared pathway within the Solanaceae.  
 
The formation of tropane alkaloids begins with the precursor amino acid L-
ornithine (Philipov and Doncheva, 2013) which, in a reaction catalysed by ornithine 
decarboxylase, is decarboxylated to form putrescine. Putrescine undergoes methylation 
via the catalytic activity of putrescine N-methyltransferase (pmt) (Stenzel et al, 2006; 
Hashimoto et al, 1989) to produce N-methylputrescine.  N-methylputrescine is the 
substrate for N-methylputrescine oxidase (a diamine oxidase (DAO)) which catalyses an 
oxidative deamination reaction to produce N-methyl-Δ1-pyrrolinium (Hashimoto 1990; 
Dewick, 2009). The mechanisms behind the conversion of N-methyl-Δ1-pyrrolinium to 
tropinone are yet to be elucidated (Rocha et al, 2002), however, N-methyl-Δ1-
pyrrolinium is the substrate which is considered to be the branch point for other alkaloid 







Figure 1.3: Chemical structure of N-methyl-Δ1-pyrrolinium.  













Figure 1.4: The first steps in the formation of tropinone.        
Representation of the biosynthetic pathway for the formation of tropinone (IV) from L-ornithine (I) via N-
methylputrescine (II) and the N-methyl-Δ1-pyrrolinium (III) cation.  




















Tropinone serves as the substrate for two NADP(H) (Nicotinamide Adenine 
Dinucleotide Phosphate) dependent tropinone reductases (trI and trII) which have 
different stereospecificities (Nakajima et al, 1993; Robins et al, 1991). It is these 
stereospecifities which indicate which arm of the pathway (as shown in Figure 1.2) 
substrate flux is diverted to and refers to the isomer of the molecule present. In both 
cases the chemical formula is the same, but it is the orientation of the molecules which 
differs. Both trI and trII act upon the same 3α-hydroxyl group in tropinone and convert 
it to the 3α-hydroxytropane of tropine or 3β-hydroxyl of pseudotropine respectively 
(Figure 1.5). Both trI and trII belong to the short-chain dehydrogenase/reductase (SDR) 
family of enzymes, with the enzymes in this family sharing low sequence similarity (up 
to 30%) and are generally of about 300 amino acids in length (Brock et al, 2008). 
However, the similarity between trI and trII within the SDR family has been reported as 
64% across 260 amino acid residues (Nakajima et al, 1993). There is evidence for the 
presence of trI in Solanum tuberosum; however, its activity is poor, with speculation 
that its function is not devoted to tropane alkaloid biosynthesis (Kaiser et al, 2006). 
Manipulation of the trI arm of the tropane alkaloid biosynstheis pathway will be 
investigeated in Chapter 5, whereas, Chapter 6 is concerned with manipulation of both 












Figure 1.5: The tropinone branch point. 
Schematic showing the two compounds tropine (bottom left) and pseudotropine (bottom right) formed 









1.5.2 The tropane alkaloid arm 
 
The formation of tropine from tropinone is catalysed by trI, which is the start of 
the pathway to the high value tropane alkaloids hysocyamine and scopolamine. Tropine 
undergoes a condensation reaction with phenyllactate to form littorine (Lanoue et al, 
2002 and Dewick, 2009), however the enzyme(s) which catalyse this reaction are 
currently unknown. It is hypothesised that a co-enzyme A ester is involved, with Robins 
et al, (1994), suggesting the use of an ‘activated ester, such as co-enzyme A thioesters, 
or an alkaloidal ester’ as a substrate for the formation of littorine from work conducted 
on transformed root cultures of Datura stromonium and Duboisia leichhardti. 
 
Early suggestions were that the conversion of littorine to hyoscyamine required 
co-enzyme B12 as a cofactor, however this compound is not found in higher plants. This 
speculation was due to the similarity found in the conversion of methylmalonyl CoA to 
succinyl-CoA (Leete, 1990; Ollangnier et al, 1998).  Vitamin B12 is a source of 5`-
deoxyadenosyl radicals in bacteria and animals; S-adenosylmethionine (SAM) exhibits 
a similar function in plants (Ollangnier et al, 1998). Ollangnier et al, (1998) have also 
demonstrated that in the presence of exogenous SAM in Datura stramonium root 
cultures, hyoscyamine levels increased to 61% (compared to 3.5% in SAM deficient 
cultures), as measured by GC-MS (Gas Chromatography-Mass Spectometry).   
 
More recently a cytochrome P450 (cyp80f1) known as littorine 
mutase/monoxygenase has been identified, which catalyses the conversion of littorine to 
hyoscyamine (Li et al, 2006). In these experiments, the cytochrome P450 gene function 
was tested by virus induced gene silencing (VIGS) assays. Experimentally, in vitro it 
was found that (R)-littorine was mainly converted to hyoscyamine aldehyde and 
(2’R,3’R)-3’-hydroxylittorine by cyp80f1 as shown in Figure 1.6. In vivo experiments 
demonstrated that the suppression of this cytochrome P450 via VIGS resulted in 
littorine accumulation, whereas, overexpression of cyp80f1 in the roots of Nicotiana 
benthamiana supplemented with littorine showed a significant increase in hyoscyamine. 
Figure 1.6 depicts the two potential routes for the conversion of littorine to 
hyoscyamine.  
 





Figure 1.6: The two proposed routes for the formation of hyoscyamine from littorine. 
Schematic of the biosynthesis pathway from tropinone to scopolamine via 2 proposed routes – the SAM 
mediated pathway (upper route) or through use of cyp80f1 (Li et al, 2006) 
 
The final step in the biosynthesis of scopolamine is the hydroxylation and 
epoxidation of hyoscyamine to scopolamine via an intermediate 6β-Hydroxy-
hyoscyamine (anisodamine) with both reactions catalysed by the enzyme hysocyamine-
6β-hydroxylase (h6h) (Rocha et al, 2002). The first step of this reaction is to introduce a 
6β-hydroxyl group onto C6 of the tropane ring. Once this intermediate is formed, the 
same enzyme catalyses the formation of scopolamine; by closing the epoxide ring 
(Humphrey and O’Hagan, 2001). This is the removal of the hydrogen bound to oxygen 
at the C7 position of the tropane skeleton, and the oxygen then becoming bound to the 












Figure 1.7: Representation of the biosynthesis of scopolamine from hyoscyamine.  
Hyoscyamine being converted to scopolamine via the intermediate anisodamine (6β-hydroxy-
hyoscyamine) by the enzyme h6h. 




1.5.3 The notropane alkaloid arm 
 
Previous studies have shown that Solanum tuberosum (potato) tissues 
completely lack tropane alkaloids (Keiner and Dräger, 1999). However, alkaloids in the 
form of nortropanes are known to accumulate in some tissues (Griffiths et al, 2008 and 
Richter et al, 2005).  The first step in the nortropane alkaloid specific pathway is the 
formation of pseudotropine from tropinone, catalysed by the enzyme trII (Richter et al, 
2005). Within these studies it was ascertained that pseudotropine accumulated quicker 
than tropine, confirming the trII activity levels shown within potato (Dräger, 2006). 
Transcripts for trII have been shown to be present in all parts of Solanum tuberosum; 
however, some tissues do not exhibit trII enzyme activity due to unknown regulatory 
factors (Keiner et al, 2002). The calystegines, the biosynthetic compounds of 
pseudotropine, are a diverse group of compounds which all share the same tropinone 
background, with the difference between the compounds being the location and number 
of hydroxyl groups present, thus they are a family of polyhydroxy-nortropanes 
(Griffiths et al, 2008).  
 
There have been studies focused on the distribution of calystegines across some 
Solanaceous and Convolvulaceae plant tissues and these centre around nine of the most 
common (A3, A5, A6, B1, B2, B3, B4, C1 and N1), (Bekkouche et al, 2001; Schimming et 
al, 2005). These studies have documented the distribution of calystegines in potato 
tissues with levels reaching up to 316 mg/kg DW (Dry Weight) in the tuber flesh and up 
to 2581 mg/kg DW within the tuber peel (Friedman et al, 2003). Griffiths et al, (2008) 
analysed 4 Phureja and 5 Tuberosum (Solanum tuberosum Group Phureja and 
Tuberosum) lines and found that the concentration of calystegines were 100-fold higher 
in tuber sprouts than tuber flesh, and 8 times that of the peel for group Tuberosum, with 
similar results reported for calystegine concentration in Phureja lines. Calystegine 
levels are also known to decrease as the plant matures and tuberises (Keiner and Dräger, 
1999). Due to the ability of calystegines to act as glycosidase inhibitors the 
determination of alkaloid levels within the edible tuber has been extensively 
investigated. Friedman et al, (2003) and Petersson et al, (2013) determined the 
calystegine content of eight and thirteen potato cultivars respectively from the flesh and 
peel of the tuber individually as well as the tuber as a whole. They showed that there is 
significant variability in the calystegine content between cultivars studied. 




Figure 1.8: Calystegine content in eight potato cultivars.         
Total fresh weight calystegine content (mg/kg) of tubers from eight potato cultivars as described by 
Friedman et al, (2003).  
 
Figure 1.9: Calystegine content from thireteen potato cultivars.                                                
Total fresh weight calystegine content (mg/kg) of tubers from thirteen potato cultivars as described by 
Petersson et al, (2013).  
 
Petersson et al, (2013) noted that calystegine A3 and B2 are found at similar 
levels between cultivars (Figure 1.9), however this differs from the finding of Friedman 
et al, (2003) (Figure 1.8). This highlights that the levels of calystegines within potato 
are variable, with possible genetic and/or environmental reasons for the differences.  
One such external consideration for variability of calystegines is the storage conditions 
of potato tubers. In a summary, Keiner and Dräger (1999) describe this variability from 




two previous studies; the first conducted by Nash et al, (1995) reported a calystegine 
level of 100 µg/g in fresh potato peel, with the rest of the tuber being one tenth of this. 
Whereas, Asano et al, (1995) find that between 3.4 and 7 µg/g fresh whole tuber mass 
was calystegine. Keiner and Dräger (1999) deduced from this and other studies that 
calystegine content decreased within the sprouts, and that sprouts of eight months of age 
have approximately half the calystegine levels of those from tubers after five months of 
storage. Within tuber sprouts they demonstrated that after exogenous tropinone 
application, only pseudotropine was detected within sprouts. There were no tropane or 
nortropane alkaloids found within control assays.  
 
1.6 Production in the Solanaceae 
 
The Solanaceae family contains nearly 3000 species (Christen, 2000) and are 
comprised of two sub-families, the Solanoidea and the Cestroideae (Griffin and Lin, 
2000). These sub-families can be further divided into seven tribes (which is a secondary 
taxonomic rank between family and genus (IAPT, 2012). Tribe members are capable of 
producing tropane alkaloids in different quantities and specificities. The sub-family 
Solanoidea consists of four tribes: the Datureae, Solandreae, Solaneae and the 
Hyoscyameae with the remaining three tribes belong to the sub-family, Cestroideae. 
These remaining three are the Anthocercideae, Nicandreae and the Salpiglossidae 












Figure 1.10: Tribes within the Solanaceae.           
Diagrammatic representation of the lineage through the various taxonomic levels of tropane alkaloid 
producing members of the Solanaceae. 
 




The alkaloids produced by tribe members of this family can be separated into 
five different sub-groups: miscellaneous alkaloids, (such as hygrine and tropinone), 
monosubstituted tropanes (tropine, littorine), 3-6 disubsitituted tropanes (3,6-
dihydroxytropane), 3-substituted-6,7-epoxytropanes (scopine and scopolamine) and 
lastly 3,6,7-trisubstituted tropanes (meteloidine) (Doncheva et al, 2006).  
 
Tropane alkaloid biosynthesis is known to take place in the roots with 
subsequent transport and accumulation in the leaves from which they are harvested 
(Hashimoto et al, 1986). More specifically, the formation of N-methylputrescine from 
ornithine occurs in the root pericycle, whilst tropinone and tropine biosynthesis and 
conversion occurs in the endodermal cells (Ziegler and Facchini, 2008). Once tropine 
has been synthesised, it is transported to the root pericycle for hyoscyamine and 
scopolamine synthesis and these are then exported (Ziegler and Facchini, 2008).  
 
Figure 1.11: Movement of tropane alkaloid metabolites during biosythesis.               
Diagrammatic representation for the pathway of metabolite movement during tropane alkaloid 
biosynthesis within the roots of producing species. Red dashed arrows show the perceived metabolite 
translocation between cellular tissue types and the blue arrows show enzymatic reactions. (Adapted from 
Ziegler and Facchini (2008)) 




Leaves from commercial Duboisia hybrids typically contain 2-4% DW tropane 
alkaloids (Ciba Foundation, 1988), with generally 60% scopolamine and 30% 
hyoscyamine. The remaining 10% is comprised of associated alkaloids. Through 
commercial cultivation, in some countries, varieties are able to accumulate up to 6% dry 
weight in their leaves, producing a total tropane alkaloid yield of 1t/ha (Palazon et al, 
2008). Commercially, tropane alkaloids are extracted from hybrid cultivars of Duboisia 
leichhardtii x myoporoides, which are native to Queensland and surrounding regions of 
Australia (Dräger, 2006; Griffin and Lin, 2000).  
 
Hybrids of Duboisia leichhardtii x myoporoides are the main source of 
production of these high valued tropane alkaloids. The interest in obtaining tropane 
alkaloids commercially began in earnest in 1940, initially from wild plant species before 
progressing onto a more industrial scale. In the early 1950’s, the pharmaceutical 
company Boehringer Ingelheim launched Buscopan® (Ohlendorf, 1996). The way in 
which Buscopan® works is through the application of an antispasmodic action to the 
muscle lining of the gastrointestinal tract, making it suitable in the treatment of Irritable 
Bowel Syndrome (IBS). Duboisia hybrids are cultivated at altitudes exceeding 500 
metres above sea level, but there is regional variation in the tropane alkaloid produced. 
This variation in tropane alkaloid accumulation has been attributed to the variety 
differences of Duboisia myoporoides. The southern pyridine variety exhibiting limited 
tropane alkaloid accumulation. The southern varieties produce higher concentrations of 
the pyridine alkaloids nicotine and anabasine (Gritsanapan and Griffin, 1991). 
Structurally, this different class of alkaloids do not exhibit the skeleton shown in Figure 
1.1, but contain the structure in Figure 1.12 (Plunkett, 1991).  For example scopolamine 
is the main tropane alkaloid produced in a region to the North of Gosford, New South 
Wales, whereas hysocyamine is the predominant tropane alkaloid when plants are 
grown to the South of Gosford (Gritsanapan and Griffin, 1991), with anabasine and 
nicotine being the dominant alkaloids when grown in regions of Queensland (Griffin 


















Figure 1.12: Represenation of pyridine alkaloids.                        
Left is a schematic of the pyridine ring, which is the common feature in pyridine alkaloids. Right is the 
chemical skeleton of the pyridine alkaloid nicotine. 
 
In the late 1940s it was noted that it was possible to isolate Duboisia ‘types’ 
which are adapted to a wide range of environmental conditions and can produce tropane 
alkaloids of interest singularly, or proportionally together depending on the 
environmental and genetic nature of the material (Barnard, 1952). Field trials conducted 
by Boehringer Ingelheim, showed changes due to ‘genotype x site interactions’ as well 
as the age of the plant resulting in a decrease in yield of all alkaloid types produced. 
This led to identification of hybrid clones in which tropane alkaloid production was less 
impacted by the effect of external factors (Ohlendorf, 1996).  
 
It has been suggested that tropane alkaloids such as hyoscyamine and 
scopolamine can be used as ecophysiological markers (Vanhaelen et al, 1991). It has 
been shown that the ratio between these two tropane alkaloids decreases through plant 
development (Table 1.1 and 1.2). Altitude and water stress have also been shown to 
influence accumulation of tropane alkaloids, depending on the vegetative cycle of the 
plant. For example Datura metel plants grown at lower altitudes had decreased 
accumulation of tropane alkaloids, whereas Datura inoxia grown at altitude had 
decreased tropane alkaloid accumulation due to slower growth rates (Vanhaelen et al, 
1991). Water stress has been shown to generally increase alkaloid content and 
conversely alkaloid levels decrease during wet periods (Vanhaelen et al, 1991), this is 
similar to the findings of Griffin and Lin, (2000).  
 
From 1950 to 2010 average rainfall in New South Wales has fallen from ~600 to 
~500mm per year, and there has been an average increase of daily temperatures across 
Australia of 0.7oC from 1960  (NSW Government, 2011). Due to the changing 




environmental conditions, and as demand for tropane alkaloids is increasing, it is 
becoming of greater importance to try and ascertain other sources for the commercial 
production of tropane alkaloids, with work conducted on hairy root cultures of 
Hyoscyamus niger (Jaremicz et al, 2014) as well as other Solanaceous species with a 











Table 1.1: Tropane alkaloid yield during differnet light regimes.        
Scopolamine and hyoscyamine yield at different growth stages and under different day lengths from 
Datura metel (mg/100g DW leaves). Stage 3 – flower bud appearance, Stage 4 – first flower bloom, Stage 
5 – fruit maturation, Stage 6 – 3 to 5 month old plant.  
 
Site Altitude (m) Roots Stem Leaves Flower Fruit Seeds 
Bombay Sea level 0.27 0.19 0.25 0.69 0.06 0.09 
Poona 563 0.52 0.29 0.32 0.86 0.79 0.1 
Pachmari 716 0.71 0.43 0.54 0.95 0.084 0.14 
Darjeeling 2166 0.89 0.46 0.58 0.99 0.097 0.19 
 
Table 1.2: Tropane alkaloid content in six tissues at different altitudes.                
Tropane alkaloid content as a percentage dry weight from Datura metel tissues when grown at different 
altitudes (adapted from Vanhaelen et al, 1991). 
 
The development of tropane alkaloids within the plant has been implicated in 
both plant and herbivore defensive mechanisms (Wink, 1998; Nash and Watson, 1995; 
Freitas et al, 1996). This has been indicated through various studies, and is not limited 
to the tropane alkaloid arm of the pathway. Wink (1988) discussed how alkaloids can be 
toxic to some vertebrates and arthropods, with atropine being utilised as an insect 
repellent. Nash and Watson, (1995) demonstrated that Lepidoptera (an order of insects 
  
Stage 
Light Period (h) Alkaloid 3 4 5 6 
16 
Scopolamine (S) 3 13.5 11 12 
Hyoscyamine (H) 0.5 3 8.5 17 
Total 3.5 16.5 19.5 29 
S/H ratio 6 4.5 1.3 0.7 
9 
Scopolamine (S) 2 4 9 7 
Hyoscyamine (H) 0.05 3 5 9 
Total 2.5 7 14 16 
S/H ratio 4 1.3 1.8 0.8 




which includes butterflies and moths) feed on members of the Solanaceae. These insects 
ingest calystegines and other glycosidase inhibitors to make themselves more 
unpalatable to predators and so reduce the rate of predation upon them. Freitas et al 
(1996), built further on this by showing that the storage of tropane alkaloids by larvae of 
Placidula led to strong rejection by vertebrates, and that this is probably a primitive trait 
to help in the survival of the young.  
 
It has been suggested that methyl jasmonate has a part to play in the tropane 
alkaloid biosynthesis pathway (Kang et al, 2004). Up-regulation of the genes along the 
tropane alkaloid biosynthetic pathway has been achieved through incidents of wounding 
from herbivorous insects. When Dendrobium nobile was treated with methyl jasmonate, 
trI mRNA levels were found to be enhanced (Chen et al, 2013), this is a homologous 
gene to the putative trI from Solanum tuberosum or the known trI from other 
Solanaceous species. Levels of scopolamine have been shown to increase in 
Brugmansia suaveolens when treated with methyl jasmonate, which resulted in a 
decrease in herbivory compared to control plants (Arab et al, 2012). Other studies 
which looked at the effects of methyl jasmonate on the production of tropane alkaloids 
found that pmt and h6h expression levels increased, which lead to an increase in 
hyoscyamine, N-methyl-putrescine and nicotine concentrations in the species being 
studied (Kang et al, 2004; Ryan et al, 2015). 
  
There is some evidence to suggest that calystegines can be degraded by 
microbes in the rhizosphere. A single strain of Rhizobium meliloti (strain 41) was 
reported to convert calystegines due to the presence of the pRme41a plasmid (Tepfer et 
al, 1988). R. meliloti 41 was able to catabolise calystegines to use them as a carbon and 
nitrogen sources, whereas R. meliloti 41 deficient in the pRme41a plasmid could not. 
This catabolic selectivity within strains of Rhizobium infers that calystegines, through 
nutritional selection, can have a minor effect on the ecology of the rhizosphere. This 
effect is minor as pRme41a deficient bacteria are able to continue the symbiotic 
relationship with Medicago hosts, and that calystegine catabolism is not linked to the 









1.7 Evolution in plants. 
 
Phylogenetic comparisons between members of the Solanaceae and 
Erythroxylaceae suggest that the last common ancestor is likely to have been in 
existence approximately 120 million years ago (Magallon and Castillo, 2009). This 
suggests either that the tropane alkaloid biosynthesis pathway is ancient and/or that it 
has evolved independently in these two families.  Jirschitzka et al, (2012) support this 
second theory as they demonstrated that the tropinone reduction step in the biosynthetic 
pathway is catalysed by members of two different enzymatic classes in the Solanaceae 
and Erythroxylaceae.  In the Solanaceae, this reaction is catalysed by two tropinone 
reductases (trI and trII) which belong to the short-chain dehydrogenase/reductase 
enzyme family (SDRs) whereas in the Erythroxylaceae a methylecgonone reductase (an 
aldo-keto reductase) catalyses this step. Furthermore, Jirschitzka et al, (2012) argue that 
as biosynthesis occurs in the roots and then the metabolites are translocated to the 
leaves in the Solanaceae whereas the site for biosynthesis in the Erythroxylaceae is in 
the young leaves, which gives extra emphasis on the different evolutionary lineage. 
Figure 1.13 shows the chemical structure of cocaine, a tropane alkaloid produced by 










Figure 1.13: Chemical structure of cocaine.                    
Cocaine is produced by Erythroxylum coca (from the Erythroxylaceae), with the tropane skeleton visible 
on the left-hand side of the structure.  
 
1.8 The short-chain dehydrogenase/reductase superfamily.  
 
Both trI and trII belong to the SDR enzyme superfamily, one of the most ancient 
protein families known, with examples present in all current taxonomic domains of life 
(Moummou et al, 2012).  Within these domains there is protein sequence divergence, 




with typically only 15 – 30% residue identity between sequences (Kallberg et al, 2002). 
There are however universal characteristics that all the SDRs share. These 
characteristics include the YxxxK catalytic motif, ‘Rossmann-fold’ β-sheets with α-
helices on each side and other conserved cofactor binding motifs (Moummou et al, 
2012; Kallberg et al, 2002).  
 
There are reported to be 7 different types of SDRs; one sub-type, the tropinone 
reductase-like SDRs (TRLs) have been grouped with the classical SDRs, which also 
includes the true tropinone reductase group ‘SDR65C’ with these groups having been 
characterised by the SDR nomenclature initiative (Reinhardt et al, 2014). Although the 
TRL sub-group of SDRs show similarity to known active tropinone reductases, there 
has been limited functionality demonstrated with only Cochlearia officinalis tropinone 
reductase (Brassicaceae) and Dendrobium nobile trI (Orchidaceae) catalysing the 
conversion of tropinone to both tropine and pseudotropine (in the case of Cotr) and 
tropine in the case of DntrI (Reinhardt et al, 2014). Other annotated TRL enzymes (such 
as those from Arabidopsis thaliana) are unable to catalyse the reduction of tropinone, 
but have been shown to have an effect on lipophilic and monoterpene ketones, 
suggesting that there is limited binding space within the active sites (Reinhardt et al, 
2014). It has also been suggested that specific His and Glu residues in trI and trII 
respectively are critical in ensuring tropinone is correctly orientated for the reaction to 
take place (Brock et al, 2008).  
 
1.9 Solanum tuberosum: the potato.  
 
The origins of the modern cultivated potato stem from its domestication in the 
Andean region of South America (The Potato Genome Sequencing Consortium, 2011) 
around 8000 years ago (Ortiz and Mares, 2017). Whilst the New World was discovered 
by Columbus in 1492, it was not until the 1530’s that the potato made its way to 
European shores with the first historical recording of the potato being from 1537 
(Hawkes and Francisco-Ortega, 1993). The use of potato as a food source suffered early 
scepticism in Europe due to its lack of adaptation to the longer day lengths in the more 
northerly geographic region, leading to the production of small tubers. Additionally, 
botanists of the time noticed its similarity to other members of the Solanaceae and 
suspected that it may be poisonous (Brown, 1993). Once this initial scepticism was 
overcome, potato became an important staple for the masses and in particular the poorer 




classes of the time, due to its un-burdensome needs from planting to harvest. Some 
anecdotal links between the rise of the use of potato as a food source and the population 
explosion seen in Ireland between 1790 and 1845 have been attributed to the ease in 
production and the lack of interest from higher societal classes (Brown, 1993). More 
recently the potato has become known as a food security crop and China, which is the 
world’s largest producer and consumer of potato, is turning to it as its main source of 
food security (Ortiz and Mares, 2017). Within the developed world production in 2009 
reached 330 million tonnes (The Potato Genome Sequencing Consortium, 2011) which 
increased further to 376.8 million tonnes in 2016 (FAO, 2018). 
 
The modern cultivated potato has become a staple food source due to its high 
nutrient content; it is rich in Vitamin C and B6 as well as containing high quantities of 
potassium, fibre and further B complex vitamins and other associated minerals (Ortiz 
and Mares, 2017).  
 
Potato is a clonal crop with many different species and landraces under 
cultivation. Due to the clonal nature of reproduction and the relatively small number of 
species initially introduced to Europe, potato exhibits a ‘narrow genetic base’ (The 
Potato Genome Sequencing Consortium, 2011). This has led to some barriers through 
disease susceptibly and adverse effects attributed to inbreeding, when attempting to 
improve cultivars in the past (The Potato Genome Sequencing Consortium, 2011). 
Many potato cultivars are autotetraploid (containing four copies of the genome) and 
suffer from inbreeding depression. Potatoes contain a set of 12 non-homologous 
chromosomes with a total genome size of 844 megabases which encode for 39031 
transcripts (The Potato Genome Sequencing Consortium, 2011). The duplication events 
which have led to the multiple copies of the genome being present are thought to have 
happened with the divergence of potato and grape ~ 89 million years ago, with a further 
duplication event occurring within potato ~ 67 million years ago (The Potato Genome 
Sequencing Consortium, 2011).  
 
The resulting effect of these duplications towards inbreeding depression can be 
seen through frameshifts, the development of premature stop codons or even in 
presence/absence variants (PAV). Frameshifts have the ability to change gene function 
due to representation of different amino acids, thus resulting in different proteins being 
encoded; premature stop codons will cause translation to stop and as a result the protein 




which is formed will be shorter in length and functionality will be affected. PAV are 
lines from the same species or cultivar in which a specific sequence is located in one 
genome, but missing from another (Springer et al, 2009).  
 
1.10 Manipulation of the potato genome and tropane alkaloid biosynthesis 
pathway 
 
As potato does not produce tropane alkaloids the pathway must be manipulated 
through genetic engineering by the introduction of known functional alkaloid 
biosynthetic genes. This process of increasing secondary metabolites by introducing a 
foreign gene to alter a biosynthetic pathway has been previously demonstrated to be 
effective in potato. Examples which demonstrate this have been shown on various 
biosynthetic pathways such as the carotenoid/flavonoid and starch pathway (Hichri et 
al, 2010; Simo et al, 2014).  Ducreux et al, (2005) introduced the phytoene synthase 
gene crtB from Erwinia uredovora into Solanum tuberosum cultivar Desiree and 
Solanum phureja. Through this approach, Ducreux et al, (2005) showed that there was a 
6.3 fold increase in carotenoid accumulation in cultivar Desiree (5µg up to 35 µg DW), 
and in Solanum phureja the increase was from 25 µg to 78 µg DW in the best line.  
 
McKibbin et al, (2006) overexpressed the sucrose non-fermenting-1-related 
protein kinase (SnRK1) in Solanum tuberosum cv. Prairie. Using this approach they 
demonstrated that there was an increase of up to 167% SnRK1 activity in 3 transgenic 
lines and this led to a decrease of up to 83% in glucose and a 30% increase in starch 
levels compared to wild type controls. These are only two cases out of many which help 
demonstrate that Solanum tuberosum is a viable candidate for genetic transformation. 
 
Attempts to manipulate the tropane alkaloid biosynthesis pathway have been 
made in a number of Solanaceous species. Moyano et al, (2002) overexpressed pmt 
from Nicotiana tabacum in stable Duboisia hybrid hairy root transgenics resulting in a 
2-4 fold increase in N-methylputrescine levels compared with the wild type. However 
there was no increase in downstream tropane alkaloid production. Jouhikainen et al, 
(1999) were concerned with enhancing scopolamine production in Hyoscyamus muticus 
through genetic engineering of root cultures. In their study, h6h from Hyoscyamus niger 
was transformed into Hyoscyamus muticus root cultures and they demonstrated that 
scopolamine content was raised to 17 mg/l, almost 100 times greater than experimental 




controls. Rocha et al, (2002) utilised particle bombardment to produce stable transgenic 
lines of Nicotiana tabacum where two Hyoscyamus niger cDNAs which encoded trI 
and h6h were introduced.  Although Rocha et al, introduced trI and h6h from 
Hyoscyamus niger, with the measurable effect primarily focused upon the nicotine 
biosynthesis pathway, with an almost 13 times increase in nicotine present (up to 149 
µg/g FW (Fresh Weight) in controls to up to 1430 µg/g FW in transgenic lines). 
   
1.11 Modular cloning methodology.  
 
As Solanum tuberosum and the tropane alkaloid biosynthesis pathway are 
readily manipulated, it is worth discussing techniques for metabolic engineering. In 
recent years there have been new developments in molecular cloning techniques which 
allow the efficient recombination of vector and cassette sequences in a single restriction 
ligation reaction.  
 
The most recent developments have stemmed from BioBrick, which was 
described and released by Knight (2003). The BioBrick system is based on the use of 
Type II restriction enzymes, such as EcoRI and XbaI. These enzymes create 4 base 
overhangs, or ‘sticky ends’. Sequences with the complementary bases are able to 
recombine with. Further developments to this system have been made in the Golden 
Gate system, where Type IIS restriction enzymes are used. The differences between the 
Type II system of BioBrick and the Type IIS system of Golden Gate is that the Type IIS 
restriction enzymes are able to recognise non-palindromic sequences (that is sequences 
which do not read the same whether read from the 5’ or 3’ end).  Type IIS enzymes 
cleave DNA outside of the enzyme recognition site (shown in Figure 1.14) (Patron et al, 
2015). There are a potential 256 potential overhang sequences using Type IIS enzymes 
which allow the construction of multiple fragments of DNA using different 
combinations of overhang sequences. Following recombination, correctly ligated DNA 
products do not contain the enzyme recognition sites and therefore cannot be cut again 










           Type II                     Type IIS 
 
  G A A T T C N N N N       G G T C T C N N N N N N N  
  C T T A A G N N N N      C C A G A G N N N N N N N  
 
G A       A T T C N N N N    G G T C T C N        N N N N N N  
C T  T A A G     N N N N    C C A G A G N N N N N      N N  
 
Figure 1.14: Type II and Type IIS restriction edonuclease cut sites.     
Example of Type II and Type IIS enzyme cut sites used in the BioBrick and Golden Gate/GoldenBraid 
cloning systems. Left is a type II EcoRI recognition site and right BsaI used in the Type IIS system. The 
overhangs created are illustrated, N denotes unknown base depending on the system. 
 
The original Golden Gate cloning system has been converted to allow 4 base 
overhangs or ‘fusion sites’ which are compatible across all parts that the system may 
require, whether promoter, terminator or coding sequence. This compatibility has been 
utilised in the MoClo and GoldenBraid 2.0 system, allowing for almost 100% 
interchangeability of parts between these systems (Patron et al, 2015). Both the MoClo 
and GoldenBraid 2.0 systems result in scarless recombination, unlike other methods 
such as Gateway cloning which in some cases leaves up to a 21 base scar between 
building blocks (Sarrion-Perdigones et al, 2013). Figure 1.15 illustrates the MoClo and 
GoldenBraid 2.0 syntax, showing the overhang fusion sites which are used in the 
potential part recombinations. An example of a simple promoter 5’ UTR, coding 









Figure 1.15: GoldenBraid methodology               
A schematic of the methodology used within the GoldenBraid cloning system which shows the 4 
nucleotide fusion sites at each junction as well as regions that parts represent from the GoldenBraid 
library (adapted from Patron et al, 2015). 




GoldenBraid was developed by the Plant Genomics and Biotechnology group at 
the Instituto de Biología Molecular y Celular de Plantas at the Universitat Politècnica de 
València, Spain (https://gbcloning.upv.es). The vectors in the GoldenBraid system are 
based on previously reported plant vectors used in transformation which have been 
modified for the cloning system. The main changes are to the existing restriction sites 
used around the Multiple Cloning Site (MCS) (Sarrion-Perdigones et al, 2013).  
 
The GoldenBraid system allows the production of GBparts by multiple labs to 
be deposited in a central location and to be used by others. The repository can be 
searched (https://gbcloning.upv.es/search/) for the cassette element required and 
requested (https://gbcloning.upv.es/order/) directly. This allows the easy exchange of 
GBparts and elements which are known to work between researchers saving valuable 
time and making cloning strategies more efficient.   
 
The cloning strategy for assembling a binary transformation construct using the 
GoldenBraid system which can be used in Agrobacterium tumefaciens mediated 
transformations, is a three stage process and is outlined below in Figures 1.16 through 






















Step 1: Domestication (the generation of GBpatches) 
 
Domestication of a sequence refers to the addition of a 4 base overhang and the 
removal of Type IIS recognition sites used in the downstream cloning strategy within 
the sequence of interest. Using the software available at 
https://gbcloning.upv.es/do/domestication/ primer design is conducted for the first step 
in the GoldenBraid cloning strategy. The software allows the CDS of the gene being 
investigated to be adapted to the GBpatch (described in Figure 1.16) as well as 
introducing the restriction sites to allow ligation into pUPD2 (2.2.3.1). Once the 
GBpatch is ligated into pUPD2, it is referred to as a GBpart. pUPD2 is a high copy 
number T-vector and allows for easy characterisation through sequencing of the inserted 


















Figure 1.16: Domestication within GoldenBraid.       
Domestication of a cloned gene fragment using the GoldenBraid 3.0 system. Gene fragments containing 
compatible restriction site overhangs designed using the GbCloning domestication software are ligated 
into the pUPD2 vector through a restriction endonuclease-ligation reaction using the restriction 








Step 2: Construction of the transcriptional unit 
 
 The GoldenBraid repository has GBparts for promotors, terminators and other 
useful sequences available that will allow the easy and rapid generation of a complete 
transcriptional unit with the GBpart containing the gene under investigation from Step 
1. To produce the transcriptional unit, these GBparts are recombined into the α level 
plasmids (pDGB3_α) through the use of the restriction endonuclease BsaI. This reaction 
occurs in a single tube and can be transformed directly into E. coli once the reaction is 
complete. The 35s CaMV (Cauliflower Mosaic Virus) promoter is a strong constitutive 























Figure 1.17: Generation of transcriptional units.          
Construction of a transcriptional unit using a domesticated gene of interest and promoter and terminator 
GBparts. The pUPD2 vector containing the gene of interest is combined with two pre-prepared GBpart 
vectors containing the CaMV 35s promoter and Tnos terminator using an endonuclease–ligation reaction 
to in the presence of a pDGB3_α series ‘destination’ binary vector to form a functional gene cassette. The 
completed gene cassette is constructed in the correct orientation due to the specific overhangs produced 
by the Type IIS restriction enzymes used. 
 
 




Step 3: Construction of multipartite constructs 
 
The generation of multipartite constructs, that is, constructs with two or more 
transcriptional units can be achieved using a GoldenBraid cloning strategy. This 
strategy, in a single restriction endonuclease and ligation reaction is able to take 
complete transcriptional units from α level vectors, and insert them together into a Ω 
level destination vector. The strategy is outlined below, and is completed with the 
generation of the transcriptional units, due to the four base ‘fusion tag’ ensuring 





























Figure 1.18: Assembly of multiple units.          
Binary assembly of multiple transcriptional units into the pDGB3_ Ω1 vector. Using the pDGB3_α2 
construct containing a transcriptional unit with the gene of interest and a second GBpart vector, 
pDGB1α_1R containing the nptII gene (GBpart, GB0034) a final restriction endonuclease and 
recombination reaction is used to generate the final construct in the pDGB3_Ω1 vector. The completed 
construct confers antibiotic selection in transformed explants. 




1.12 Methods used for the detection of tropane alkaloids.  
 
Many recent studies into tropane alkaloids have used Thin Layer 
Chromatography (TLC), High Performance Liquid Chromatography (HPLC), Gas 
Chromatography Mass Spectroscopy (GC-MS) and more recently Triple Quadrupole 
Liquid Chromatography Mass Spectroscopy (QqQ-LC-MS) to quantify the presence of 
alkaloids within samples (Dräger, 2002; Steenkamp et al, 2004; Zhou et al, 2017).  
 
1.12.1 Thin Layer Chromatography 
 
TLC can be applied to separate molecules of interest by a solvent on a stationary 
phase and then detected through specific derivatizing chemicals. The polarity of this 
stationary phase has been shown to have an effect on the separation and detection of 
tropane and nortropane alkaloids. Detection of calystegines  using TLC shows 
differences in retention factor (Rf) values for the different classifications of calystegine 
as well mobile phases used in separation, summarised in Dräger (1995, 2002).  
 
TLC has its advantages, such as high sample throughput, rapid analysis times, 
limited extraction and clean up requirements and finally, the availability of specific 
alkaloid detection and derivatizing chemicals (Kokotkiewicz et al, 2017). TLC has been 
demonstrated to be effective in both plant (Keiner and Dräger, 1999) and bacterial 
assays (Coa et al, 2015). Detection of tropane alkaloids uses the derivatizing solution, 
Dragendorff reagent, or a variation, the Dragendorff Munier reagent.  Dragendorrf 
reagent contains a mixture of bismuth nitrate, acetic acid and potassium iodide which 
reacts with alkaloids present. In the presence of high nortropane alkaloid concentrations 
a light pink spot is produced (Dräger, 1995). Dragendorff Munier replaces the acetic 
acid with tartaric acid, producing a light purple spot on a yellow background to a 
sensitivity of 0.1 µg of tropine and pseudotropine (Keiner and Dräger, 1999).  
Calystegine detection via TLC uses a silver nitrate reagent for detection, with the LOD 










1.12.2 HPLC-UV  
 
        HPLC-UV utilises UV detection to determine compounds within a sample being 
analysed.  Whilst not as quantitatively accurate compared to other LC systems to be 
used in this study, the instrumentation is suitable for the detection and estimation of 
compounds of interest. 
            
The use of photo-diode array detectors (PDA) for confirmation of the presence 
of tropane alkaloids in a multitude of sample preparations has been investigated 
thoroughly. Steenkamp et al (2004) demonstrated that the LOD and LOQ (limit of 
quantification) for PDA detection of both atropine and scopolamine were 1 µg/ml and 
10 µg/ml respectively. Tamerdashev et al, (2012) also demonstrated that it is possible to 
determine the concentration of atropine and scopolamine from different Datura metel 
organs using an HPLC-UV system. The LOQ in this study was 3 µg/ml for both 
metabolites. 
 
1.12.3 Gas Chromatography Mass Spectroscopy (GC-MS) 
  
 GC-MS has been previously used in studies primarily concerned with the 
extraction and quantification of the calystegines (Friedman et al 2003; Keiner et al 
2000; Griffiths et al 2008); however, it has also been used to show if there is any 
change in metabolite flux towards the tropane alkaloid biosynthetic pathway during 
feeding assays (Keiner and Dräger, 1999). GC-MS involves sample extracts being 
derivitised in the presence of N-methyl-N-trimethylsilytrifluoroacetamide, producing 
silyated esters (Griffiths et al 2008; Keiner and Dräger 1999). These esters make it 
easier to detect the compound of interest using the specific chromatography.  
  
Detection limits for metabolites along the tropane and nortropane alkaloid 
biosynthetic pathway have been described. The LOD for the calystegines has been 
reported as approximately 1µg/ml, with the LOQ being 10µg/ml (Keiner et al 2000, and 
Keiner and Dräger, 1999). The LOD for the tropane alkaloids tropine and tropinone is 
reported as 10µg/ml, whereas pseudotropine is 50µg/ml, suggesting that the GC-MS 
system was more sensitive for the calystegines than the tropane alkaloids being 
investigated in the Keiner and Dräger, (2000) study.  
 




1.12.4 Agilent Triple-quadrupole LC-MS (QqQ-LC-MS) 
 
A feature of the QqQ-LC-MS systems is that they need to detect and isolate 
multiple specific parent ions in a mixture, fragment them through collisions and then 
detect the unique representative product ions in the mixture and quantify them 
(Kitteringham et al, 2009). From their inception as radio frequency traps, quadrupole 
LC-MS has become more sophisticated allowing tandem mass spectrometry (MS/MS) 
to be implemented. This has enabled collision induced dissociation (CID) assays to be 
conducted (Perchalskl et al, 1982). Changes in radio frequencies (RF) cause ions to be 
ejected from the ion trap at different times due to increases in resonation (measured in 
kHz).  This technique, known as ‘resonant ejection’ overcomes issues which can arise 
from mass/charge ratios and the influence other ions may have within the ion trap 
(March, 1997). In turn this increases the resolution of the mass scans.   
 
Fragmentation patterns for individual metabolites can be coupled together to 
enable the detection of multiple metabolites within a sample. This is known as a 
multiple reaction monitoring (MRM) analysis. Ions which are being targeted need to be 
predetermined for this to take place (Kitteringham et al, 2009) and Figure (1.19) below, 
shows a schematic representation of this ‘optimization’ process through the three 
quadrupoles. Any QqQ-LC-MS machine is capable of being used for this type of 
analysis. 
 
Figure 1.19: Representation of metabolite fragmentation and detection through the three 
different quadrupoles of the QqQ-LC-MS.          
Parent ions are analysed in quadrupole one, (in this representation scopolamine is shown), before moving 
into the collision quadrupole where fragmentation takes place via CID. The fragments produced in 
quadrupole two are analysed for the abundance of each ion. The most abundant fragmented ions are then 
selected to be representative ions of the parent metabolite. In quadrupole three, selected daughter ions are 
screened for in the samples presented to quantitatively determine the amount of the initial parent present 
in the sample.  The fragmented ions shown in quadrupole two are four generated from Zhou et al, (2017). 
        Quadrupole One                                     Quadrupole Two                                  Quadrupole Three 




1.13 Extraction method differences 
 
 Consensus for the extraction of tropane alkaloids from plant material involves 
agitation in a diluted polar organic solvent (Jakabova et al, 2012; Chen et al, 2017). 
However, there are variations of this method which involve further steps, such as 
prolonged agitation in extraction buffer, or the resulting supernatant being solubilised 
under acidic conditions (El Bazoui et al, 2009). Differences between extraction methods 
for the tropane and nortropane alkaloids have been reported.  Friedman et al, (2003), 
reported that non-acidified buffers work well for the extraction of nortropane alkaloids, 
whereas an acidified extraction buffer has been demonstrated to work well for tropane 
alkaloids (Chen et al, 2017; Cirlini et al, 2018).  For both extraction methods there is no 
unique difference in preparation between samples for analysis on either LC or GC-MS 
systems. 
 
Successful extraction methods must result in a high percentage recovery of the 
tropane and nortropane alkaloid profile from the tissues under analysis. As briefly 
discussed some extraction protocols require a more complex method for tropane and 
nortropane alkaloid extraction, which is followed by either a solid-phase extraction 
(SPE) or liquid-liquid extraction (LLE) clean up, to remove further interfering 
compounds which could impede detection. SPE and LLE clean-up has been shown, in 
some cases, to result in greater peak clarity during subsequent chromatography steps. 
SPE clean-up for samples generally use cation exchange resin columns (Dräger, 1995; 
Friedman et al, 2003), whereas LLE clean-up can be achieved using commercially 
available EXtrelut® columns (Merck, Germany) (Richter et al, 2007; Sramska et al, 
2017).  
 
Cation exchange resin columns have been used for the determination of 
calystegine (nortropane alkaloid) concentrations within different members of the 
Solanaceae. Dräger (1995) demonstrated that nortropane alkaloids can be extracted 
from root cultures of Atropa belladonna, whereas Friedman et al, (2003) extracted the 
same nortropane alkaloids from 8 different potato cultivars and in both cases the 
extracts were applied to a cation exchange resin column. The nortropane alkaloids are 
retained by these resin columns due to the charge of the secondary amino group 
(Mroczek et al, 2006). Most other molecules present flow through the resin column 
when washed, prior to the bound molecules of interest being eluted in an alkali solution.  





LLE clean-up of tropane alkaloids on EXtrelut® columns has been reported to be 
successful (Richter et al, 2007), however Sramska et al (2017) were unable to use this 
approach. The purpose of these EXtrelut® columns is to allow a liquid-liquid clean-up 
of samples, permitting greater sensitivity in the detection system. Sramska et al (2017) 
reported that using EXtrelut® columns for clean-up results in less than half the initial 
spike amount of atropine being recovered from samples when comparing two differing 
extraction methods (16.5±2.6% from 40 mg kg-1 DW and 35.9±2.1% from 160 mg kg-1 
DW). Whereas the best performing extraction method tested (which included longer 
ultra-sonication and a greater number of hexane washes) showed recovery rates of 
45.1±2.3% from 40 mg kg-1 DW and 66.7±3.4% from 160 mg kg-1 DW respectively.  
  
Comparisons between SPE and LLE have been conducted for alkaline based 
drugs, due to an interest from forensic laboratories (Juhascik and Jenkins, 2009). Whilst 
not using the same brand of SPE column as in previously cited studies, atropine and 
scopolamine had a limit of detection (LOD) of 50 ng/ml and 250 ng/ml respectively; 
however LLE purification of these samples was not undertaken in this study.  A tropane 
alkaloid which did undergo both SPE and LLE in this study was cocaine (produced by 
Erythroxylum coca, a member of the family Erythroxylaceae), and this showed a similar 






















There are limited sources of plants that produce natural tropane alkaloids. 
Increasing demand for and yield variability in these metabolites makes the development 
of a stable production platform more important. Solanum tuberosum offers the potential 
to increase and stabilise supply of the metabolites. Solanum tuberosum can be grown 
universally and contains tropane alkaloid precursors, up to the tropinone branch point. 
The tropinone branch point in potato represents the first known lesion of this pathway in 
Solanum tuberosum, where tropinone flux is diverted towards the nortropane alkaloids 
through trII activity.  The objectives of this study are to elucidate and assess the 
functionality of the tropane alkaloid biosynthesis pathway within Solanum tuberosum, 
and understand why potato does not produce tropane alkaloids. The development of 
robust detection methods for tropane alkaloids and associated metabolites will also be 
undertaken for the platforms that are available. These detection methods will be 
deployed to determine metabolite accumulation primarily within leaves, however, other 
tissues will be investigated. This will be achieved through: 
 
1. The development of a robust detection method for metabolites found along 
and associated with the tropane alkaloid biosynthesis pathway. 
2. The generation of trI over-expression transgenics 
3. The generation of trII down-regulation transgenics 
4. The generation of co-transformed trI over-expression and trII down-
regulating transgenics 
5. Discern the functionality of annotated downstream tropane alkaloid genes 





































































2.1 Media, antibiotics and buffers.  
 
2.1.1  Bacterial culture media 
 
Lysogeny Broth (LB) (pH 7.5): 
 
Tryptone 1.0 % (w/v) 
NaCl   1.0 % (w/v) 
Yeast extract  0.5 % (w/v) 
 
Super optimal broth with catabolite suppression (SOC) media (pH 7.0): 
 
Tryptone 2.0 % (w/v) 
Yeast extract  0.5 % (w/v) 
Glucose  20 mM 
MgSO4  20 mM 
MgCl2   10 mM 
NaCl   10 mM 
 
2.1.2  Tissue culture media 
 
MS 20 (Murashige and Skoog, 1962) (pH 5.7): 
 
Sucrose        2.0 % (w/v) 
Agar         0.8 % (w/v) 
Murashige and Skoog basal medium (Melford)   0.5 % (w/v) 
 
MS 30 (Murashige and Skoog) (pH 5.7): 
 
As MS 20 media, except 3 % (w/v) Sucrose.  
 
HB1 medium (MS30 plus the following) (pH 5.8): 
 
α-naphthalene acetic acid (NAA)   0.2 mg l-1 
Gibberellic Acid (GA3)    0.02 mg l
-1 
 Zeatin Riboside (ZR)    2.5 mg l-1  
4 ml-1 HB1 supplement is used per 1 l-1 MS30  




HB2 medium (MS30 plus the following) (pH 5.8): 
 
α-naphthalene acetic acid (NAA)   0.02 mg l-1 
Gibberellic Acid (GA3)    0.02 mg l
-1 
 Zeatin Riboside (ZR)    2.00 mg l-1  
4 ml-1 HB2 supplement is used per 1 l-1 MS30 
 
2.1.3 Antibiotics  
 
 
All antibiotics were prepared in double distilled water (ddH2O) with the 
exception of chloramphenicol which was dissolved in 100% ethanol and 




Agrobacterium inoculation buffer 
 
10 mM MgCl2 
10 mM MES buffer, pH 5.6 
150 µM Actosyringone 
 
Promega Ligation buffer (2x) (Promega, UK) 
 
30 mM Tris.HCl, pH 7.8 
10 mM MgCl2 
10 mM DTT 
1 mM ATP 
Antibiotic 
Conc. required for 
E. coli (µg ml) 
Conc. required for A. 
tumefaciens (µg ml) 
Conc. required for 
plant media (µg ml) 
Conc. of stock 
(mg ml) 
Ampicillin 50 - 100 - - 100 
Cefotaxime - - 500 125 
Chloramphenicol 50 - 100 - - 34 
Kanamycin 50 50 100 12.5 
Rifampicin - 100 - 10 
Spectinomycin 50 - 100 100 - 
 Tetracycline - 5 - 12.5 
     IPTG 32 - - 20 
X-Gal 32 - - 20 




10x Platinum™Taq High Fidelity buffer (Invitrogen, USA) 
 
600 mM Tris-SO4 (pH 8.9) 
180 mM (NH4)2SO4 
Total volume 1.25 ml 
 
T4 DNA Ligase buffer (pH 7.4) (Promega, UK) 
 
10 mM Tris-HCl  
 50 mM KCl 
 1 mM   DTT 
 0.1 mM EDTA 
            50 % glycerol (v/v) 
 
RNA Loading buffer 
  
0.55 % (w/v) Bromophenol Blue 
 0.8 mM EDTA 
 0.23 M Formaldehyde 
 4 % (v/v) Glycerol 
 6 % (v/v) Formamide 
 
10x Tris-Buffered Saline (TBS) (pH 7.5) 
 
0.4 M Tris Base 




50 ml 10x TBS 
0.5 ml Tween20 
449.5 ml ddH2O 
 
10% SDS Protein Extraction Buffer 
  
10 % (w/v) SDS 




20x NuPAGE™ MOPS SDS Running Buffer (pH 7.7) (Invitrogen, USA)  
 
50 mM MOPS 
50 mM Tris-Base 
0.1 % (w/v) SDS 
1 mM EDTA 
 
20x NuPAGE™ Transfer Buffer (pH 7.2) (Invitrogen, USA) 
  
25 mM Bicine 
 25 mM Bis-Tris (free base) 




























2.2 Plasmids  
 
2.2.1  pGEM®-T Easy  
 
pGEM®-T Easy (Promega, UK) is a high copy number vector containing the T7 
and SP6 RNA polymerase promoters flanking a multiple cloning site (MCS) with the α-
peptide coding region of β-galactosidase gene allowing blue/white screening of 
colonies, and ampicillin selectable marker (AmpR). pGEM®-T Easy are linearized 
vectors containing 3’ and 5’ terminal thymidine (T) overhangs allowing easy T/A 




















Figure 2.1: pGEM®-T Easy vector  











2.2.2 pET-28a(+) (Novagen®, Germany) 
 
pET-28a(+) vectors (Novagen®, Germany) contain a T7 promoter, kanamycin 
selectable marker and a MCS which is flanked on both the 5’ and 3’ termini with a 
sequence encoding a histidine repeat enabling tagging of recombinant proteins for 
efficient purification and analysis. Figure 2.2 below shows the vector schematic with 





















Figure 2.2: pET-28a(+) vector.  
















pUPD2 is the updated ‘domestication vector’ used in the GoldenBraid system. 
The backbone for this vector is pSB1C3 which is a high copy number plasmid and 
carries chloramphenicol resistance (CmR) (https://gbcloning.upv.es/pUPD/). Figure 2.3 
below shows the plasmid map with key features annotated as well as the restriction 



















Figure 2.3: pUPD2 vector 
Schematic of the pUPD2 GoldenBraid domestication vector annotated with regions of interest and 














pDGB1_α1R is a GoldenBraid alpha series binary vector used for the ligation of 
amplicons in the reverse orientation.  This vector contains two Type II BsaI restriction 
sites used in the Goldenbraid system cloning and is a derivative of the plant vector 
pGreenII (Sarrion-Perdigones et al, 2013). pDGB1_α1R holds the sequence for 






















Figure 2.4: pDGB1_α1R vector 
Schematic of pDGB1_α1R destination vector annotated with regions of interest and restriction enzyme 












pDGB3_α1 and pDGB3_ α2  are GoldenBraid binary vectors used for the 
recombination of GBparts and patches into functional transcriptional units enabling the 
generation of multipartite constructs. pDGB3_α series vectors are based on the 
pCAMBIA series vectors (Sarrion-Perdigones et al, 2013) Cloning is facilitated using a 
restriction endonuclease digestion and ligation reaction (section 2.5.3.4.3) utilising the 





















Figure 2.5: pDGB3_α  vector 
Schematic of pDGB3_α series destination vector annotated with regions of interest and restriction 













pDGB3_Ω1 and pDGB3_Ω2 are GoldenBraid Omega series binary vectors that 
can be used to generate multipartite constructs by the recombination of transcriptional 
units cloned in pDGB3_alpha series vectors.  Amplicons are cloned into this destination 
vector using a restriction endonuclease digestion and ligation reaction (section 
2.5.3.4.3) catalysed by the enzyme BsmBI and T4 DNA ligase (Promega®, UK). The 
pDGB3_Ω series vectors contain for a SmR gene encoding spectinomycin antibiotic 
resistance The vector backbone is based on the pCAMBIA series vectors (Sarrion-



















Figure 2.6: pDGB3_Ω vector. 
Schematic of pDGB3_Ω series destination vector annotated with regions of interest and restriction 











2.3 Bacterial Strains 
 
2.3.1 Escherichia coli DH5a 
 
Library efficiency® Escherichia coli DH5α (ThermoFisher™, UK) is a high 
yielding recombination supressing strain used for the propagation of plasmids. ‘Library 
efficiency®’ refers to the transformation efficiency of >1x108 cfu/µg plasmid DNA 
(colony forming units/µg), which is suitable for the transformation of low copy number 
constructs and blunt end ligations. The Φ80lacZΔM15 genotype allows for blue/white 
colony screening due to α-complementation of the β-galactosidase gene when grown on 
media plates containing 32 µg/ml X-gal (5-bromo-4-chloro-3 indolyl-β-D-
galactopyranoside) and 32 µg/ml IPTG.  
 
2.3.2 Escherichia coli BL21 (DE3) 
 
Chemically competent Escherichia coli BL21 (DE3) (Merck™) holds a 
chromosomal copy of the T7 RNA polymerase gene and is a lysogen of λDE3. This is 
controlled by the lacUV5 promoter.  
 
2.3.3 Agrobacterium tumefaciens AGL1 
 
Electro-competent Agrobacterium tumefaciens strain AGL1 contains the binary 
helper plasmid pSoup used for for plasmid replication. pSoup is a Ti (tumour inducing) 
plasmid, which helps facilitate the transfer of the cloned gene cassette into the plant 
genome during transformation. Supplied by Dr. A Barakate of The James Hutton 
Institute, UK.  
 
2.4 Plant material 
 
All plant material was grown under glasshouse conditions in 15 or 30 cm 
diameter pots for potato plants and either 30 or 45 cm diameter pots for Brugmansia 
aurea, Withania somnifera and Hyoscyamus niger detailed in section 2.4.1. The 
compost mix used as a growth media was of the following composition: 85.05 % (v.v) 
Peat (Everris, UK); 7.01 % (v.v) Pavoir Sand (Geddes, UK); 7.01 % (v.v) Perlite 
(Westland Garden Health, UK); 0.25 % (w.v) Osmocote Exact 3-4 month (ICL, UK);  
0.18 % (w.v) Limestone (Calcium) (Thomas Elliot Fertilisers, UK); 0.18 % Limestone 




(magnesium) (Keith Singleton Horticultural Products, UK);  0.10 % (w.v) Osmocote 
Exact Start (ICL, UK); 0.04 % (w.v) Celcote wetting agent (LBS Horticulture, UK); 
0.03 % (w.v) Exemptor insecticide (Bayer CropScience, UK). Glasshouse conditions 
were maintained at 18oC daytime and 14oC night time temperature, mean day length of 
16 hours and light intensity varying between 400 and 1000 µmol m-2s-1. Plants were  
grown over the summer months (April to October) and shading into effect once the 
temperature rose above 25oC, with the temperature monitored through the duration of 
growth by two temperature/humidity data loggers (DS1923 iButton®, Maxim, USA). 
These captured temperature and humidity data every hour and were changed fortnightly.  
 
2.4.1 Growth and maintenance of Brugmansia aurea, Withania somnifera and 
Hyoscyamus niger 
 
Several species of plants known to produce tropane alkaloids were bought from 
online horticultural retailers. Brugmansia aurea (Golden Angels Trumpets) were 
purchased as pot plants and re-potted upon arrival into large 40 cm diameter pots. 
Withania somnifera and Hyoscyamus niger seeds were purchased from Nickys Nursery, 
UK. Seeds were germinated on a damp towel at 4oC then transferred to 20 cm diameter 
pots and grown under the standard glasshouse conditions as detailed in section 2.4.  
 
Plants were watered daily and fed twice a week using Phostrogen All Purpose 
Plant Food (Bayer CropScience, UK) prepared as directed by the manufacturer. The All 
Purpose Plant Food contained 16 % (v.v) nitrogen; 10 % (v.v) phosphorous pentoxide; 
24 % (v.v) potassium oxide; 2.5 % (v.v) magnesium oxide; 5.8 % (v.v) sulphur trioxide 
and trace amounts (combined total of 0.1436 % (v.v)) of micronutrients (copper, iron, 
manganese, molybdenum and zinc).  
 
2.4.2 Maintenance of stock and transgenic potato material 
 
Solanum tuberosum L. cv Désirée and cv. Bintje were purchased from Scottish 
Agricultural Science Agency (SASA) and maintained by axenic propogation on MS20 
medium. Plants were subcultured using internodal sections from 3 to 4 week old tissue 
culture plantlets and grown in a growth cabinet maintained at 18oC and under artificial 
light on a 16 hour light, 8 hour dark light cycle at 100 µmol m-2 s-1. 
 




2.4.3 Harvesting of plant material  
 
Plant tissues were harvested into 15 ml Falcon™ tubes (Corning™) and flash 
frozen using liquid nitrogen. Harvested tissues were stored at -80oC until required for 
molecular and biochemical analysis.  
 
2.5. Molecular Protocols 
 
2.5.1 Nucleic acid extraction 
 
Isolation of RNA 
 
RNA was isolated from Solanum tuberosum cultivar Désirée root, stem and leaf 
tissue and cultivar Bintje leaf tissue using a Tri-reagent (Sigma-Aldrich) extraction 
method following the manufacturer’s protocol.  The extracted total RNA was then 
purified and DNase I treated using an RNeasy Mini Kit (Qiagen, Germany).  
 
Isolation of genomic DNA 
 
Genomic DNA was isolated from Solanum tuberosum cultivar Désirée and 
cultivar Bintje leaf tissue using an AquaGenomicTM MoBiClo (MultiTarget 




Extraction of Plasmid DNA from bacterial cultures 
 
Plasmid DNA was isolated from 4 ml of bacterial culture grown overnight at 
37oC with the appropriate antibiotics using the Wizard Plus SV Miniprep DNA 
purification system (Promega, USA) following the manufacturer’s protocol. The 
extraction procedure is based on the alkaline lysis of bacterial cells with the plasmid 
DNA being absorbed onto a silica membrane in the presence of a high salt buffer. 
Endonucleases are then removed by washing with buffer PB and salts removed by 
washing with the ethanol based PE buffer. Purified DNA was then eluted in a low salt 
buffer EB (10 mM Tris.HCL pH 8.5).  
 




2.5.2 Analysis of nucleic acids 
 
Quantification of nucleic acids by spectrophotometry 
 
Concentrations of DNA and RNA were estimated using a NanoDrop® ND-1000 
full-spectrum UV/Vis spectrophotometer (NanoDrop®, USA) measuring 1 µl of highly 
concentrated aqueous nucleic acid solution at up to 50-times higher concentrations than 
using a standard cuvette spectrophotometer (NanoDrop®, 2007). The NanoDrop uses a 
modified Beer-Lambert equation to correlate the calculated absorbance with 
concentration. DNA and RNA samples were measured at 260 and 280 nm absorbance, 
with a ratio of 1.8 being accepted as ‘pure’ for DNA and 2.0 for RNA.  
 
Gel electrophoresis  
 
Agarose gels were prepared by mixing 0.4 to 1 g of agarose with 50 ml of 1X 
Tris-borate/EDTA (TBE) buffer. This mixture was heated in a microwave on low power 
for 1 minute at a time, before being mixed and re-heated until all agarose had dissolved. 
The resulting mixture was cooled to ca.  60oC before adding 1 µl of 10 mg ml-1 
ethidium bromide. The gel was then cast in a gel tank with the required size comb and 
allowed to set under a fume hood for 1 hour. Once set the comb was removed and 
sufficient TBE buffer added to ensure the gel was fully submerged. Samples were then 
loaded onto the gel, in the lanes formed by the comb, and separated for 40 to 50 minutes 
by electrophoresis at 40 V. Imaging of the gel was made under UV light, using the 
UVITech transiluminator (UVITech, Cambridge, UK).  
 
DNA and RNA quality determination by gel electrophoresis 
 
DNA and RNA were separated and analysed by electrophoresis on ethidium 
bromide stained agarose gels to check quality using the method in section 2.5.2.2. To 
either 1% or 2% (w/v) agarose gels (for DNA and RNA respectively) stained with 
ethidium bromide, 5 µl of nucleic acid samples were added to lanes and separated. Total 
RNA samples had 1 µl of RNA loading buffer (section 2.1.4) added and were denatured 
at 70oC for 10 minutes prior to loading in the gel. Both were visualised under UV light 








DNA recovery from agarose gels 
 
Vector and DNA fragments (from PCR and restriction endonuclease digestions) 
were separated by electrophoresis using ethidium bromide stained agarose gels and the 
desired band excised under UV illumination. Excised bands were purified using a 
Wizard® SV Gel and PCR clean up system (Promega, USA) following the 
manufacturer’s protocol. Samples were eluted in between 20 and 50 µl of SDW and 
stored at 4oC until required for downstream applications. 
 
2.5.3 Enzymatic manipulation of nucleic acids 
 
Polymerase Chain Reaction (PCR) 
 
PCR was conducted using two different types of Taq polymerase. For routine 
PCR to determine presence/absence and length of amplicons a non-proof reading 
GoTaq® G2 DNA polymerase (Promega, USA) was used. Whereas for PCR reactions 
where the product was to be sequenced, used for generation of recombinant proteins or 
in transformations, Platinum™ Taq DNA Polymerase High Fidelity (Invitrogen) was 
used. This polymerase has 3’ to 5’ exonuclease proof reading activity allowing 
nucleotide incorporation errors to be corrected, making it suitable for cloning 
applications.  
 
Routine PCR reactions were carried out in a volume of 25 µl containing 1 unit 
(U) of Promega GoTaq® G2 DNA polymerase, 5 µl of 5x Green GoTaq® reaction 
buffer, and between 20 and 75 ng of template DNA per reaction. Also included were 
gene specific forward and reverse primers at a final concentration of 0.4 µM and the 
four deoxynucleotides (dNTPs) adenine, cytosine, guanine and thymine at a final 
concentration of 0.4 mM. The reaction contained MgCl2 at a final concentration of 1 
mM and was bought up to the final reaction volume with ddH2O. Thermal cycling 
conditions used to generate the PCR fragments were as follows: 2 minutes denaturation 
at 94oC followed by 20 to 35 cycles of 94oC for 30 sec, 30 sec at the desired melting 
temperature (Tm) for the primer pair used (this was generally 5oC below primer melting 
point), and a 60 sec extension time per 1 kb of expected fragment at 72oC.  Positive 
(where possible) and negative controls were included with each reaction. 
 




PCR reactions using high fidelity Taq polymerase were carried out in a total 
reaction volume of 25 µl and as per the manufacturer’s instructions, with each reaction 
containing 0.1 µl (5 U/µl) of Platinum® Taq DNA Polymerase High Fidelity, 2.5 µl of 
High Fidelity PCR buffer, gene specific forward and reverse primers at a final 
concentration of 0.2 µM, dNTPs at a final concentration of 0.2 mM and up to 50 ng of 
template DNA used per reaction. The  final reaction contained MgSO4 at a final 
concentration of 2 mM and a final reaction volume of 25 µl with ddH2O. Thermal 
cycling conditions were as follows: 2 min denaturation at 94oC followed by 25 to 35 
cycles of 94oC for 15 sec, 30 sec at the desired melting temperature (Tm) for the primer 
pair used (this was generally 5oC below primer melting point) and 60 sec extension time 
per 1 kb of expected fragment at 68oC. 
 
Restriction endonuclease digestion reactions 
 
Plasmid DNA preparations (0.5 to 1 µg) underwent routine restriction 
endonuclease digestion in the presence of 5 to 10 units of enzyme, as well as at the 
appropriate temperature (normally 37oC) and in the recommended buffer as per 
manufacturer’s guidelines for 3 to 4 hours. Digested plasmid was visualised by ethidium 
bromide stained Tris-borate (TBE) agarose gel electrophoresis (section 2.5.2.2). In some 
instances digested fragments were excised from the gel and this was purified using the 
Promega Wizard® SV Gel & PCR clean up system (USA) as per manufacturer’s 
protocol. This purified fragment was then used in subsequent ligation reactions.  
 
 cDNA synthesis  
 
cDNA was synthesised from purified RNA samples for RT-qPCR analysis. 
During the project two methods were used for this purpose, these being Invitrogen™ 
SuperScript™ III Reverse Transcriptase or the TaKaRa CloneTech RNA to cDNA 
EcoDry™ Premix (Double Primed) lyophilized master mix.  Once synthesis was 
complete all cDNA was diluted to 10ng/µl through the addition of ddH2O. 
 
cDNA was synthesised using the Invitrogen™ SuperScript™ III Reverse 
Transcriptase and up to 5 µg of DNase I treated total RNA. To the RNA, 1 µl of both 
Oligo(dT)20 (concentration) and 1 µl of dNTP mix (10 mM) was added, then the total 
volume was bought up to 13 µl with RNase free water. This mixture was then heated at 




65oC for 5 minutes then incubated on ice for a further minute.  For the reverse 
transcription step of this protocol, 4 µl of First Strand Buffer (5x), and 1 µl of each of 
the following 0.1 M DTT, RNaseOUT™ (40 U/µl) and Superscript™ III RT (200 U/µl) 
was added. The mixture was then mixed by pipette and then heated at 50oC for 60 
minutes, before the enzyme deactivated by incubating at 70oC for 15 minutes.  
 
A second method used for synthesising cDNA was using a TaKaRa CloneTech 
RNA to cDNA EcoDry™ Premix (Double Primed) beads kit. 5 µg of DNase I treated 
total RNA in a final volume of 20 µl RNase-free H2O was added to the lyophilized 
EcoDry™ Premix. The mixture was then mixed by pipetting and centrifuged to remove 
any potential air bubbles before heating at 42oC for 60 minutes prior to deactivating the 
enzyme at 70oC for 10 minutes. 
 
2.5.3.4 Ligation reactions  
 
pGEM®-T Easy (Promega, USA)  
 
PCR synthesised DNA fragments containing adenine (A) overhangs were ligated 
into pGEM®-T Easy, using T4 DNA ligase (Promega, USA). T4 DNA ligase catalyses 
the formation of new bonds between the 5’ phosphate residue and the 3’ hydroxyl 
groups of fragment and plasmids. To ensure greater ligation efficiency the incubation 
conditions used were different to the manufacturer’s guidelines. The thermal conditions 
were 10 cycles of 25oC for 30 minutes, 22oC for 30 minutes and 16oC for 30 minutes 
with a final holding stage of 16oC. The reaction mixture comprised of 1 µl T4 DNA 
Ligase buffer, 1 µl T4 DNA Ligase (3 U/µl), 1 µl pGEM®-T Easy (50 ng), a variable 
amount PCR product (depending on concentration and ratio being used) in a final 
reaction volume of 10 µl made up with with ddH2O. Once complete, the ligation 




DNA fragments were ligated into the linearised plasmid vector pET-28a(+) using 
a T4 DNA ligase (Promega, USA) catalysed reaction. For each sample, 75 ng of 
linearised vector was mixed with 40 ng of DNA fragment,1 µl T4 DNA ligase and 2 µl 
10x ligase buffer (section 2.1.4) before being bought to a total volume of 20 µl with 




ddH2O.  Samples were then incubated in a thermal cycler at conditions of 10 cycles of 
25oC for 30 minutes, 22oC for 30 minutes and 16oC for 30 minutes. Once complete, 5 µl 
of the reaction mixture was used for transformation into competent E. coli cells. 
 
Ligations in the GoldenBraid system 
 
Restriction ligation reactions were carried out in a 0.5 ml PCR tube, to this, 75 
ng destination vector and 75 ng of each of the required GBparts and GBpatches were 
added. To this, 1 µl of 10 U/µl restriction endonuclease (either BsaI or BsmBI (both 
Promega, USA) depending on site being cleaved), 1 µl of 3 U/µl T4 DNA ligase and 1 
µl T4 Ligase buffer were added. ddH20 was then added to a final total volume of 10 µl 
and the samples incubated in a thermocycler at 37oC for 30 minutes, followed by 75 
cycles of 37oC for 2 minutes and 16oC for 5 minutes respectively and held at 16oC for 
30 minutes. 2 µl of the ligation mixture was transformed into heat-shock E. coli as per 
the protocol in section 2.5.4.1. The reaction conditions described above are the same for 
each level of the GoldenBraid system as described in chapter 1.11. 
  
2.5.3.2 Design of primers 
 
Gene specific primers for PCR were designed by submitting the sequence in 
FASTA format (5’ to 3’ orientation) into the online software Primer3 programme 
(http://primer3.ut.ee/). Primer sequences were then purchased from Eurofins genomics 
(Germany) and re-suspended in ddH2O to a final concentration of 100 µM upon arrival.  
 
2.5.3.3 RT-qPCR (Universal Probe Library) 
 
RT-qPCR was performed using cDNA prepared as described in section 2.5.3.3. 
Primers and probe sequences were designed using The Roche Universal Probe Library 
Assay Design Centre (https://lifescience.roche.com/en_gb/brands/universal-probe-
library.html). All qRT-PCR reactions were performed using an Applied Biosystems 
StepOne Plus Real Time PCR system. 50 ng total cDNA was used as template in all 
reactions, which were composed of 12.5 µl 2x FastStart Universal Probe Master Mix 
(Rox) (Roche, UK), 10 µM Universal Probe, and 20 µM of both forward and reverse 
primer  before being made up to a final volume of 25 µl with ddH2O. Thermocycling 
conditions were as follows, denaturation stage of 95oC for 10 mins, 40 cycles of 95oC 




for 15 sec and 60oC extension for 1 min. Samples were ran in triplicate, using 
elongation factor-1α (ef-1α) as an endogenous control. This gene can be used as a 
control as it encodes a ubiquitous protein which is utilised in protein synthesis by 
binding aminoacyl-transfer RNA to ribosomes (Stürzenbaum and Kille, 2001) and has 
been shown to be highly consistent between different tissue samples and growth stages 
(Nicot et al, 2005; Ross et al, 2011). Calculations of relative expression levels for 
transgenic lines manipulating the Solanum tuberosum tropinone reductase II were 
performed using the Pfaffl method (Pfaffl, 2001). For transgenic lines which over-
expressed a non-endogenous tropinone reductase I within Solanum tuberosum, the 2-∆CT 
has been shown to describe the relative expression levels of the introduced gene 
(Schmittgen and Livak, 2008).  
 
2.5.3.4 Sequencing of DNA 
 
Sequencing was performed by the Genome Technology Service at The James 
Hutton Institute, Dundee, UK. Plasmid templates were purified using the Promega 
Wizard® SV Miniprep DNA Purification System (USA) (section 2.5.1.3) and quantified 
by Nanodrop ND-1000 (Nanodrop, USA) (section 2.5.2.1). PCR templates were 
purified using the Promega Wizard® SV Gel & PCR clean up system (USA) and 
visualised by agarose gel electrophoresis. For plasmid templates, concentration for 
sequencing reactions ranged between 40 and 250ng/µl and for PCR templates the 
concentration range was between 1 and 50 ng/µl depending on fragment size. 
Sequencing reactions were conducted on a capillary based Applied Biosystems AB3730 
DNA Analyser and the raw data visualised using the sequencing analysis software, 
Sequencher (version 5.2.4) (Gene Codes Corporation, USA).   
 
2.5.3.5 Recombinant protein induction 
 
The pET-28a(+) vector coupled with E.coli BL21 (DE3) is a powerful tool for the 
cloning and expression of recombinant proteins within E. coli where  genes are 
expressed by a bacteriophage T7 RNA polymerase transcription signals from the host 
cell. Initial cloning and induction is performed in E. coli strain BL21 (DE3) hosts which 
do not exhibit basal T7 RNA polymerase activity due to the presence of a lac repressor, 
thereby preventing expression of the introduced gene without the addition of 1 mM 
IPTG (Isopropyl β-D-1-thiogalactopyranoside). Simultaneously the addition of IPTG 




and substrate which the protein would act on was added at a final concentration of 100 
mg/l. From here the cultures were allowed to grow at 16oC, 22oC, 28oC and 37oC for 48 
hours with samples taken at 0, 24 and 48 hours post induction. Once samples were 
taken, the cell culture was centrifuged to pellet the cells (9400 x g for 5 minutes) and the 
supernatant was removed to a fresh Eppendorf for further metabolite analysis (as 
described in section 2.6.3). The pelleted cells underwent protein extraction and western 
blot analysis to check for induction as described in section 2.5.3.9.   
 
2.5.3.6 Protein extraction and Western Blot 
 
Crude protein extraction was conducted on pelleted cells (from 2 ml of inducted 
cultures (9400 x g for 5 minutes) by applying 500 µl SDS buffer, re-suspending the 
pellet and boiling for 10 minutes at 95oC. Once boiled, the suspension was centrifuged 
(9400 x g for 5 minutes at 4oC) to pellet cell debris; the supernatant was then moved to 
a fresh eppendorf. 26 µl of supernatant was then used for the western blotting.  
 
To the supernatant being run on the gel 10 µl Novex NuPAGE SDS Running 
Buffer and 4 µl Novex NuPAGE Reducing Agent (Invitrogen, UK) were added. The 
samples were then denatured for 5 minutes at 90oC whilst the gel and running buffers 
were prepared. 
 
A Novex NuPAGE 4-12% Bis-Tris 15 well pre-cast gel (Invitrogen, UK) was 
placed in the running chamber and was surrounded with Novex NuPAGE MOPS SDS 
running buffer (one litre was made by adding 50 ml buffer to 950 ml ddH2O). Once the 
samples where denatured they were pipetted into the wells of the gel, following 
manufacture’s advice regarding well volume. 10 µl of Precision Plus Protein Dual 
Colour Standard (BioRAD, USA) was added to a well in the gel as a size marker. The 












After the protein sample had been run and separated on the gel, the gel was 
removed from its housing and washed in ddH2O. Proteins were transferred from the gel 
to a nitrocellulose membrane (Novex 0.45 um pore size (Invitrogen, UK)), and the set 
up for this stage can be seen in Figure 2.7. All materials which were used in this transfer 
step were wetted prior to use in transfer buffer (50 ml Novex NuPAGE Transfer Buffer 









Figure 2.7: Schematic representation of the completed protein transfer cell.  
 
Once protein transfer had been completed, the membrane was briefly washed in 
TBS-T buffer (see Appendix x for recipes). To 100 ml of TBS-T, 5 g of dry non-fat 
milk was added and shaken until completely dissolved. The membrane was incubated in 
15 ml of this blocking solution for 1 hour at room temperature before two successive 5 
minute washes in 15ml TBS-T. To another 25 ml of the milk solution 2.5 µl of 6x-
HisTag Monoclonal Antibody (Invitrogen, UK) raised in Mouse (Mus) was added 
(dilution 1:10000). This was applied to the membrane and left on a shaker at 4oC 
overnight.  
 
The next day the membrane underwent 4 successive 5 min washes in 15 ml 
TBS-T before addition of the secondary antibody. In this case the secondary antibody 
was a goat anti-mouse IgG-HRP (Santa Cruz Biotechnology, USA) with 2.5 µl being 
added to 25 ml TBS-T milk solution (1:10000 dilution). This was left to incubate for 1 
hour at room temperature.  After this, the membrane underwent 4 successive 5 min 
washes in 15 ml TBS-T to remove excess antibody. Detection of any antibody tagged 
proteins used the chemiluminescent substrate SuperSignal™ West Femto (Thermo 
Scientific™, USA) as per the manufacturers protocol. Imaging of the membrane was 












2.5.4 Bacterial Protocols 
 
2.5.4.1 Heat shock transformation of competent E.coli (strains DH5α and BL21 
(DE3)) 
 
100 µl aliquots of competent cells stored at -80oC were thawed on ice (DH5α 
from ThermoFisher™, UK and BL21 from Merck™) for 5 minutes. To this, 2 µl of 
ligation reaction was added to 50 µl of competent cells and incubated on ice for between 
5 and 30 minutes depending on the strain of E.coli (BL21 (DE3) and DH5α). After 
incubation, tubes were heated for 30 sec or 45 sec at 42oC then incubated on ice for a 
further 2 min. 900 µl of warmed SOC media was then added to this mixture and further 
incubated at 37oC for 2 hours and shaking at 250 rpm. Following incubation, 200 µl of 
the bacterial culture was spread over LB agar plates with appropriate antibiotic selection 
for the plasmid vector and once dried, inverted and incubated overnight at 37oC to allow 
colony growth. Vectors which allowed blue/white colony screening were grown on LB 
plates containing IPTG and Xgal in addition to the antibiotic selection; plates were 
placed at 4oC for 3 hours to enhance any colouration present.   
 
2.5.4.2 Transformation of electro-competent Agrobacterium 
 
Transformation of electro-competent Agrobacterium tumefaciens AGL1 
(supplied by Dr. A Barakate, The James Hutton Institute) was performed using a Bio-
Rad electroporator following the manufacturer’s protocol. 40 µl of electro-competent 
Agrobacterium cells were gently thawed on ice for 5 minutes. 1 µl of plasmid DNA 
(50ng/µl) was then added, mixed using a pipette, then transferred to a pre-chilled Bio-
Rad electroporation cuvette (Bio-Rad; 0.2 cm electrode gap) placed in the electroporator 
with the following conditions. 200 Ω resistance; 25 kV voltage; 25 µF capacitance. A 
single pulse was applied to the cuvette then 500 µl of warmed SOC medium (section 
2.1.1) added, decanted into a sterile 1.5 ml eppendorf tube and incubated at 28oC for 4 
hours at 250 rpm. Following incubation, cells were plated onto LB plates containing the 









2.5.4.3 Preservation of bacterial cultures 
 
After cultivation E. coli and Agrobacterium tumefaciens bacterial cultures were 
stored as glycerol stocks. These were made by mixing 1200 µl of bacterial culture 
(OD600 between 0.6 – 0.8) with 650 µl 50% glycerol (w/v). Samples were then inverted 
to ensure mixing before being snap frozen in liquid nitrogen and stored at -80oC until 
needed.  
 
2.5.4.4 Generation of bacterial cultures for transient and stable inoculation 
 
For production of stable transgenics Agrobacterium tumefaciens cultures 
containing the binary transformation vectors (generated in section 2.5.3.4.3) were grown 
overnight in lysogeny broth media at 28oC at 250 rpm. Following incubation, 20 µl of 
acetosyringone was added at a final concentration of 0.2 mM the incubated for another 
4 hours at 28oC. The OD600 was measured using a spectrophotometer (Amersham 
Bioscience Ultrospec 2100pro (UK)) and cells used for plant transformation when the 
OD600 was between 0.5 and 0.8. 
 
2.5.4.5 Tissue culture of generated transgenic lines 
 
Tissue culture was carried out in a laminar flow cabinet cleaned with 75% (v/v) 
ethanol, prior to work being carried out to ensure sterile conditions. Internodal sections 
from 5 week old potato plantlets cv. Désirée and cv. Bintje were taken, sections were 
between 5 and 10 mm long were cut longitudinally. Internodes were collected stored in 
liquid MS30 media for ca. 1 hour until enough explants were harvested (~ 100 per 
transformation required). Samples were moved to a petri dish containing the MS30 
media and explants and 100 µl of freshly prepared Agrobacterium culture added (OD600 
between 0.6 and 0.8) and incubated in the dark at 24oC for 20 minutes at 50 rpm. After 
incubation, explants were removed and dried on Whatman™ filter paper before being 
transferred to callus induction media (HB1 (section 2.1.2)) at a maximum density of 100 
explants per plate. Plates were then incubated for 2-3 days in low light conditions. 
 
After this initial growth period, explants were transferred to fresh HB1 media 
containing the antibiotics cefotaxime and kanamycin as selection, at a density of 20 per 
plate and then allowed to further incubate in the growth cabinet for 7 days under 16:8 




hour light conditions. Following this 7 day period, the media was again changed every 
14 days until calli formation.   
 
Once calli were present, explants were moved onto regeneration media (HB2 
(section 2.1.2)) containing kanamycin and cefotaxime at a density of 20 explants per 
plate and subcultured every 14 days until shoots start to appear on the calli. As the 
shoots appear (ca. 4 to 6 weeks) and the calli grow the number of explants per plate 
were reduced accordingly.  
 
Shoots over 1 cm in length were excised and assigned an identification number 
according to corresponding calli and plate number. Samples were transferred to fresh 
MS20 media containing cefotaxime and kanamycin. Shoots which exhibited root 
formation from the base of the shoot were subcultured onto fresh media and the 
presence of the transgene tested by PCR analysis (section 2.5.3.1). PCR positive lines 
were propagated for further replication.   
 
2.6 Biochemical Analysis 
 
2.6.1 Chlorophyll and Carotenoid extraction 
 
Chlorophyll and carotenoid contents of transgenic leaf material were determined 
spectrophotometrically according to Miazek and Ledakowicz, 2013. The following 
method was carried out in low light conditions.  100 mg of ground, freeze dried leaf 
material was weighed out into a 15 ml Falcon® tube. To this, 5 ml of 95% ethanol was 
added and samples vortexed for 30 seconds then incubated at 60oC for 1 hour followed 
by another 30 seconds of mixing. Samples were then centrifuged at 2800 x g for 2 
minutes to form pellet and 100 µl of supernatant transferred to a cuvette containing 900 
µl 95% ethanol.  Spectrophotometer readings were taken at 470, 648 and 664 nm. To 
calculate the concentrations of Chlorophyll A, Chlorophyll B and Carotenoids in µg/g 
the following equations were used (Miazek and Ledakowicz, 2013): 
 
Chlorophyll A = ((13.36 x 664nm reading – 5.19 x 648nm reading) x 10)/weight (g) 
 
Chlorophyll B = ((27.43 x 648nm reading – 8.12 x 664nm reading) x 10)/weight (g) 
 
Carotenoid = ((1000 x 470nm reading) x 10)-(1.82 x Chlorophyll A value)-(85.02 x 
Chlorophyll B value)/198 




2.6.2 Extraction of tropane alkaloids from plant tissue 
 
Plant tissue was collected, frozen in liquid nitrogen and lyophilised in a 
CHRiST® Gamma I-16 LSC freeze dryer (0.700 mbar vacuum and -49oC condenser 
temperature). Samples were then ground to a fine powder using a mortar and pestle and 
stored in 15 ml Falcon® tubes. 40 mg of sample was removed and placed in a 2 ml 
eppendorf tube and two 3mm tungsten carbide beads (QiaGEN, USA) were added. The 
samples were then further homogenised in a QiaGEN TissueLyzerII (QiaGEN, USA) 
for 1 min and at a frequency of 20/s (kHz). 
 
1.5 ml extraction buffer (49% MeOH, 49% ddH2O and 2% Formic Acid) was 
added and the samples vortexed for 60 sec to ensure they were thoroughly mixed, then 
incubated on a blood rotator at 30 rpm for 1 hour at 4oC. Samples were then centrifuged 
at 3000 x g for 15 minutes at 4oC to pellet the tissue. 1 ml of supernatant removed and 
dried at 40oC using a rotary evaporator until 300 µl was remaining. The samples were 
then frozen and dried using a freeze drier.  
 
For samples which were expected to be high in calystegine content the formic 
acid was omitted from the extraction buffer as described in Petersson et al, (2013). 
When ready for analysis on the Agilent QqQ-LC-MS/MS, samples were re-suspended 
in 200 µl of 50% methanol which was spiked with reserpine (10 µM final 
concentration) used as an internal standard (ITSD).  
 
2.6.3 Extraction of tropane alkaloids from media 
 
Tropane alkaloids from bacterial biotransformation experiments were extracted 
whilst still in LB media. To ensure that there was no bacterial cells in the extract, 2ml of 
LB broth was removed from the culture and centrifuged at 9400 x g for 10 minutes at 
4oC. From this, the supernatant was removed and the pellet retained for western 
analysis. 200 µl of the supernatant was removed and analysed on the QqQ-LC-MS/MS 











Methods were developed for using the HPLC which was equipped with the UI-
100 Universal Chromatography Interface (Dionex, USA), Gynkotek UVD340U, 
Ultimate 3000 Autosampler (Dionex, USA) and using Chromeleon 6.60 SP9 (Build 
1566) Software (Dionex, USA). The running method used in the first instance was 
previously described in Pietsch et al (2008), and can be seen below in Table 2.1.  UV 
detection wavelengths of 207, 225, 250 and 280 nm were used for the detection of peaks 
within the samples Buffer A = 100% Acetonitrile, Buffer B = 0.01 M phosphate buffer 
(pH 6.5). Modifications were made to the running conditions, with Buffer B changing 
from 0.01 M Phosphate buffer (pH = 6.5) to 0.1% TFA, which was run under the same 
gradient. A Cronus CRONUSIL-S ODS2 5µm 25x0.46 cm (Labhut, UK) column was 
used.   
 
 





Table 2.1: HPLC running conditions.  
Time and percentage composition of both buffers used during the run of a sample on the HPLC.  
 
2.6.5 ThermoFisher Scientific’s OrbiTrap™ LC-MS system.   
 
For the analysis of the TAs a LTQ OrbiTrap™ XL (ThermoFisher Scientific, 
Germany) system was used. This system was equipped with an Aceela PDA Detector, 
Acella Autosampler and Acella 600 pump. The column used was a Synergi 4µm C18 
Hydro-RP80 150 x 2.0 mm (Phenomenex, USA) which was kept at 30oC. The running 
method consisted of two mobile phases. A: ddH20 with 0.1% formic acid and B: 
methanol with 0.1% formic acid. The buffer gradient can be seen in Table 2.2 below. 
Data from runs were extracted and analysed through Xcalibur (ThermoFisher Scientific, 
USA). The injection volume was 5 µl. 
 
 
Time (mins) Buffer A % Buffer B % 
00:00 10 90 
15:00 10 90 
37:30 75 25 
46:30 75 25 
50:00 10 90 




Time (mins) Mobile Phase A (%) Mobile Phase B (%) 
00:00 100 0 
03:00 100 0 
17:00 0 100 
22:00 0 100 
23:00 100 0 
29:00 100 0 
 
Table 2.2: LCMS running conditions.  
Time and percentage composition of both mobile phases for during the run of a sample on the OrbiTrap™ 
LCMS system. There is a gradient of mobile phase B from 00:04 to 00:16 minutes, before stabilisation 




An Agilent Technologies™ 6460 Triple Quad LC/MS was used for a targeted 
analysis of the tropane alkaloids. The mobile phases, column and gradient conditions 
were the same as described previously for the Orbitrap™-LC/MS (Section 2.6.5). The 
Triple Quad LC/MS was equipped with the following Agilent Technologies™ Infinity 
1260 series components: Diode Array Detector (DAD), Thermostatted Column 
Compartment (TCC), Automatic Loading Sampler (ALS) and a Quaternary Pump.  
 
Individual metabolites which are to be analysed on the QqQ-LC/MS system 
underwent initial optimisation to generate fragment patterns which would allow for the 
generation of a multiple reaction monitoring reaction (MRM) and is further detailed in 
Chapter 3. 
 
2.7 Statistical methods 
 
T-test statistical analysis was conducted using the IBM SPSS® platform 
(Version 22). Comparisons between individual lines and controls (Désirée and Empty 


































































Robust and highly sensitive quantification methods for tropane and nortropane 
alkaloid analysis from different plant tissues and microbial sources were developed as 
important tools to be used throughout this project. 
 
3.1.1 Composition of alkaloids and extraction from plant material 
 
As previously discussed in Chapter 1, tropane alkaloids such as hyoscyamine 
and scopolamine are synthesised in the roots of some solanaceous plants. These 
compounds are then translocated to the leaves where they are stored (Mano et al, 1986). 
As tropane alkaloids are found throughout the plant, extraction from above and below 
ground tissues have been studied. Jakabova et al, (2012) extracted tropane alkaloids 
from five above ground tissues of four Datura species. Across the four species 
analysed, there was no consensus as to where the highest concentrations of the tropane 
alkaloids scopolamine or hyoscyamine (measured as atropine) were located. For 
example, in Datura inoxia scopolamine was the most abundant tropane alkaloid in all 
plant tissues tested. The highest concentrations of atropine was found in stems of fruit 
producing plants, whereas in Datura stramonium and Datura stramonium var. tatula all 
organs contained higher concentrations of atropine compared to scopolamine with var. 
tatula displaying up to 2.5-fold more total tropane alkaloids compared to D. 
stramonium. Kohnen et al, (2017) analysed root, stem and leaf samples from Duboisia 
myoporoides at three time points through plant development. It was found that whilst 
tropane alkaloid concentration increased in all tissues as the plant developed, 
scopolamine concentration in the leaves showed the greatest increase from 5.5 mg/g-1 
DW (6 weeks post planting from cutting) to 14.8 mg/g-1 DW (6 months post planting 
from cutting), whereas in the roots it was hyoscyamine which showed the highest 
concentration at 6 months (4.2 mg/g-1 DW). These studies indicate that depending on 
the tissue of interest, tropane alkaloid concentrations are widely variable, and accurate 
quantification requires robust analytical methods.  
 
Chemically, alkaloids are basic molecules, due in part, to the free electron pair 
located on the amine nitrogen atom bound to C1 and C5 of the tropane skeleton (El-
Sakka, 2010). This aspect of their chemistry results in the alkaloids being readily 
soluble in polar organic solvents (Christen, 2007). A range of extraction and recovery 




methods have been developed for tropane and other classes of alkaloids, and these were 
summarised in section 1.13.  
 
3.1.2 A new LC-MS system for detection of tropane alkaloids.  
 
Whilst GC-MS, TLC, HPLC-UV have been used for the detection of tropane 
alkaloids in previous studies and have been introduced in the chapter 1, the use of the 
ThermoFisher Scientific OrbiTrap™ LC-MS system has only recently started to be used 
for the detection of these metabolites (Romera-Torres et al, 2018).  
 
3.1.3 ThermoFisher Scientific’s OrbiTrap™ LC-MS system (hereafter 
OrbiTrap™).   
 
The Orbitrap™ system achieves its ‘ion trapping’ through the generation of an 
electrical potential being applied to a central wire and its cylindrical housing. This 
generates an electric field, attracting ions that have insufficient velocity to escape the 
field and results in them becoming trapped (Makarov, 2000). Although a rudimentary 
version of this technique has been used since 1923, this was known as a ‘Kingdon trap’; 
the technique was re-visited in 2000, and it was improved upon for accurate mass 












Figure 3.1.1: OrbiTrap™ electrode field scheme.  
Example of ion trajectory within the OrbiTrap™ electrode field. Z denotes the symmetrical plane (Z = 0), 
and R is the radius from the central point of the electrostatic field. R1 is indicating the position of the 
central electrode and R2 shows the outer electrode. (Makarov, 2000).  
 
 




OrbiTrap™ systems display a high degree of sensitivity and mass accuracy for 
ions within samples. The high degree of mass accuracy in conjunction with associated 
software (ThermoScientific™ Xcalibur™ version 2.2.44 (2011)) assists with 
determination of the elemental formulae and structure of unknown molecules within the 
samples (Makarov and Scigelova, 2010). Therefore the OrbiTrap™ system provides a 
powerful detection approach for the metabolites that have been produced by an 
engineered metabolic pathway. It is hoped that the chromatography and detection 
methods developed on the OrbiTrap™ can be translated to the quantitatively accurate 
Triple-Quadrupole LC-MS/MS.   
 
3.1.4 Agilent Triple-Quadrupole (QqQ) LC-MS/MS tropane alkaloids 
fragmentation patterns in literature 
 
The structural similarity of tropane alkaloids stems from the nitrogen containing 
tropane skeleton, previously described in Chapter 1.2 and Chapter 3.1. Therefore 
fragmentation patterns (see Chapter 1.12.4) generated from the QqQ-LC-MS/MS that 
can be used to discriminate between different tropane and nortropane alkaloids will be 
dependent on the nature of other parts of the molecule including any side groups added 
to this skeleton. For example, it is possible to discriminate between hyoscyamine and 
scopolamine due to the presence of the epoxide oxygen ring on the tropane skeleton at 
C-6 and C-7 of scopolamine. The fragments derived from this will exhibit an m/z of 138 
in scopolamine compared to 124 in hyoscyamine. 
 
Recent developments in detection techniques through using the QqQ-LC-
MS/MS systems have shown that the fragmentation of the higher valued tropane 
alkaloids, hyoscyamine and scopolamine yields the patterns shown in Table 3.1.1. 
These fragments can be selected for individually, so that if they are detected within a 
sample once it has been fragmented the peak generated will correspond to a known 
panel of metabolite. The abundance of this peak compared to a standard sample enables 
accurate quantification. The process of fragmentation, detecting, quantifying and 
monitoring these peaks through the duration of the chromatography is referred to as 








Molecule m/z Fragments generated (m/z) Reference 
Atropine 290.2 
142.1 124.0 103.0 93.0 91.0 77.0 
67.0 
Chen et al, (2017) 
142.0 124.0 93.0 67.0 Zhou et al, (2017) 
Anisodamine 306.1 158.0 140.0 122.0 121.0 79.0 Zhou et al, (2017) 
Scopolamine 304.0 
156.0 138.0 121.0 110.0 103.0 98.0 
79.0 
Chen et al, (2017) 
156.0 138.0 121.0 103.0 79.0 Zhou et al, (2017) 
 
Table 3.1.1: Known tropane alkaloid fragmentation patterns. 
Fragmentation patterns for the three larger tropane alkaloids atropine (racemic hyoscyamine), 
































3.2 Materials and Methods 
 
3.2.1 Extraction methods.  
 
In assays below, two extraction methods are compared. Method S is refered to in 
section 2.6.2 and method V is adapted from Vorst et al, 2005.  
 
Extraction buffer in method V is comprised of 62.5% MeOH, 37.375% ddH2O 
and 0.125% Formic Acid. 1.5 ml of extraction buffer was added to the ground sample 
and then vortexed for 60 seconds to allow for thorough mixing. The sample was then 
placed in an ultrasonication bath for 10 minutes, before being centrifuged at 3000 x g 
for 15 minutes to pellet tissues. Supernatant was removed and filtered through a 0.45 
μm syringe filter prior to being dried in a rotary evaporator at 40oC. Samples were then 
re-suspended in 100 μl 50% MeOH.  
 
Extraction method S uses 1.5 ml extraction buffer (49% MeOH, 49% ddH2O 
and 2% Formic Acid) was added and the samples vortexed for 60 sec to ensure they 
were thoroughly mixed, then incubated on a blood rotator at 30 rpm for 1 hour at 4oC. 
Samples were then centrifuged at 3000 x g for 15 minutes at 4oC to pellet the tissue. 1 
ml of supernatant removed and dried at 40oC using a rotary evaporator until 300 µl was 
remaining. The samples were then frozen and dried using a freeze drier, before being re-


















3.3 Results  
 
3.3.1 Thin Layer Chromatography (TLC)  
 
TLC was developed as a potential rapid screening method for the detection of 
tropane alkaloids from bacterial assays. The TLC plate in Figure 3.3.1 shows bands 
stained a pink/red hue for 30µl of 10mM, 25mM and 50mM hyoscyamine 
hydrobromide as well as a brown band for 50mM tropinone. This level of sensitivity 
was estimated to be insufficient to be used in the bacterial assays which are discussed in 
Chapter 4. The level of sensitivity was lower than previously reported for this method 
(Coa et al, 2015), where sensitivity at 250µl of 0.2mM hyoscyamine was achieved.  
 
Figure 3.3.1: Alkaloid detection by TLC 
TLC plate which has been sprayed with Dragendorff Munier reagent to detect various concentrations 
(10µM to 50mM) of hyoscyamine hydrobromide and a single concentration of tropinone (50mM). White 
bands have been overlaid on the figure above to indicate the leading edge of the band being detected of 
each visualised lane. 
 
3.3.2 HPLC-UV  
 
Methods for detection of tropane alkaloids using HPLC-UV were developed to 
overcome sensitivity issues presented by TLC. This technique was tested with the aim 
of providing a more sensitive determination of tropane alkaloids in samples from 
bacterial expression assays.  
      10 µM      100 µM       1 mM    10 mM     25 mM      50 mM                                    50 mM                            










Figure 3.3.2: HPLC Chromatogram using tropane alkaloid standards 
Chromatogram of metabolite standards which were used in the bacterial experiments (described in 
chapter 4). 5 µl of a 1 mg/ml of standard was injected with detection at 207nm, peaks for the tropane 
alkaloids being detected can be seen labelled, A = hyoscyamine, B = anisodamine and C = scopolamine.   
 
Figure 3.3.3: HPLC Chromatogram of media spiked with tropane alkaloids. 
Chromatogram of LB media spiked with hyoscyamine for the detection of tropane alkaloids in the whole 
cell biotransformation experiments. It appears that there is masking of the hyoscyamine by the 
constituents of the LB media, so either Solid-Phase Extraction (SPE) or Liquid-Liquid Extraction (LLE) 
would be required to remove interfering compounds from these samples 












1 - 1_12_16_RE-START #3 [modified by hplcuser] Hyoscyamine Std. 1000 UV_VIS_1
2 - 1_12_16_RE-START #5 [modified by hplcuser] Anisodamine Std. 1000 UV_VIS_1


































































 Figure 3.3.2 shows an overlapped chromatogram of tropane alkaloid standards 
which will be under investigation in subsequent assays. The chromatogram shows that 
the tropane alkaloids hyoscyamine (black trace), anisodamine (blue trace) and 
scopolamine (pink trace) can be detected and there are peaks which are unique to each 
of them allowing for differentiation. Whilst the tropane alkaloids can be detected when 
run as standards, Figure 3.3.3 shows that there is a masking affect for media samples 
which have had hyoscyamine added and run under the same conditions. This indicates 
that the composition of the LB media which will be used in whole cell 
biotransformation assays (discussed in chapter 4) masks the detection of the peaks for 
hyoscyamine.  
 
3.3.3 ThermoFisher Scientific’s OrbiTrap™ LC-MS system 
 
As it was clear that components of the LB media interfered with the detection of 
tropane alkaloids using HPLC, a system which allowed for greater sensitivity was used 
for the development of sample extraction and chromatography conditions. The 
OrbiTrap™ LC-MS/MS system was used for the elucidation of both these processes, 











Table 3.3.1: Column retention times for tropane alkaloids 
Retention times for TAs and associated compounds used in method development using the OrbiTrap™ 
LC-MS system. A chromatogram of these compounds can be seen in Figure 3.3.4. 
 
Compound Retention Time (minutes) 
Ornithine 1.61 











Figure 3.3.4: Tropane alkaloid chromatogram generated during method development on 
the OrbiTrap™. 
Chromatogram of the compounds summarised in Table 3.3.1 from the OrbiTrap™. There is a clustering 
of the smaller molecular weight compounds (such as ornithine, tropinone and tropine) being eluted within 
the first three minutes, during which the mobile phase is ddH2O + 0.1% formic acid (Phase A). A = 
ornithine, B = calystegine A3, C = tropinone, D = tropine, E = phenylalanine, F = scopolamine, G = 
atropine.  
 
Within the first three minutes the clustering of the smaller molecular weight 
metabolites of interest indicated that they are not well retained or separated on the 
column compared to the relatively higher molecular weight tropane alkaloids 
hyoscyamine and scopolamine. Although the smaller metabolites elute relatively 
quickly using this method, the ability to detect them individually is not affected.  
 
3.3.3.1 Comparison of extraction methods.  
 
A reliable method for the extraction of tropane alkaloids from plant tissues was 
developed and validated. This was done through the comparison of two published 
extraction methods (method S described in section 2.6.2; and the method V described in 
Vorst et al, (2005)) and using the OrbiTrap™ for detection. The analysis was conducted 
on 100 mg extracts of Datura stromonium leaves and the results can be seen in Figure 
3.3.5. For each metabolite, the average relative peak abundance of three injections for 
each Datura leaf sample has been given. These extraction methods show that there are 
significant differences in the detection of the metabolites; ornithine (P = 0.0011), 
littorine (P = 0.0009), phenylalanine (P = 0.0138) and phenylpyruvic acid (P = 0.0038) 
between the methods, with the other metabolites under initial investigation showing no 
significant difference in detectability. There is also no significant difference seen 
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used the Vorst et al (2005) method, which are indicated in Figure 3.3.6. This shows 
method S is more reliable because there is less variability and in most cases comparable 
recoverability for the metabolites associated with the tropane alkaloid biosynthesis 
pathway, such as phenylalanine, showing greater stability in the extraction.  
 
Figure 3.3.6 shows two chromatograms from a single injection of the sample 
‘V3’. This demonstrates that there are also other metabolites co-eluting at the same 
retention times as the metabolites of interest in this study. The lower chromatogram 
indicates the masses and the relative intensity of metabolites which are eluted from the 
column between ten and twelve minutes. The peaks of m/z 304.15 and 290.17 relate to 
atropine (hyoscyamine) and scopolamine. Due to the nature of the plant extract being 
analysed and the structural similarity of the higher molecular weight, more 
economically valuable tropane alkaloids. It can be suggested that the peak with an m/z 
of 306.17 probably relates to the intermediate anisodamine which has a reference mass 
























































Figure 3.3.5: Extraction methods differences on Tropane alkaloid recovery. 
Recovery of tropane alkaloids from extracts of Datura leaf using two different extraction methods: S = 
method described in 2.6.2, V = Vorst et al, 2005. Each bar shows the average peak area for compounds 
being detected from three injections of each extract. Error bars represent standard deviation between each 
injection (n = 3). * indicates a significant difference where P < 0.05, ** indicates a significant difference 
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Figure 3.3.6: Chromatogram and detailed peak analysis from an extract analysed on the OrbiTrap™. 
Top: Chromatogram of the compounds eluted from a single injection of a spiked sample using one of the potential extraction methods under investigation (extraction method as 
described in Vorst et al, 2005). Bottom: m/z and abundance of compounds found under the peaks highlighted by the red bar in the top chromatogram. This enables the determination 
































3.3.4 Agilent QqQ-LC-MS/MS 
 
With chromatography for the detection of tropane alkaloids developed using the 
OrbiTrap™ LC-MS system a method for the quantitative detection of tropane alkaloids 
and associated metabolites was optimised. 
 
Table 3.3.2 outlines the conditions to generate the product ions required for 
detection of each of the metabolites which are to be quantified within associated studies 
(Chapters 4, 5 and 6). The product ions given are the ones used in the MRM method for 
the detection and quantification of these metabolites, along with the fragmentation 
voltages and collision energies required to generate these product ions. A schematic 
representation of the fragmented ions produced by this process can be seen in Figure 
3.3.7, where the four ions produced from scopolamine can be seen, the other 
metabolites undergo the same process and the masses of all fragments produced can be 
found in appendix A.3.2.  
 
Once the metabolites which were to be investigated within this project had 
undergone optimisation using QqQ-LC-MS/MS, the linear range for quantification 
needed to be determined. To do this a mixture of metabolite standards was produced, 
serially diluted and then 5 µl of each dilution was injected in triplicate. This process was 
required to validate the MRM to be used in subsequent analysis. These were 
subsequently tested using both Datura leaf and potato tuber sprouts, and the results of 























































































Table 3.3.2: Tropane alkaloids ions optimised for the QqQ-LC-MS/MS. 
List of parent and fragment ions for metabolites from the tropane alkaloids biosynthesis pathway under 
investigation and used in the MRM. Also included are the fragmentation voltages and collision energies 
used to generate the observed fragment ions. See A.3.2 or a complete list of all fragments produced for 
each metabolite of interest.  
 



















Figure 3.3.7: Fragmentation of scopolamine.  
Schematic representation of the one of the tropane alkaloids, scopolamine showing the fragments 













Table 3.3.3: Generated standard curve data for metabolites under investigation. 
Slope, Intercept and Linear Correlation of metabolites during the MRM method development.  
 
Table 3.3.3 shows the standard curve data produced for the MRM being used in 
this study. These are a result of the injections of a metabolite mixture at eight 
concentrations from 0.01 to 20 ppm. The linear correlations are within an acceptable 
range for the metabolites to be detected across this broad concentration range.  
 
Metabolite Slope Intercept R2 
Ornithine 5646.89 334.42 0.99 
Labelled Ornithine 11531.99 877.38 1.00 
Tropinone 22721.94 28682.47 0.99 
Calystegine A3 14950.69 -7138.12 0.99 
Tropine 30626.44 16584.28 0.98 
Phenylalanine 107562.83 10163.79 1.00 
Littorine 55695.74 36461.28 0.99 
Hyoscyamine 150563.81 94885.50 0.99 
Anisodamine 58827.89 47832.83 0.99 
Scopolamine 64568.69 56966.47 0.99 
















































Figure 3.3.8: Multiple Reaction Monitoring metabolite detection 
Detection of metabolites of interest from freeze dried Datura leaf and Solanum tuberosum cultivar 
Desiree sprout, using an MRM with most of the metabolites of interest from the tropane alkaloids 
biosynthesis pathway. This is a single sample for each which has undergone two injections, with the error 










Whilst initially suggested for the removal of interfering compound from the LB 
media of planned bacterial expression assays, the possibility that samples may need to 
undergo LLE (Liquid-Liquid Extraction) purification was investigated using Datura 
leaf and Solanum tuberosum tuber sprouts. Figure 3.3.9 A and B shows the effects of 
sample clean up after using the EXtrelut® NT-1 columns, when run on the Agilent QqQ-
LC-MS/MS. Samples underwent this LLE clean-up technique to determine if 
metabolites which could interfere with the detection of the tropane alkaloids being 
investigated are able to be removed and then the tropane alkaloids can be concentrated 
prior to undergoing detection. There are both Datura leaf and Solanum tuberosum 
samples which have and have not undergone LLE on the EXtrelut® NT-1 column. The 
samples which were to undergo LLE purification had exogenous atropine added to them 
to determine if there was retention on the column for this tropane alkaloid. Within the 
Datura leaf sample (Figure 3.3.9, A), there is a clear elevated level of hyoscyamine 
from the sample which underwent LLE, however, there are no other tropane alkaloids 
present in a comparable level to the sample which did not undergo LLE. In Figure 3.3.9 
B, the comparison from Solanum tuberosum sprout tissue indicates that the precursors 
to the tropane alkaloids biosynthesis pathway and the endogenous metabolites of the 
nortropane alkaloids pathway are present in higher levels within the sample which has 
not undergone the LLE protocol. The levels of hyoscyamine retained were also lower 
within the sprout sample which underwent the LLE, compared to the Datura sample; 
however, this could be due to the presence of endogenous atropine within Datura.  
 
Figure 3.3.9 also shows that without any manipulation to the tropane and 
nortropane alkaloid pathway the metabolites prior to the tropinone branch point are 
detectable in Solanum tuberosum sprout tissue, whereas, in Datura leaf samples the 
metabolites from both the tropane and nortropane biosynthesis pathways are detectable. 
Appendix table 3.3 (A.3.3) gives a numerical representation for the results displayed in 
Figure 3.3.9 as some of the values are too small to visualise. 
 




Figure 3.3.9: Effects of LLE on metabolite recovery.  
Comparison of peak areas from Datura leaf (A) and Solanum tuberosum cultivar Desiree sprout (B) 
samples run on the QqQ-LC-MS/MS. Samples highlighted by ■ have not undergone LLE, whilst those 
denoted by □ have undergone LLE on the EXtrelut® NT-1 columns. Samples which underwent LLE had 
exogenous atropine applied to determine the recovery of this compound after clean up. There is an 
indication that whilst atropine is able to be recovered in both the Datura and potato samples, the further 
downstream metabolites such as scopolamine in the Datura sample do not appear to be as well detected in 
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The development of a rapid method for the detection of tropane and nortropane 
alkaloids from bacterial recombinant protein and transgenic assays was necessary. This 
would allow for high sample through-put, whilst reducing the demand upon the LC-MS 
facility. Previously, Dräger (1995 and 2002), Keiner and Dräger (1999) and 
Kokotkiewicz et al, (2017) have suggested that TLC is a suitable tool for this rapid 
screening; however it was found that the sensitivity achieved was unsuitable for the 
requirements of the planned assays within this study. The detection of metabolites of 
interest was conducted to a low concentration, however, to achieve a comparable level 
of sensitivity to Keiner and Dräger (1999) and Kokotkiewicz et al, (2017), a 500 µl 
loading of 0.1mM of hyoscyamine would needed to have been applied and detected on 
the TLC plate. This leads to technical difficulties, as the ability to efficiently spot this 
volume would not have been able to be conducted easily, nor would using a more 
concentrated sample preparation to reduce the required volume. Although this technique 
should be able to be optimisable, limitations with not knowing concentrations of tropane 
alkaloids potenitally produced in assays this technique could be applied too, and the 
availablilty of equipment with greater sensistivity means that for the purposes of the 
project this technique was not followed up on.  
 
Similarly, the masking of compounds seen in Figure 3.3.3, by the LB media in 
samples run on the HPLC-UV indicated that a clean-up protocol needed to be 
considered if the HPLC-UV was to be used. The purification of samples by LLE was 
examined and tested on samples run on the Agilent QqQ-LC-MS-MS system and is 
discussed further below. To overcome the issues which were presented from the TLC 
and HPLC-UV, the development of detection methods which allowed for greater 
sensitivity and metabolite selection were undertaken.  
 
The OrbiTrap™ offered greater qualitative sensitivity, as it was able to give an 
indication of the presence of, and accurate mass values for metabolites within a sample. 
Whilst being able to give accurate mass readings, if there are metabolites within a 
sample which had no reference mass size, the OrbiTrap™ is able to fragment these 
unknown metabolites. Then based on the fragmentation size and pattern of the unknown 
peaks chemical formulae can be suggested, to later check against reference standards. 
These suggested formulae are then able to be screened against suspected metabolites 




and then checked against a reference standard, which should give the same peak and 
retention time. This is one of the unique features of this detection apparatus and allows 
it to stand out as a highly accurate investigative tool for use in manipulated pathway 
interactions. However, whilst the OrbiTrap™ allows for an accurate qualitative 
determination of alterations to metabolomic pathways, the QqQ-LC-MS/MS system can 
give greater quantification to the same samples.  
 
 Metabolites which have been optimised from the tropane alkaloid biosynthesis 
pathway using the QqQ-LC-MS/MS within this study, give parent and fragment ions for 
the high value tropane alkaloids which are consistent with the recently published ions 
generated in Chen et al, (2017) and Zhou et al, (2017) as described in Table 3.1.1, and 
A.3.2. The overlap in these ions indicates that although different systems were being 
used, the reproducibility of the product ions produced by CID was as expected. With 
this information, there is confidence that the product ions which are given for the other 
metabolites along the biosynthetic pathway will be able to be replicated. Therefore the 
quantitative and robust method for known and expected metabolites along the 
biosynthetic pathway suggests that the QqQ-LC-MS/MS system was of more use due to 
the quantifiable nature of the data provided and the high accuracy and specificity that 
the system is able to provide.  
 
Whilst moving towards detection apparatus which exhibit greater sensitivity, the 
development of suitable extraction and running methods for use on the OrbiTrap and the 
QqQ-LC-MS/MS systems was required and accomplished with the adaptation of 
previously published methods. Once the chemistry and packing material of the 
chromatographic column to be used in the separation of tropane and nortropane 
alkaloids in this study was selected, the chromatographic method could be developed.  
 
The method used was adapted to the column, as retention and separation of 
metabolites within the column is affected by the solvents and gradients used. The final 
separation method, as described in 2.5.3.5, was adapted from Jakabova et al, (2012), 
with the formic acid concentration being reduced from 1% to 0.1% (v/v), as well as 
mobile phase A being held at 100% for the first three minutes. A reduction in formic 
acid was applied to the mobile phases so as to reduce the interactions between the 
formic acid and the calystegines. This change was found to have a positive effect on the 
detection of the calystegines. Mobile phase A was  held for three minutes to allow the 




smaller metabolites under investigation to be eluted from the column with some 
separation occurring, whereas, if a gradient of methanol mobile phase was used, these 
small metabolites eluted with the column breakthrough.  
 
A change in the gradient phase through an extension from three to seventeen 
minutes was implemented so that 100% mobile phase B is reached over fourteen 
minutes compared to the ten minutes in the Jakabova et al (2012) study. This extension 
was applied to increase the methanol concentration within the column more slowly 
which allowed for greater separation of the tropane alkaloids hyoscyamine, anisodamine 
and scopolamine. Whereas in Jakabova et al, (2012) where 90% mobile phase B is the 
highest level of methanol, 100% was used in this study with an extended plateau at this 
stage, ensuring that the retained metabolites are eluted off the column in between 
samples. In the method developed for the LC-MS/MS systems, the plateau of 100% 
phase B is for only five minutes, before the phases are returned to 100% A over one 
minutes, for a further six minute period, ensuring the column has been re-equilibrated 
for the next sample injection.  
 
The adaptation in the running method was required, as stated for the lower 
molecular weight metabolites, such as ornithine, tropine, pseudotropine and the 
calystegines, but also due to initial uncertainty as to the interaction of hyoscyamine, 
anisodamine and scopolamine with the column. In the study conducted by Jakabova et 
al, (2012) the separation and detection of atropine and scopolamine was investigated, 
giving an indication of the retention times expected for these metabolites. Figure 3.3.4 
shows that there is clear separation for the tropane alkaloids hyoscyamine, anisodamine 
and scopolamine, yet the lower molecular weight precursors and nortropane alkaloids 
can be detected but not separated. Whilst there is this co-elution of lower weight 
metabolites, there is no detrimental effect on the detection and quantification of these 
products in the MRM which has been developed. 
 
The method for extraction of metabolites from the tropane alkaloid biosynthetic 
pathway was required to recover metabolites from plant material with a high efficiency.  
There are numerous methods described for metabolite extraction (Keiner and Dräger, 
2000; Vorst et al, 2005 and Jakabova et al, 2012) and in some cases metabolite 
detection is conducted by GC-MS.  From the two methods which were trialled in this 
project, method S, (as described in 2.6.2) is overall more effective in extracting the 




lower molecular weight metabolites of interest as well as not showing any significant 
difference in extraction and recoverability of the higher molecular weight (and more 
economically important) tropane alkaloids. The ability to extract the early, low 
molecular weight metabolites was important in the development of the extraction 
method as this is the area of the biosynthetic pathway which is predicted to see the 
greatest effect in transgenic work to be undertaken. Whilst there was no significant 
difference in the extractability of the higher molecular weight tropane alkaloids between 
method S and the method described in Vorst et al, (2005) the lower molecular weight 
metabolite and pathway precursor ornithine and tropane alkaloid intermediate littorine 
were retained and detected significantly better from extracts using method S (P values 
<0.01 and <0.001 respectively (n=3)). This can be seen in Figure 3.3.5 where the 
relative peak abundance for each of the metabolites is shown. For the metabolites 
extracted using method S there was no significant difference between each of the 3 
extracts tested, whereas for metabolites extracted using the Vorst method, there were 
significant differences shown between extracts V1 and V3 when they were compared to 
extract V2 for the metabolites littorine, ornithine, phenylpyruvic acid and atropine 
(racemic hyoscyamine) (P <0.01), and phenylalanine and phenyllactic acid (P <0.05). 
Method S and the method described by Vorst et al (2005), differ with respect to solvent 
used with 1:1 methanol:H2O (v/v) with no formic acid in S, compared to 62.5:37.5 (v/v) 
with 0.125% formic acid in Vorst et al, (2005). This difference in ornithine recovery is 
in agreement with the findings of Friedman et al, (2003) who suggest that non-acidified 
buffers are better suited for the nortropane alkaloids, which are lower in molecular 
weight compared to tropane alkaloids. It has been shown that the non-acidified buffer 
used in method S, did not have any detrimental effect on tropane alkaloid recovery.  
 
To understand the differences between the two extraction methods trialled and 
the variability within the samples, during the extraction method development (Figure 
3.3.5), the addition of a known quantity of metabolite and the recovery of this from the 
sample would be a useful tool. These, however, were not undertaken in the development 
of the extraction protocol, due to machine time constraints, but will be discussed due to 
the use through determining if LLE purification is suitable.  
 
The LLE purification protocol which has been trialled in this method 
development was previously described as successful by Richter et al, (2007). However, 
more recently Sramska et al, (2017) found that less than half the initial spiked amount 




of hyoscyamine was retained and recovered from the purification columns in the studies 
they undertook. This shows similarity to the results which are indicated in Figure 3.3.9, 
in particular the differences between the detectability of the high value tropane alkaloids 
in the Datura samples which have undergone LLE and those that have not. Having 
followed the protocol in Richter et al, (2007) it was unclear as to why similar results 
were not seen, this lead to the belief that the characteristics of the column had changed 
in the time between the two studies. Through personal communication with a 
representative of Merck Millipore Technical Services, it was confirmed that the packing 
material of the EXtrelut® columns had changed after the assays were undertaken by 
Richter et al, and prior to the work in this study and the assays of Sramska et al being 
conducted. Therefore the LLE purification method hoped to be utilised for plant and 
bacterial samples was no longer suitable for this study.   
 
A single 100mg sample of Datura stromonium leaf and potato sprout was 
extracted using method S and run on the QqQ-LC-MS/MS to determine if the 
metabolites along the tropane alkaloid and nortropane alkaloid biosynthesis pathway 
could be detected from both sources within the MRM developed.  Figure 3.3.8 shows 
that whilst there is variation between the two samples with regards the concentration of 
individual metabolites this can be explained through the tissues which have been 
extracted. Datura leaf is not the site of tropane alkaloid biosynthesis (Hashimoto et al, 
1986), however the leaves are the storage sites for the alkaloids, so the reduced levels of 
ornithine, calystegine and increased tropane alkaloids compared to the potato sprout 
where the nortropane alkaloid biosynthesis pathway is active, indicative of the higher 
calystegine level. Although this experimental data set is extremely small with only a 
single extraction and two injections into the machine it highlights that the metabolites 
along the tropane alkaloid and nortropane alkaloid pathway are able to be detected from 













3.4 Moving forward 
 
 With the development of a robust and repeatable extraction and detection 
method for the Agilent QqQ-LC-MS/MS, there is confidence in the ability to discern 
any metabolite changes to the tropane alkaloid biosynthetic pathway in transgenic lines 
being produced and any tropane alkaloid conversion during recombinant protein assays. 
  
 If this study was repeated and to increase the throughput of screening assays, the 
development of spectrophotometric techniques could be an advancement. Utilising a 
spectrophotometric plate reader, multiple samples could be read in tandem and in 
replication, thus discerning any tropane alkaloid changes within them. These samples 
could then be followed up using the more sensitive QqQ-LC-MS/MS technique for 






















              
















Chapter 4: Functional characterisation of a candidate 



















              





It is known that there is a lesion in the tropane alkaloid biosynthesis pathway at 
the tropinone branch point within potato, due to the limited expression and/or enzyme 
activity of trI (Keiner and Dräger, 1999). However, there is little understanding as to the 
presence and functionality of any downstream genes which are responsible for the 
production of high value tropane alkaloids. The purpose of the work described in this 
Chapter is to investigate if any of these downstream genes are present within the potato 
genome and elucidate any functionality, which may be present, whilst also ensuring that 
a limited MRM detection method which was developed in Chapter 3 can be applied to 
bacterial assays.  
 
In members of the Solanaceae which produce the high value tropane alkaloids 
hyoscyamine and scopolamine, littorine mutase/monoxygenase (cyp80f1) and 
hyoscyamine-6β-hydroxylase (h6h) are known to be expressed in the cells of the root 
pericycle. Expression and conversion of hyoscyamine to scopolamine has also been 
reported in cultured cells of Datura stramonium, leaves of Hyoscyamus muticus and 
shoots of Datura metel (Pramod et al, 2010a) suggesting that the h6h enzyme is 
functional in these tissues and alkaloid biosynthesis can occur. Functional expression 
analysis of h6h has been undertaken in a number of solanaceous species such as 
Hyoscyamus niger (Rocha et al, 2002), Datura metel (Pramod et al, 2010b), Anisodus 
tanguticus (Liu et al, 2005) and Atropa belladonna (Li et al, 2012). The formation of 
hyoscyamine requires the re-arrangement of littorine, and this is catalysed by a 
cytochrome P450; cyp80f1 (Li et al, 2006). cyp80f1 activity results in the formation of 










              















Figure 4.1.1: Conversion of hyoscyamine to scopolamine by h6h.  
Schematic representation of the conversion of hyoscyamine (A) through the intermediate anisodamine (B) 
to the final high value tropane alkaloid scopolamine (C). h6h catalyses the introduction of a 6β-hydroxyl 
group onto the tropane ring (indicated by the *), with h6h then closing and forming an epoxide ring 
through the removal of the hydrogen atoms at C7 and on the introduced hydroxyl group (denoted by the 
**) (Humphrey and O’Hagan, 2001).  
 
To assess the functionality of annotated h6h genes from Brugmansia candida 
and Anisodus actuangulus, recombinant protein expression assays have been developed 
(Cardillo et al, 2017; Coa et al, 2015). This has been shown to be a useful tool in the 
determination of protein functionality and in some cases conversion through whole cell 
biotransformation assays has yielded the downstream tropane alkaloids; anisodamine 
and scopolamine. Cardillo et al, (2017) have shown that conversion to anisodamine and 
scopolamine can occur in the presence and absence of co-factors (such as sodium 
ascorbate and 2-oxoglutarate) but the percentages of substrate conversion are 
remarkably different. Utilising the h6h cDNA sequence from Brugmansia candida and 
in the presence of co-factors, 82.16 ± 5.28 % hyoscyamine was converted to 
anisodamine and 12.82 ± 4.28 % to scopolamine, whereas in the absence of these co-
factors conversion was 5.22 ± 0.18 % and 0.67 ± 0.39 % respectively after 25 hours. 
Coa et al, (2015) also demonstrated that E. coli expressing a S14P/K97A mutant of 
Anisodus actuangulus h6h yielded 100 % hyoscyamine conversion to scopolamine after 
48 hours, when compared to E. coli cells which expressed the wild type Anisodus 





              
  Chapter 4 
92 
 
the remaining 25 % to scopolamine.  S14P/K97A Aah6h mutants have mutations at the 
Ser14 and Lys97 amino acids, which are conserved within h6h of solanaceae members.  
Although these amino acids are outside the binding regions for co-factors and 
substrates, it is speculated that changes in these regions can have an effect on enzyme 
activity through interactions with other residues resulting in changes in enzyme 
conformation (Coa et al, 2015). 
 
Using the recombinant h6h protein from Atropa belladonna in functional assays, 
Li et al, (2012) demonstrated that the affinity for Abh6h to hydroxylate hyoscyamine is 
lower than that of other tropane alkaloid producing species such as Hyoscyamus niger 
and Anisodus tanguticus. The Km values for the h6h proteins assayed were 52.1 ± 11.5 
µM (Abh6h), 35 µM (Hnh6h) and 15.1 ± 0.3 µM (Ath6h). As well as Abh6h exhibiting a 
lower affinity for hysocamine in the hydroxylation step, the Km and Vmax values for the 
epoxidation step of the reaction (the formation of scopolamine from anisodamine) 
indicate that Abh6h is not as efficient as the h6h from the other sources. The Vmax value 
for the epoxidation step was 0.1% that of the Vmax for the hyoscyamine hydroxylation 
step. Li et al, (2012) concluded from this that the epoxidation step is slower than the 
hydroxylation step within Atropa belladonna, but it is not known if this is universal 
across TA producing species for this part of the pathway.   
 
Enhancement of tropane alkaloid production in members of the solanaceae has 
also been achieved through the overexpression of h6h.  Duboisia hybrid hairy root 
cultures were shown to exhibit an increase in the content of scopolamine present from 
74.3 and 74.9 % in control lines to between 76.0 and 89.7 % in transformed 
overexpression lines (Palazon et al, 2003). Rahman et al, (2006) overexpressed h6h in 
hairy root cultures of the non-hybrid, Duboisia leichhardtii and observed scopolamine 
production rates of 38.2 mg l-1 after 6 weeks growth using an initial 9 mg of fresh roots, 
but when using a Duboisia hybrid (similar to that of the Palazon et al study), 74.5 mg/l 
scopolamine was produced after 4 weeks and with 100 mg fresh roots. Rahman et al, 
(2006) also noted that dramatic increases in scopolamine production rates were seen 
when combining h6h with putrescine N-methyltransferase (pmt) and this yielded 411.2 
mg/l scopolamine from Hyoscyamus niger root cultures. This suggests that exogenous 
expression of h6h and associated genes may have a greater enhancement effect for 
increasing the production of high value tropane alkaloids from current production 
sources.  
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The potato, Solanum tuberosum as discussed in Chapter 1, does not produce 
high value tropane alkaloids, such as hyoscyamine and scopolamine, due in part to the 
aforementioned lesion at the tropinone branch point. However, in wild potato species 
there has been shown to be homology between 2-oxoglutarate-dependent dioxygenases 
within the species Solanum chacoense Bitt. and h6h from Hyoscyamus niger (60 % 
similarity and 44% amino acid identity) (Lantin et al, 1999). As h6h is a 2-oxogluterate-
dependent enzyme (Kanegae et al, 1994) like the dioxygenase found in the wild potato 
species, it is possible that the Solanum tuberosum genome may hold orthologues of h6h, 
but the reaction products are not detected because of a lack of substrate being produced, 
due to the trI lesion. Through the process of wounding as well as plant defence response 
elicitors the expression of an h6h-like protein was induced within potato (Nakane et al, 
2003), suggesting that h6h orthologues are present within the potato genome.  
 
This study will, in the first instance, search the potato genome for h6h 
orthologues, and then attempt to synthesise, express and determine functionality of 
these through whole cell biotransformation assays. This will allow us to determine if 
they are functional or if they represent another lesion along the tropane alkaloid 
biosynthesis pathway. In planta functional assays will be undertaken in parallel to 
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4.2 Materials and Methods 
 
4.2.1 Generation and characterisation of h6h recombinant plasmids 
 
 Figures 4.2.1, 4.2.2 and 4.2.3 detail the process of generating plasmids capable 
of producing recombinant h6h proteins through the pET-28a+ expression vectos.  
 
4.2.2 Biological Replication 
 
  Bacterial transformation assays for each temperature and construct were carried 
out in triplicate (n = 3). For the hyosycamine plate feeding assay on Solanum tuberosum 
cultivar Désirée plantlets, replication occurred with n = 3 for control plantlets and 






















              





















































































































































































































































































































              




Figure 4.2.2: Diagram of the completed pET28a+-Sth6h_A vector.                                    
The BamHI/NdeI restriction endonuclease digestion sites are shown on the diagram and yield a 1066 and 












Figure 4.2.3: Virtual and enzymatic digestion of pET-28a+ vectors 
A: Virtual digestion map showing the expected band sizes for two of the pET-28a+ h6h plasmids (lane 1 = 
pET-28a+ Sth6h_A; lane 2 = pET-28a+ Dsh6h), produced using the online software Benchling 
(www.benchling.com). B: BamHI/NdeI restriction endonuclease digestion of pET-28a+ Sth6h_A (lane 1 = 
pGEM-T_Sth6h_A, lane 2/3/4 = pET-28a+ Sth6h_A) C: EcoRI/NheI restriction endonuclease digestion of 
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Using a keyword search within the potato genome browser (www.SpudDB.com) 
for ‘hyoscyamine’ two sequences were returned with high similarity to the h6h 
sequence of tropane alkaloid producing species. These sequences were 
PGSC0003DMT400070444 (NCBI Gene Accession number: XM_006340300.2) and 
PGSC0003DMT400069454 (NCBI Gene Accession number: XM_006352681.2) and 
will be respectively referred to as Sth6h_A and Sth6h_B through the rest of this work. 
To ensure that the sequences returned via SpudDB from potato were homologous to 
bonafide h6h sequences from tropane alkaloid producers; these sequences underwent 
BLASTp analysis within the NCBI. With these genes identified within the potato 
genome, a phylogenetic analysis was conducted against species which are known 
producers of TAs and it can be seen that there is a close relationship with the sequences 
from potato and Hyoscyamus aureus for Sth6h_A and Datura inoxia and Duboisia for 



































Figure 4.3.1: Phylogentic relationships between h6h from potato and tropane alkaloid 
producers.  
Phylogenetic relationships between Sth6h_A in panel A, and Sth6h_B in panel B compared to nucleotide 
contigs of h6h genes from tropane alkaloid producing species. These contigs have been generated from a 
BLASTn analysis by Daniel Schlesinger (ARO, Israel), with the trees produced with MEGA6 using 
Maximum Likelhood method with 1000 replications. 
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The phylogenetic relationships and coding sequence similarities (shown in 
Figure 4.3.2) between the two h6h genes from potato and tropane alkaloid producing 
species suggest that there is potential for the potato h6h genes to share h6h activity. The 
regions highlighted for both the Fe2+ and 2-oxogluterate substrate binding domains are 
the areas which are important for the catalytic activity of the enzyme (Jaber-Vazdekis et 
al, 2009 and Dehghan et al, 2013). This analysis stimulated further studies to 
understand how well these potato orthologues are expressed within potato tissue. 
Interestingly, there is 93% sequence similarity between the Sth6h_A and the predicted 
h6h sequence from Solanum lycopersicum (XM_004527798.2).  
 
qRT-PCR analysis showed that the expression profiles for these two h6h potato 
orthologues varied across growth stages of Solanum tuberosum cultivar Désirée from 
both leaf and root tissues. These genes were both highly expressed in root tissue (Figure 
4.3.3.A) compared to leaf at all time points (Figure 4.3.3.B), correlating with the site of 
tropane alkaloid biosynthesis in plant species which produce tropane alkaloids 
(Hashimoto et al, 1991). The error bars for the two Sth6h genes analysed in both tissues 
show large variation at certain time points. In the samples from roots, large error bars 
appear during the Tuber Initiation stages (T.I I and T.I II). In leaf tissue, the largest error 
bars can be seen in the Vegitative Growth stage III (V.G III). The size of the error bars 
in both cases, could be caused by a number of reasons such as; the quality of the 
extracted RNA used in the assays; physiological changes within the tissues at the time 
of harvest and extraction or there are inhibitory factors within the reaction mixtures 
from cDNA synthesis through to the qRT-PCR. 
 
As these genes are expressed in planta, functional analysis was undertaken. The 
cDNA representing these genes were cloned from potato root and ligated into the 
recombinant protein expression vector pET-28a+ (Chapter 2.2.2) with h6h from Datura 
stromonium being used as a positive control in downstream assays. Figure 4.3.4, shows 
that after protein induction with 1 mM IPTG, there was production of the histidine 
tagged recombinant h6h protein. The signal seen in Figure 4.3.4 is of the 
chemiluminescent detection solution working against the secondary antibody. This 
indicates that the h6h protein from all sources was induced and expressed over the 48-
hour time period, and that the protein generated was of the expected molecular weight.  
 



















Figure 4.3.2: h6h amino acid aligments between species within the solanaceae.           
Schematic of amino acid alignment with 2-oxogluterate and iron binding domains expanded to show differences between species within the solanaceae that can and 
can not produce tropane alkaloids. The species which do not produce tropane alkaloids are Sth6h_A, Sth6h_B and Slh6h (XP_004251246.1), with Dsh6h 
(ALD59774.1), Aah6h (ABM74185.1), Abh6h (AEN79443.1), Hnh6h (BAA05630.1), Bch6h (ACB40931.1), Dmh6h (AAQ04302.1) all producing tropane 
alkaloids. Amino acids with 100% similarity are highlighted in black, and those with > 50% similarity are highlighted in grey. Coloured amino acids highlight 
differences. Protein length is between 360 - 365 amino acids. The orange boxes represent the regions which contain the Fe2+ binding domains and the green box 
representing the 2-oxogluterate substrate binding domains. Alignments produced using BioEdit version 7.2.5 
 
 






Figure 4.3.3: qRT-PCR time course analysis of h6h in potato tissue.                        
A = qRT-PCR analysis of Sth6h_A and Sth6h_B relative expression levels from Solanum tuberosum 
cultivar Désirée roots. This indicates that both h6h genes under investigation within potato are expressed 
well in the roots with expression reaching its highest levels during tuber induction. B = qRT-PCR 
analysis of Sth6h_A and Sth6h_B relative expression levels from Solanum tuberosum cultivar Désirée 
leaf. This indicates that the expression levels of the two h6h genes from Solanum tuberosum are not well 
expressed within the leaves. (V.G – Vegetative Growth, T.I – Tuber Induction, T.B – Tuber bulking, M – 



























Figure 4.3.4: Western blot analysis of histidine tagged recombinant h6h  
Protein extracted from IPTG induced E. coli strain BL21 cells over a 48 hour time course. For the three 
h6h proteins under investigation it can be seen that there is protein expression after 24 and 48 hours, 
giving proteins of the expected molecular weight (Dsh6h – 41.5 kDa, Sth6h_A – 41.1 kDa and Sth6h_B – 
40.3 kDa); un-induced Dsh6h is used as a control to ensure there is no basal protein expression within the 
BL21 cell cultures. Primary antibody: 6x-His Tag Monoclonal antibody raised in mouse (Mus), 
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With these h6h proteins being expressed within bacterial cell cultures, 
metabolite conversion assays were carried out. Figure 4.3.5 and 4.3.6, show that there 
was conversion of hyoscyamine to both anisodamine and scopolamine over the 48 hour 
time period for Dsh6h at both 16 and 28oC, whereas for both Sth6h_A and Sth6h_B 
there was no metabolite conversion detected over the same time period. This suggests 
that whilst the CDS encodes for a protein that was induced and expressed, there is no 
evidence of h6h activity for the potato protein in contrast to that observed with the 
control Dsh6h. With regards to Dsh6h conversion assays, at 16 and 28oC there were 
detectable levels of scopolamine present within the cells cultures after 48 hours as well 
as no detectable hyoscyamine within the 16oC assay after 48 hours. Assays at 24 and 
37oC were also conducted and showed that there was conversion to anisodamine for 
Dsh6h at both temperatures, as well as further conversion to scopolamine detectable at 
24oC, although this was lower than the levels detected in both the 16 and 28oC assays. 
For both Sth6h assays at these temperatures there was no conversion detected (data not 
shown).  
 
With recombinant protein assays for Sth6h demonstrating that the h6h sequences 
under investigation were not functional within the bacterial system, in planta feeding 
assays were undertaken to determine if h6h exhibits activity in planta. During a pilot 
study using cultivar Désirée plantlets, root growth appeared to be suppressed in plants 
which were grown on hyoscyamine spiked MS20 media. Although this data is not 
shown due to the small scale of the experiment, for the subsequent in planta assays, 
Désirée plantlets were sub-cultured onto fresh spiked media with and without roots to 





























Figure 4.3.5: Tropane alkaloid biotransformation by Dsh6h and Sth6h at 16oC. 
Panels representing the change in tropane alkaloid level over the 48 hour time course, for h6h 
recombinant protein assays at 16oC. In the Datura stromonium control assays, it can be seen that 
hyoscyamine is converted into anisodamine and scopolamine over the 48 hour time course. However, in 
both of the Solanum tuberosum h6h assays at this temperature, no conversion is detected. The results at 





























Figure 4.3.6: Tropane alkaloid biotransformation by Dsh6h and Sth6h at 28oC. 
Panels representing the change in tropane alkaloid level over the 48 hour time course, for h6h 
recombinant protein assays at two temperatures 28oC. In the Datura stromonium control assays, it can be 
seen that hyoscyamine is converted into anisodamine and scopolamine over the 48 hour time course. 
However, in both of the Solanum tuberosum h6h assays at this temperature, no conversion is detected. 
The results at each time point are the averages of 3 replicates and the s.e.m is shown (n=3).  




Figure 4.3.7: Functional assay to determine In planta h6h activity.  
In planta functional assay to determine if there is any endogenous h6h activity within Solanum tuberosum 
cultivar Désirée plantlets. The plantlets in this assay were grown on MS20 in the presence or absence of 
hyoscyamine, as well being sub-cultured with roots still intact (Désirée plus roots (n = 3)) or as a fresh 
nodal cutting (Désirée and no roots (n = 4)). There was no anisodamine or scopolamine detected in plants 
grown in the presence of hyoscyamine. * indicates a significant difference to control plantlets (n = 3) 
where P < 0.05.  
 
The in planta assay shown in Figure 4.3.7 demonstrates that whilst there is 
uptake of hyoscyamine from the tissue culture media, there is no conversion into the 
downstream metabolites. The analysis of plantlets and other tissues has been shown to 
be an effective way to determine the functionality of h6h. This approach has been 
utilised by both Khanam et al, (2001) and Kai et al, (2012). In their respective studies, 
Khanam et al, (2001) were concerned with the production of tropane alkaloids in shoot 
cultures of Duboisia myoporoides, whereas, Kai et al, (2012) investigated the effects of 
over-expressing trI and h6h in Anisodus acutangulus. Whilst in these previous studies, 
there was no application of exogenous hyoscyamine, Rocha et al, (2002) expressed h6h 
from Hyoscyamus niger in Nicotiana tabacum and assessed functionality through the 
application of 1 mM hyoscyamine in detached leaf assays. Within this system there was 
uptake of hyoscyamine into the leaves but this was not uniform across the lines tested; 
3000 µg/g compared to 600 µg/g FW in the best and worst lines respectively. 
Subsequent conversion to anisodamine and scopolamine was weak, with these two 
tropane alkaloids accounting for a total of 342 µg/g FW from the best line in the Rocha 
et al, (2002) study.  
* * 






Previously, the functional characterisation of h6h has been conducted for 
multiple species within the Solanaceae (Cao et al, 2015; Kai et al, 2011; Cardillo et al, 
2017; Li, van Belkum and Vederas, 2012; Hashimoto, Matsuda and Yamada, 1993; 
Jaber-Vazdekis et al, 2009; and Pramod, Singh and Jayabaskaran, 2010b), determining 
the effects of exogenous elicitors (Kang et al, 2004) as well as required reaction co-
factors (Cardillo et al, 2017) on this important enzymatic step in the tropane alkaloid 
biosynthesis pathway.     
  
The principle aim of this study was to determine whether a functional h6h gene 
that catalyses the hydroxylation and epoxidation steps of the tropane alkaloid 
biosynthesis pathway could be identified from potato. Within the potato genome 
sequence two genes were identified that were annotated as h6h genes. These sequences 
were cloned and expressed within a bacterial expression system to determine if they 
catalysed the hydroxylation and epoxidation of hyoscyamine to the final metabolite 
scopolamine.  
 
Phylogenetic analysis and CDS alignments have been used to show that 
nucleotide h6h sequence similarity between active genes from tropane alkaloid 
producers and those found within potato.  The two sequences annotated from potato 
show a relationship to sequences from other Solanaceous species in which tropane 
alkaloid biosynthesis occurs. Within the phylogenetic trees shown in Figure 4.3.1, the 
branch support (also known as bootstrap values) between Sth6h_A and Hyoscyamus 
aureus 1332 is 69, this is just below the accepted relationship level of 70, which 
indicates a convincing level of support (Lee, 2000). Due to this it cannot be strictly 
inferred that there is a true relationship between these two h6h sequences, however it 
does produce an interesting avenue for investigation. The branch support between 
Sth6h_B and the h6h contig from Datura inoxia is not indicative of a strong 
phylogenetic relationship as it returns a bootstrap value of 30. The previous branch 
which contains the Duboisia h6h and a branch support of 54, gives a little more strength 
to the possibility of a loose phylogenetic relationship, but not enough to completely 
accept the relationship. Bootstrap values are used to indicate the variability in 
distribution within the sequence data through resampling the data multiple times 
(Felsenstein, 1998). In the case of this study 1000 replicates were used in the 




development of the phylogenetic trees, which for the Sth6h_B/Datura inoxia 7865 node 
resulted in a bootstrap value of 30, indicating that node was reproduced 300 times out of 
the 1000 replicates.  
 
There is 65.9% nucleotide sequence identity for Sth6h_A and 61.8% sequence 
identity for Sth6h_B when compared to Dsh6h which was used as a control within this 
study. Whilst there are large areas of shared sequence identity between the sequences 
from potato and those from the tropane alkaloid producing species presented, 
differences within the 2-oxogluterate substrate and iron binding domains in Figure 4.3.2 
could be indicative of why no h6h activity could be detected for those potato genes 
across the four temperatures tested. Other regions exhibiting sequence differences can 
influence the activity of the potato h6h sequences, however it is unclear as to the effect 
these have.  
 
The E. coli recombinant biotransformation assays conducted to determine the 
functionality of the two Sth6h orthologues within this study have shown that there is no 
h6h activity when compared to an active h6h. The Dsh6h used within these assays, 
showed activity at all the temperatures tested, although to varying degrees. Comparison 
of this active h6h to previous studies has shown that it follows a similar pattern to the 
wild type results described in Cao et al, (2015). At 16oC, Cao et al, demonstrated that 
the wild type Anisodus actuangulus h6h catalysed the hydroxylation of hyoscyamine 
into anisodamine after 8 hours with 100% efficiency. The epoxidase activity of this 
enzyme however, appeared to be limited with 25% of the intermediate anisodamine 
being converted into scopolamine after 24 hours, with this level being maintained for 
the duration of the experiment. Whilst Cao et al, (2015) saw 100% conversion of 
hyoscyamine after 8 hours, in the assay at 16oC it took 48 hours to reach this level of 
conversion. The levels of scopolamine, from the epoxidation of anisodamine, continued 
to rise from 24 to 48 hours, suggesting that the reaction was not complete. Similar 
results were seen in the Dsh6h assays at 28oC. The similarities between the Dsh6h 
control used in this assay and the results from the Coa et al, (2015) study indicate 
Dsh6h was a suitable control to determine if the reaction conditions were appropriate to 
indicate any Sth6h activity.  
 
Cofactors such as ascorbate and catalase have been shown to be required for the 
efficient catalysis of substrates within some organisms. Catalase is required within 
organisms to keep hydrogen peroxide levels below toxic levels and E. coli is able to 




produce endogenous catalase for this purpose. The oxygen produced from the catalysis 
of hydrogen peroxide is used in the conversion of hyoscyamine into anisodamine    
Previous research conducted by Cardillo et al, (2017) discounted issues related to 
reaction co-factors being omitted as they demonstrated that bacterial strains produce 
catalase to a sufficient level that exogenous catalase is not required to be added. 
Therefore, there are no negative effects on the hyoscyamine conversion rates during 
their study. They have shown that omission of 2-oxogluterate limited the 
biotransformation efficiency of hyoscyamine to anisodamine with 95% remaining 
unconverted after 25 hours and no scopolamine being detected. In the two Dsh6h assays 
shown in Figures 4.3.5 and 4.3.6, show there is almost 100% conversion of 
hyoscyamine over the 48 hours the assay was allowed to continue. Therefore, whilst 
supplementing the culture media used in the assays within this study, may have shown 
an improvement in the reaction efficiency of the positive control, and possibly allowed 
for an increase in the amount of scopolamine produced, it is doubtful that the Sth6h 
assays which showed no hydroxylation activity would exhibit activity.  
 
The translated recombinant proteins used in this assay were produced with an N-
terminus Histidine tag. Histidine tags are six or more histidine residues and are 
relatively small in size (about 2.5 kDa) (Booth et al, 2018). Histidine tags are useful as 
90% of determined protein structures have been elucidated through the use of a protein 
tag, and the histidine tag represents a large portion of these (Booth et al, 2018). The 
histidine tag has been shown to decrease the substrate affinity and kinetic parameters 8-
fold in the GNAT enzyme superfamily, when compared to untagged enzymes (Booth et 
al, 2018).  The distribution of histidine tagged proteins within bacterial cells has been 
shown to be uneven, when expressed at 37oC over 12 hours (Park et al, 2015). 
Interference of the histidine tag on recombinant protein expression and function has 
been shown to be variable. The impact of the histidine tag on proteins expressed in this 
assay may be a contributory factor in why the Sth6h expressed proteins did not convert 
hyoscyamine. With the knowledge that the proteins from the assays in this study were 
expressed and hyoscyamine conversion in the Datura stromonium control assay, there is 
evidence that substrate binding occurred. With this it can be said that, at least Dsh6h 
protein structure was not affected by the presence of the histidine tag, this is unable to 
be confirmed for the two Sth6h proteins. Whilst it may be speculated that enzyme 
kinetics may have been decreased due to the presence of the histidine tag, which is 
similar to the results described in Booth et al, (2018) without experimental comparisons 




of the kinetics of untagged enzymes this cannot be proven. Comparison of untagged to 
tagged Sth6h protein may elicit differences due to the removal of the tag and is an 
avenue for further research.   
 
In planta Solanum tuberosum cultivar Désirée plantlet feeding assays were 
deployed to determine if there was conversion of hyoscyamine into the downstream 
metabolites. Plantlets were sub-cultured with and without roots and subsequently grown 
on MS20 media with hyoscyamine hydrobromide added. Plantlets with and without 
roots were used to alleviate concerns that hyoscyamine may inhibit the root 
development and uptake of hyoscyamine into the plantlets which was seen in a small 
pilot study. Plantlets without roots had the developed roots removed 2 mm above the 
highest root prior to sub-culturing onto the MS20 hyoscyamine hydrobromide media 
used in the assay. Figure 4.3.7 shows that for the plants grown on hyoscyamine enriched 
media there is a significant uptake of the alkaloid into the plant system compared to the 
plantlets grown on MS20, however, there was no detectable anisodamine or 
scopolamine in these samples. Rocha et al, (2002) investigated the functional 
expression of Hnh6h in Nicotiana tabacum. This was achieved through the generation 
of transgenic lines and then feeding detached leaves hyoscyamine and measuring the 
conversion to anisodamine and scopolamine. Nicotiana tabacum, like potato does not 
produce these tropane alkaloids, therefore any conversion in the controls would indicate 
a functional h6h enzyme. Rocha et al, (2002) showed that there was uptake of 
hyoscyamine into the leaves of the controls, but no further conversion was detected. 
However, two of the generated h6h transgenic lines did show limited conversion to 
anisodamine and scopolamine. Rocha et al, (2002) may have seen better results if they 
had utilised roots as this is the site of tropane alkaloid biosynthesis. The controls show 
similarities to the in planta assays conducted within this study, through the uptake of 
hyoscyamine into the tissues being studied, but no downstream conversion.    
 
With the results of the bacterial recombinant expression and in planta assays, it 
can be suggested that whilst there are annotated h6h sequences within the potato 
genome, these genes are not functional and represent a further lesion on the tropane 
alkaloid biosynthesis pathway within this crop.  
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5.1 Introduction  
 
Within the Solanaceae, tropinone reductase I (trI) has been studied extensively 
due to its importance in the production of the tropane alkaloids (Nakajima et al, 1993; 
Kaiser et al, 2006; Küster et al, 2017). trI catalyses the conversion of tropinone to 
tropine (also known as 3α-tropanol and seen in Figure 5.1.1), a precursor for the 
formation of the economically important tropane alkaloids hyoscyamine and 








Figure 5.1.1: Conversion of tropinone to tropine. 
Schematic representation of the conversion of tropinone (A) to tropine (B). trI is responsible for the 
NADPH dependent reduction of oxygen located on the 3rd carbon of the tropane alkaloid skeleton (see 
Figure 1.1), producing tropine.   
 
As described in Chapter 1.8 trI is a member of the short-chain 
dehydrogenase/reductase (SDR) family of enzymes. This enzyme family shares 
conserved amino acid motifs (Moummou et al, 2012) and between the two tropinone 
reductase enzymes (trI and trII) from Datura there are 167 identical amino acids 
resulting in 64% sequence identity. Comparisons of the trI amino acid sequence from 
Solanaceous species shows that the conserved regions of the SDR family are present, 
even in species in which the production of tropane alkaloids is non-existent.  This 
comparison can be seen in Figure 5.1.2, taken from Kushwaha et al, (2013).  
 
trI 
A                         B 




Figure 5.1.2: trI protein sequence alignment.  
Protein sequence alignment of Solanaceous trI sequences from producers of tropane alkaloids and potato. 
Highlighted residues indicate amino acids involved in the following; Grey – co-factor binding, Green – 
tropinone binding, Black – the catalytic tetrad, Yellow – conserved SDR motif, along with the enclosed 
YxxxK region. Figure reproduced from Kushwaha et al, (2013). 
 
Kushwaha et al, (2013) have also bought together information from other 
studies which look at trI activity either from recombinant protein (expressed in E. coli) 
or purified native plant protein. Although the Kushwaha et al, (2013) study is primarily 
focused on Withania somnifera trI as a recombinant protein, they show that trI from this 
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such as Hyoscyamus niger (1.01), Datura stromonium (0.117) and Solanum tuberosum 
(0.188), indicating that the substrate is required in a slightly greater concentration for 
optimal recombinant enzyme activity. This has led to speculation that along with gene 
expression and protein levels, the concentration and availability of tropinone within 
tissues could be a factor for tropine formation in planta (Dräger, 2006; Kushwaha et al, 
(2013)). It is noted in Kaiser et al, (2006), that the specific activity at optimal pH for the 
purified recombinant SttrI protein (530 ± 55 pkat/mg at pH 6.0) is considerably lower 
than that of DstrI (864,000 pkat/mg at pH 7.0). It has been hypothesised that this 
reduction in catalytic activity is a result of amino acid differences which participate in 
tropinone binding. Within the SttrI sequence two of the amino acids which are involved 
in substrate binding are A101 and L159, however, these differ to the trI sequences from 
species which show high catalytic activity. Datura stromonium has V110 and V168, 
and Hyoscyamus niger has V111 and V169 respectively in these positions when aligned 
against each other. These differences are highlighted by the orange boxes in the 
sequence alignment shown in Figure 5.1.2.   
 
Inactivity of trI within Solanum tuberosum has previously been demonstrated to 
be the primary bottleneck in any potential flux through the tropane alkaloid biosynthesis 
pathway (Keiner and Dräger, 1999).  Studies into trI activity within potato have recently 
been conducted through both the over-expression and down-regulation of the 
endogenous potato trI. This work, conducted by Küster et al (2017) has shown that 
through SttrI over-expression, and in the presence of exogenous tropinone there is an 
increase in tropine formation, when compared to control lines (up to 75 µg/g compared 
to 25 µg/g FW). Conversely down regulated trI lines still exhibit trace amounts of 
tropine formation, but this was comparable to the control lines. This, according to the 
authors, suggests that trI from potato is expressed and active in vivo, although this arm 
of the pathway is less active than the nortropane alkaloid arm. Therefore, tropine does 
not accumulate in potato tissues to comparable levels seen within members of the 
solanaceae which produce tropane alkaloids, as the catalysis of tropinone is directed 
towards pseudotropine     
 
The aim of this study is to determine if the transgenic expression of a non-potato 
trI gene displaying high tropinone catalytic properties results in tropinone conversion 
towards the tropane alkaloid biosynthesis pathway via tropine production, as seen in 
Figure 1.2. The potential removal of this bottleneck in potato is the first step to re-
engineering the tropane alkaloid biosynthesis pathway.  
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5.2 Materials and Methods: 
 
5.2.1 Production of transformation vectors. 
 
The WstrI coding sequence was synthesised and transformation vectors were 
generated. After confirmation that these plasmids contained the gene cassettes in the 
correct orientation by Sanger sequencing and restriction endonuclease digestion (Figure 
5.2.1), they underwent transformation into Agrobacterium tumefaciens (section 2.5.4.2). 
Agrobacterium mediated transformation into Solanum tuberosum cultivar Désirée was 
used to produce transgenic lines (sections 2.5.4.4 and 2.5.4.5). 
 
Genomic DNA was extracted from Agrobacterium transformed calli which were 
producing shoots (2.5.1) prior to undergoing PCR (2.5.3) to determine if the WstrI gene 
cassette had been inserted into the Solanum tuberosum genome, shown in Figure 5.2.2 
and 5.2.3. 
 
Once lines had undergone initial characterisation for transgene presence, as 
outlined by Figures 5.2.2 and 5.2.3, RNA from lines positive for the transgene was 
extracted (2.5.1). The RNA was checked both by gel electrophoresis (Chapter 2.5.2) as 








































Figure 5.2.1: Manufactured plasmid vectors and expected enzymatic digestion pattern.   
Top left: Complete 3α1 destination vector containing the 35sCaMV:WstrI:Tnos gene cassette, produced 
using the GoldenBraid cloning strategy described in sections 1.11 and 2.5.3.4.3. Top right: Final 3Ω1 
destination vector containing the transgenic selectable marker gene nptII as well as the 
35sCaMV:WstrI:Tnos gene cassette from the 3α1 vector. The vector diagram also includes the diagnostic 
restriction endonuclease cut sites for SspI and NheI which will be used to determine if the recombinant 
ligation reaction has been successful. These two vectors were generated using the GoldenBraid cloning 
methodology detailed in chapter 1.11 and 2.5.3.4.3. Bottom left: Predicted restriction digestion map for 
the finalised 3Ω1 Tnos:nptII:Pnos 35sCaMV:WstrI:Tnos transformation vector using SspI/NheI. Lane 1 - 
DNA ladder; Lane 2 - shows predicted band size of completely digested vector which are 
4771/4150/1539/5 bases. Bottom right: Image of ethidium bromide stained electrophoresis gel showing 
the expected banding pattern of the complete transformation vector. The band expected at 5 bases is too 
small to be resolved and imaged on the gel, which is why it is unable to be seen in the image. The two 
bands visible at the top of the image which represent the 4771/4150 fragments. Vector maps generated 
using SnapGene® Viewer 3.2.1and predicted digestion image generated using Benchling online software 
(www.benchling.com).  

























Figure 5.2.2: gDNA electrophoresis in characterisation of transgenics. 
Top: Electrophoresis image of genomic DNA which has undergone PCR to test for the presence of ef-1α 
which is being used as a loading control. The band produced is 917bp which can be seen below the main 
1kb band of the DNA ladder. Bottom: Electrophoresis image of the same genomic DNA samples, testing 
for the presence of the nptII gene (which confers kanamycin resistance to the plantlet). A 600bp fragment 










Figure 5.2.3: Characterisation via PCR for positive WstrI transgenic lines.  
Electrophoresis image of genomic DNA which has undergone PCR to test for the presence of WstrI from 
samples positive for the presence of nptII. Positive lines went forward for RT-qPCR analysis for WstrI 









































Figure 5.2.4: RNA extraction and cDNA characterisation prior to qRT-PCR analysis    
Top: Ethidium bromide stained agarose gel image to visually check the integrity of RNA extracted from 
WstrI positive plantlets determined in 5.2.7. The bands shown point to the presence of the 28S and 18S 
ribosomal RNA sub-units from extracted samples. The presence of these two bands in an approximate 2:1 
intensity ratio and lack of smearing indicate the RNA has not been degraded during extraction.  RNA 
quality was also determined by spectrophotometer with a representative example of this being seen in 
table 5.2.1 Bottom: Electrophoresis image of ef-1α PCR conducted on cDNA from the RNA extracted 
from plantlets prior to undergoing RT-qPCR. This reaction was 25 cycles, to show that the cDNA 
synthesis reaction was uniform across the reactions, through using ef-1α as a control.  
 
Sample  ng/µl A260 A280 260/280 260/230 
WstrI/AstrII 20.1 757.44 18.94 8.87 2.14 1.13 
WstrI/nptII 47.1 354.04 8.85 4.36 2.03 1.04 
WstrI/AstrII/nptII 3.2 478.05 11.95 5.74 2.06 1.11 
Désirée WT A 494.76 12.37 5.71 2.17 1.41 
WstrI/nptII 16.1 284.71 7.12 3.39 2.10 1.74 
WstrI/AstrII 36.1 498.01 12.45 5.80 2.15 1.74 
WstrI/AstrII 6.1 642.72 16.07 7.49 2.15 1.74 
WstrI/nptII 18.3 439.83 11.00 5.12 2.15 1.43 
 
Table 5.2.1: Representitive spectrophotometer readings from RNA extracts.           
Reproduced table of the read out from the Nanodrop® ND-100 spectrophotometer showing the 
concentration of RNA present in the sample (ng/µl) as well as 260/280 and 260/230 purity ratios.  
 
5.2.2 Biological replication 
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Figure 5.3.1: trI time course expression data from four tissues. 
qRT-PCR expression data of SttrI from four different tissues during seven stages of plant development. 
Each panel represents a different tissue, with A – root; B – tuber; C – stem and D – leaf. Developmental 
stages relate to the following with average height given as an indicator: V.G – Vegetative Growth (stage I 
(27.0 cm) to III (61.8 cm)), T.I – Tuber Initiation (stage I (93.2 cm) and II (109.5 cm)), T.B – Tuber 
Bulking (131.6 cm) and M – Maturation/Senescence (128.2 cm). The definitions of growth stages are 
taken from Patil et al, (2016). Three replicates were used at each growth stage, with the standard error 
being represented by the error bars. 
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RT-qPCR analysis of trI expression from potato displayed in Figure 5.3.1 shows 
that the endogenous gene exhibits a different expression pattern within all of the four 
tissues tested throughout plant development. It appears that the highest relative 
expression level, compared to the endogenous control elongation factor-1α (ef-1α) 
occurs during tuber initiation II (T.I II), in all tissues tested. In the roots, which has been 
established as the site of tropane alkaloid biosynthesis (Hashimoto et al, 1986), the ratio 
of trI/ef-1α expression is c.a 1.0. As trI is expressed at significant levels in roots, 
corresponding trI enzyme activity might be expected. However, evidence for trI activity 
in potato roots has not been reported.     
 
The phylogenetic analysis of tropinone reductases from members of the 
solanaceae and other plant families shows that tropinone reductases fall into three 
distinct groups (Figure 5.3.2). Group I are the tropinone reductase I genes from only  
members of the solanaceae, Group II are tropinone reductase II (trII) genes from the 
solanaceae, and Group III contains those genes exhibiting tropinone reductase activity, 
but belonging to other plant families.  
 
Whilst Kushwaha et al, (2013) conducted alignments of the trI amino acid 
sequences from producers of tropane alkaloids and included the potato trI sequence; it is 
of interest to include other non-tropane alkaloid producing species to highlight any 
consistent similarities between these sequences.  The nucleotide and CDS alignments in 
Figures 5.3.3 and 5.3.4 highlight sequence similarities of known trI genes from 
members of the solanaceae, these being the sequences which have a black background. 
The differences in nucleotide sequences are displayed by the colour of the base shown, 
with bases being represented by: green = adenine, red = thymine, blue = cytosine and 
black = guanine.  
 
 
























Figure 5.3.2: Phylogentic tree detailing tropinone reductase clusters across species which 
exhibit reductase activity. 
Phylogenetic relationships between tropinone reductases of members of the Solanaceae and other plant 
families which exhibit tropinone reduction activity. Three distinct clades are visible from the dendrogram, 
with trI clustering in Group I, trII clustering in Group II and tropinone reductases from other families and 
species which exhibit activity clustering in Group III. GenBank Accession Numbers: DmtrI – 
AQU12716.1, WctrI – AGB56644.1, AatrI – ACB71202.1, DitrI –AIN39992.1, AbtrI – AFP55030.1, SttrI 
– CAC34420.1, SntrI – CAQ19734.1, HntrI – BAA13547.1, SttrII – CAC19810.1, AbtrII – AGH24753.1, 
SdtrII – CAQ19732.1, AatrII – ACB71203.1, WstrI – AGY46257.1, AltrII – AGL76990.1, BatrI – 
AIN39993.1, AltrI – AGL76989.1, DstrII – AAA33282.1, HntrII – AAB09776.1, CstrI – CAD20555.1, 
Cotr – CAO02390.1, Ostr –ABF95192.1, Zmtr – ACG34080.1, ZmtrII – NP_001147765.1. Figure 



















































































Figure 5.3.3: Amino acid sequence alignement of Solanaceous trI.              
Multiple sequence alignment of Solanaceous trI amino acid sequences from Solanum tuberosum – SttrI 
(NP_001275290.1), Solanum lycopersicum - SltrI (XP_004249378.1), Datura inoxia –DitrI 
(AIN39992.1), Brugmansia arborea – BatrI (AIN39993.1), Withania somnifera - WstrI (AGY46257.1) 
and Hyoscyamus niger – HntrI (BAA13547.1). Identical amino acids are highlighted in black and the 
coloured amino acids show differences. Figure produced using BioEdit version 7.2.5. 
 
trI from Withania somnifera has high recombinant enzyme activity (Kushwaha 
et al, 2013) and catalyse tropinone production efficiently. This trI enzyme has the four 
critical amino acids required for tropinone reduction and a sequence identity of 87.2% 
compared to SttrI. For these reasons, this gene was selected for the production of trI 
over-expression transgenic lines.  









































* continued on next page 




Figure 5.3.4: Withania somnifera and potato trI amino acid sequence alignment.        
Sequence alignment of trI from Solanum tuberosum (NM_001288361.1) and Withania somnifera 
(KF360055.1). Both the nucleotide and amino acid sequences are aligned indicating that whilst there may 
be nucleotide differences between the two sequences in places, the translated protein sequence may be 
identical. Identical nucleotides are highlighted in black and the coloured bases show nucleotide 
differences. Orange underline shows conserved SDR region, Red underline indicates the YxxxK SDR 
motif and the blue asterisk (*) shows the regions of the sequence which participate in tropinone binding. 







* * * 
  Chapter 5       
125 
 
 5.3.1 Transgene characterisation.  
 
Figure 5.3.5: WstrI transgene characterisation         qRT-PCR 
expression ratios between WstrI and ef-1α from the five transgenic lines which were investigated further 
due to exhibiting consistent expression ratios.  Expression levels from 18 plantlets were tested, with the 
data from these shown in Appendix A.5.2.2. Error bars represent the standard error between technical 
replicates in the RT-qPCR analysis.  
 
 Figure 5.3.5 shows that there is variation in the WstrI/ef-1α expression ratios 
between transgenic lines produced. Comparison to the constitutively expressed ef-1α 
indicates that WstrI expression is 5.00 ± 1.02 times higher than ef-1α in line WstrI/nptII 
18.3, whereas in line WstrI/nptII 15.1 the expression ratio is 0.41 ± 0.04. 
 
 These lines were grown in the glasshouse as detailed in Chapter 2.4 from May 
through to August of 2017, with four biological replicates in a randomised block design. 
Weekly height measurements were taken for all plants grown during this period, with 
the average height for the transgenic lines grown shown in Figure 5.3.6. Four of the five 
lines grown did not show any significant growth differences when compared to the 
Désirée and Empty Vector controls, however, there was one line, WstrI/nptII 15.1 
which appeared to be stunted and grew slower than the other lines. WstrI/nptII 15.1 
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5.3.2 Growth and Phenotypic Characterisation  
 
Figure 5.3.6: Plant height measurements during growth of WstrI transgenics.              
Average weekly plant height measurements for the five WstrI/nptII transgenics lines grown in glasshouse 
conditions. This indicates that four of the five lines grown did not exhibit any adverse growth effects 
which could result in stunting when compared to the controls, whilst there was one line (WstrI/nptII 15.1) 
that only grew to an average height of 90 ± 15 cm. These are the average of the 4 biological replicates 
with the Standard Error being shown (n = 4). Cultivar Désirée and an Empty Vector (EV) transgenic were 
also grown as experimental controls.  
 
The growth parameters measured in Figures 5.3.6, 5.3.7 and 5.3.8 indicate that 
four out of the five WstrI/nptII transgenic lines under investigation within this study, did 
not suffer any adverse phenotypic effects as a result of the Agrobacterium 
transformation process. This is shown through the height chart in Figure 5.3.6, the non-
significant differences in biomass produced across the four tissues harvested and finally 
the carotenoid and chlorophyll abundance in Figure 5.3.8. Conversely, there were 
highly significant differences in the biomass of the four tissues harvested from 
WstrI/nptII 15.1 when compared to the transgenic and control lines. Whilst, there did 
not appear to be any difference in carotenoid or chlorophyll content, data from further 
analysis for this line will not be shown.  
 
 











Figure 5.3.7: Harvested fresh weight potato organ data.        
Panel A = root, B = stem, C = leaf, D = tuber mass, E = tuber number.  As indicated in Figure 5.3.6, 
WstrI/nptII 15.1 shows a highly significant decrease in fresh weight when compared to the control lines, 
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Figure 5.3.8: Analysis of growth characteristic.            
Chlorophyll and Carotenoid levels from harvested leaves during week 12 of their growth, showing no 
significant difference between the transgenic and control lines (n = 4).  
 
5.3.3 Tuber and Root alkaloid content 
 
The tropane and nortropane alkaloid content of harvested tubers and roots can be 
seen in Figures 5.3.9 and 5.3.10. From the panel of ten tropane and nortropane alkaloids 
in the MRM method developed in Chapter 3, only three were detected in the tuber and 
five in the roots. Whilst the same three metabolites, ornithine and the two calystegine’s 
(A3 and B2) were detected in both tissues, the detection of pseudotropine and 
importantly tropine within the root was an indication that the normal metabolic flux at 






























Figure 5.3.9: Tuber metabolite analysis of selected transgenic lines.              
Ornithine and tropane alkaloid content of tubers from WstrI/nptII transgenic lines compared to controls. 
Panel A = ornithine, B = calystegine A3 and C = calystegine B2. These were the only tropane alkaloid 
biosynthesis pathway associated metabolites detectable in the tuber. Data generated using the MRM 
method developed in Chapter 3 and is the result of a single injection from each of the four replicates 
grown. Control lines in this assay were Désirée and EV19 (Empty Vector).  * indicates a significant 
difference where P < 0.05 and ** indicates a significance of P < 0.01 (n = 4) with transgenic lines 

































Figure 5.3.10: Root metabolite analysis of selected transgenic lines             
Metabolite content of roots harvested from WstrI/nptII transgenic lines compared to controls. Panel A = 
Ornithine, B = Pseudotropine, C = Calystegine A3, D = Calystegine B2 and E = Tropine. These were the 
only tropane alkaloid biosynthesis pathway associated metabolites detectable in the roots. Control lines in 
this assay were Désirée and EV19 (Empty Vector). Data generated using the MRM method developed in 
Chapter 3 and is the result of a single injection from each of the four replicates grown. The error bars 
shown is the Standard Error, * indicates a significant difference where P < 0.05 and ** indicates a 
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5.3.4 Exogeneous tropinone leaf disc assays 
 
Figures 5.3.11 and 5.3.12 show the results from leaf disc assays taken over three 
different developmental stages for the transgenic and control lines. These time points 
were at weeks 5, 7 and 11 which correspond to vegetative growth III, tuber initiation I 
and tuber bulking (Patil et al, 2016), which allows for endogenous trI expression levels 
to be compared from cultivar Désirée in Figure 5.3.1. With the addition of exogenous 
tropinone, across all three time points the conversion to pseudotropine is consistent 
within the lines. The transgenic lines produced significantly less pseudotropine than the 
control lines (0.61 ± 0.18 µg/g for WstrI/nptII 6.1, compared to 5.24 ± 0.44 µg/g FW in 
cultivar Désirée from assay 1). Similarly, with respect to the conversion to tropine, the 
transgenic lines show increased levels of tropine within the samples. The highest levels 
of tropine can be seen in the second disc assay where in lines WstrI/nptII 6.1 and 24.1 
tropine reaches 161.00 ± 3.61 and 156.65 ± 14.52 µg/g FW respectively. In contrast the 
Désirée and empty vector controls contain tropine at levels of 0.63 ± 0.05 and 0.75 ± 
0.09 µg/g FW.  
 
RT-qPCR was conducted on the same leaves used in the leaf disc assays to 
determine the WstrI and SttrII relative expression levels at these times points. Figure 
5.3.12 shows that during the first assay WstrI is expressed at twice the level as ef-1α for 
WstrI/nptII 6.1 and 24.1, with WstrI/nptII 47.1 showing a threefold relative expression 
increase. For these transgenic lines, in assays 2 and 3 the relative expression levels 
decrease and are expressed at the same level as ef-1α. SttrII expression levels appear to 
fluctuate across the three assays; however, there is no significant difference in the levels 
of expression between the controls and transgenic lines. Whilst there is expression of 
trII within the transgenic lines, the decrease in pseudotropine in the assays can be 
attributed to the presence of an active trI resulting in a change in metabolite flux 

































Figure 5.3.11: Pseudotropine and tropine content of WstrI transgenic leaf discs. 
Pseudotropine (top) and tropine (bottom) content of leaf discs from WstrI/nptII transgenic lines and 
controls during three separate assays conducted during plant development. Developmental stages were 
Vegitative Growth (V.G) III at 5 weeks for assay 1, Tuber Initiation (T.I) I at 7 weeks for assay 2 and 
Tuber Bulking (T.B) at 11 weeks for assay 3. Exogenous tropinone was applied to these leaf discs, before 
they were left for 48 hours. Assays were also conducted with KCl applied to leaf discs at the same stages 
to act as a control (data not shown due to no detectable levels of metabolites from the MRM method).  
Data generated using the MRM developed in Chapter 3 and is the result of a single injection from each of 
the four replicates grown. * indicates a significant difference where P < 0.05, ** indicates a significance 
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Figure 5.3.12: Tropinone reductase activity from transgenic lines during leaf disc assays. 
RT-qPCR data showing the WstrI/ef-1α (top) and SttrII/ef-1α (bottom) expression ratios from WstrI/nptII 
transgenic lines and controls during the three separate leaf disc assays conducted during plant 
development. Developmental stages were V.G III at 5 weeks for assay 1, T.I I at 7 weeks for assay 2 and 
T.B at 11 weeks for assay 3. The WstrI/ef-1α expression ratio shows that there is a slightly higher level of 
WstrI expression within the leaf tissue during the earlier developmental stages, with this decreasing to a 
comparable level to ef-1α for the latter two assays. SttrII was tested to ensure there was no effect on this 
gene through the transformation process and to ensure that the gene was still expressed during this assay. 
There is no significant difference in expression ratios between the WstrI/nptII transgenics for trII when 









WstrI/ef-1α expression ratio 
SttrII/ef-1α expression ratio 
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5.3.5 Exogeneous tropinone tuber sprout feeding assays 
 
Tuber sprout feeding assays were conducted as this tissue is reported to be the 
site of nortropane alkaloid biosynthesis and contains a high level of calystegines 
(Keiner and Dräger, 1999). It is therefore of interest to investigate if the presence of an 
active trI within this tissue influences the nortropane alkaloid content, and if there is an 
increase in any tropane alkaloid associated metabolites. Exogenous tropinone and KCl 
were added to sprouts from transgenic and control lines and these sprouts were kept 
under 16:8 hour light/dark conditions for 48 hours, before undergoing metabolite 
analysis.  
 
Figure 5.3.13 shows that for the tropinone fed lines there were some significant 
differences when compared to the control. Detection of pseudotropine for lines 
WstrI/nptII 6.1 and 24.1 indicates that there is a significant difference in the 
concentration throughout the sprout when compared to the tropinone fed control lines 
(P<0.01). Other significant differences can be seen for line WstrI/nptII 24.1 with respect 
to calystegine B2 and WstrI/nptII 47.1 for tropine (P<0.05 in both cases). Tropine levels 
in the sprouts of the transgenic lines was 62.2 ± 22.9, 71.8 ± 27.3 and 77.7 ± 15.3 µg/g 
DW for WstrI/nptII 6.1, 24.1 and 47.1 respectively. In WstrI/nptII 47.1 for metabolites 
downstream of tropine displayed higher levels compared to the control and other 
transgenic lines, from both tropinone and KCl fed sprout samples.   
 
There are indications that the downstream tropane alkaloids are detectable with 
levels variable between the transgenic lines and controls. WstrI/nptII 47.1 as well as 
exhibiting the highest levels of tropine, displayed the highest levels of hyoscyamine, 
anisodamine and scopolamine when compared to sprouts from the other transgenic lines 
and Désirée control. Variation in tropane alkaloid levels was also detected between the 
control and tropinone fed sprouts and these can be seen in Figure 5.3.13. The levels of 
hyoscyamine, anisodamine and scopolamine in the Désirée tropinone fed lines are; 0.01 
± 0.00, 0.10 ± 0.01 and 0.19 ± 0.02 µg/g DW. Whereas, in WstrI/nptII 47.1 tropinone 
fed lines the levels of these same three tropane alkaloids was 0.32 ± 0.25, 0.21 ± 0.07 
and 0.42 ± 0.14 µg/g DW. This indicates that, at least for this line there is a diversion of 
tropinone flux along the tropane alkaloid biosynthesis pathway, when in the presence of 
exogenous tropinone.  
 
































Figure 5.3.13: Detection of tropane alkaloids in sprouts from exogenous feeding assay. 
Detection of metabolites from the tropane and nortropane alkaloid biosynthesis pathway from tuber 
sprouts which have been fed exogenous tropinone (■) and the controls which were fed KCl (□). Each 
panel represents a different metabolite with: A = ornithine, B = pseudotropine, C = calystegine A3, D = 
calystegine B2, E = tropine, F = littorine, G = hyoscyamine, H = anisodamine and I = scopolamine. * 
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Figure 5.3.14: Detection of tropane alkaloids in plantlets grown in the presence of methyl 
jasmonate and tropinone.  
Detection of metabolites from a plantlet feeding assay, where plantlets were grown on MS20 media (□), 
MS20 + 5 mM tropinone (■) and MS20 + 5 mM tropinone + 1 mM methyl jasmonate (■). Data is shown 
for the metabolites which were detected within the samples. Each panel represents a different metabolite 
with: A = ornithine, B = pseudotropine, C = tropine, D = anisodamine. * indicates a significant difference 
where P < 0.05, ** indicates a significant difference where P < 0.01, *** indicates a significant difference 
where P < 0.001 (n = 4) 
 
 Assays which involved feeding plantlets on three different media types (MS20 
as a control, MS20 with 5 mM tropinone and MS20 with both 5 mM tropinone and 1 
mM methyl jasmonate) were conducted to determine if methyl jasmonate can enhance 
tropine conversion. Figure 5.3.14, indicates that the plantlets which were grown in the 
presence of methyl jasmonate, with the exception of WstrI/nptII 47.1 in the case of 
ornithine and tropine do not exhibit an increase in metabolite content. Of the 11 
metabolites used in the MRM detection method, only four were detectable within these 
samples. It can be noted that the plantlets which were grown in the presence of 
























































Figure 5.3.15: WstrI and trII expression data from methyl jasmonte application assays.   
RT-qPCR data showing the WstrI/ef-1α (top) and SttrII/ef-1α (bottom) expression ratios from WstrI/nptII 
transgenic lines and controls for samples from the plantlet feeding assay. Plantlets grown on control (□), 
and tropinone + methyl jasmonate (■) media were tested to see if the addition of the methyl jasmonate 
elicitor had any effect upon the expression of WstrI and SttrII. ** indicates a significance of P < 0.01 
 
compared to cultivar Désirée. This result supports data seen in the leaf disc and sprout 
feeding assays (Figures 5.3.11 and 5.3.13). RT-qPCR assays were also undertaken to 
determine if the addition of methyl jasmonate affected the expression of WstrI and 
SttrII. Figure 5.3.15, indicates that WstrI expression ratios in plantlets grown in the 
presence of methyl jasmonate are not different to those grown on the control media, 
whereas with respect to SttrII both the transgenic and Désirée plantlets show an increase 
in trII expression in the presence of methyl jasmonate compared to those grown on 
control media.  
** 
** 
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5.4 Discussion   
 
5.4.1 Patterns of trI expression in potato and tropane alkaloid producing 
plants. 
 
The trI expression level within the roots of the current commercial tropane 
alkaloid production platform Duboisia myoporoides has been reported for the 6-week, 3 
month and 6 months growth stages (Kohnen et al, 2017). Highlighting the level of 
expression within this species at these time points and within the root tissue is of 
importance as the roots are the site of tropane alkaloid biosynthesis (Ziegler and 
Facchini, 2008) and whilst a direct comparison to the expression of trI in potato is 
unable to be inferred, trends in trI expression may be identified.   
 
trI expression within Duboisia roots has been shown to be 2.5 to 5-fold higher 
than the endogenous control gadph at the 6 week and 3-month time points respectively. 
Within potato, trI expression levels from plants of the same age, show levels which are 
25-fold lower at 6 weeks, rising to only 5-fold lower at 6 months. Similarly, trI 
expression from Withania somnifera, is higher in the root tissues compared to leaf and 
stem (Kushwaha et al, 2013). Although Kohnen et al, (2017) use gadph as the 
endogenous control in their study and ef-1α is used in this study, these two 
housekeeping genes have been shown to exhibit similar gene expression levels and 
stability. This can be seen from comparative analysis conducted by Rocha et al (2016) 
and Boa et al, (2016). 
 
Interestingly, trI expression levels within other tissues of potato show a different 
trend to that seen in the roots. trI expression in potato leaves is approximately 3 to 10-
fold higher at the 6 week and 6-month time points. The determination that the 
expression level of trI is higher in leaf and stem potato tissues compared to the roots 
suggests that whilst trI may be expressed, tropinone availability in these tissues is a 
limiting factor. Previously, it was reported that within roots of potato, trII is more active 
and more highly expressed than trI (Dräger, 2006). trII drives the conversion of 
tropinone to pseudotropine and suggests that any tropinone present is converted before 
translocation into the stem or leaves can take place. Therefore, tropine is unable to be 
accumulated in these tissues. This is important as it aids the understanding of why 
tropane alkaloids, or at least, tropine does not accumulate in the roots or other tissues of 
potato.  
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5.4.2 Phylogenetic analysis of tropinone reductases 
 
The phylogenetic analysis of tropinone reductase enzymes from members of the 
solanaceae and other plant families which convert tropinone can be seen in Figure 5.3.2. 
These form three distinct groups. Group I encompass trI proteins, Group II contains the 
trII proteins and both are from only solanaceous species. Group III contains proteins     
from other species. From this analysis there is 98 % trI amino acid similarity between 
potato and Black Nightshade (Solanum nigrum), and it has been shown in previous 
studies that Solanum nigrum does not contain tropane or nortropane alkaloids (Dräger et 
al, 1994). 
 
There are regions of similarity within trI nucleotide sequences from species 
which produce tropane alkaloids and those that do not. However, it is the differences 
which may explain the lack of functionality in non-producers. Comparing the trI CDS 
sequences between Withania somnifera and potato there are regions which contain 
single nucleotide polymorphisms. These polymorphisms result in a change in the amino 
acid sequence possibly influencing protein structure and function. It should be noted 
that the amino acid sequences for the conserved SDR motifs, and those relating to 
tropinone binding are identical. The structural differences which may be presented by 
these comparatively minor changes and the low expression rates of trI within roots, 
suggests that tropine is not readily formed in potato as trII is more active in this tissue.  
 
5.4.3 Detectable endogenous tropane and associated alkaloid content 
 
Tropine levels within the roots of transgenic lines in this study were found to be 
500-fold lower than previously reported levels present in Withania somnfiera roots 
(Kushwaha et al, 2013). The levels of calystegine A3 and B2 within the roots of 
WstrI/nptII 47.1 is significantly lower than control plants. In these samples there is an 
almost 50% reduction in calystegine A3 and a 90% reduction in B2 per dry weight mass. 
Küster et al (2017) analysed the fresh weight content of calystegines in transgenic tuber 
sprouts. In SttrI over-expressing lines they found that the concentrations of calystegine 
A3, B2 and B4 were significantly lower than in wild type controls. The reduction in the 
calystegine content of these tuber sprouts, follows the similar patterns seen in Figure 
5.3.10. Although the tuber sprouts and roots are different tissues this is an interesting 
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finding, suggesting that there has been manipulation of the biosynthetic pathway at the 
tropinone branch point.  
 
Tubers were analysed for their concentrations of tropane, nortropane and 
associated metabolites using a targeted MRM approach developed using pure standards.         
Only three of the ten metabolites targeted were detected; ornithine, calystegine A3 and 
B2. There was a significant reduction in calystegine A3 levels in line WstrI/nptII 24.1, 
which exhibited a 50% reduction compared to controls. Interestingly in line WstrI/nptII 
6.1 there was a 30% increase in calystegine B2 levels compared to controls.  
 
Tropine was not detected in tubers of transgenic lines analysed within this study. 
Tropine accumulation within the roots of Duboisia and other solanaceous species has 
not been extensively reported due to the rapid conversion towards the tropane alkaloids 
hyoscyamine and scopolamine. From available literature, the levels of tropine in 31-day 
root cultures of Atropa belladonna is less than 5 µmol g-1 (DW). The levels detected 
within the roots of transgenic line WstrI/nptII 47.1 equates to 896 µmol g-1. This shows 
that the transgenic lines exhibit higher detectable levels of tropine than some known 
tropane alkaloids producers. However, these producers accumulate the downstream 
tropane alkaloids suggesting that there are further lesions in the potato pathway 
downstream of this step. 
 
   Previous studies have reported that tropine levels can be enhanced and 
produced in tuber peel tissue through alterations to carbohydrate metabolism, this was 
not investigated in this study. Richter et al, (2007), demonstrated that in invertase over-
expression and down-regulating sucrose synthase lines there was a 2.5 to 3-fold increase 
in tropine accumulation. These results, as well as others reported in previous literature 
(Rothe et al, 2001) indicate that sucrose presence can influence tropane alkaloid 
biosynthesis. The addition of sucrose to Atropa belladonna root cultures primarily 
increased calystegine content (Rothe et al, 2001), but there was a slight, non-significant 
increase in hyoscyamine.  These data suggest that sucrose is having an effect on the 
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5.4.4 Tropinone feeding assays 
 
Application of exogenous substrates to determine the functionality of 
metabolomic pathways is a useful tool, ensuring the required substrate is present in 
sufficient concentration for potential changes to be detected.  
 
Küster et al, (2017) conducted leaf assays on over-expressing SttrI lines where 
they demonstrated that tropine accumulation was between 2 and 5-fold greater than in 
wild type controls when supplied with exogenous tropinone.  As tropine is accumulated 
in wild type leaves, this increase in tropine accumulation correlates with the higher 
levels of trI expression observed. However, it should be noted that in the wild type, 
pseudotropine levels were 4-fold greater than detectable tropine. Within the SttrI over-
expressing lines generated by Küster et al, (2017) pseudotropine levels were 4 to 6-fold 
greater than tropine levels. So, whilst the accumulation of tropine within their SttrI 
transgenics was enhanced, there was no reduction in pseudotropine accumulation.  
 
trI overexpression lines produced within thus study displayed the opposite 
effect. In the leaf disc assays from all lines, pseudotropine decreased, tropine increased 
and was significantly higher than in the controls. Although the level of tropine detected 
in the controls was negligible, the level of tropine accumulation across the leaf disc 
assays suggests the generated transgenic lines are comparable to Küster et al, (2017) on 
a concentration basis. The reduction of pseudotropine coupled with no significant 
difference in trII expression between the leaf disc assays suggests that the trI transgene 
within the WstrI/nptII transgenic lines is more efficient at converting tropinone. 
Therefore diverting substrate flux away from the nortropane alkaloid biosynthesis arm 
of the pathway.  
 
The leaf assay experiments described in Küster et al, (2017) are not directly 
comparable to those conducted in this study.  Firstly, the leaves used in this study were 
one week older at the time of the first experimental assay. Secondly, the exogenous 
tropinone application was applied for 48 hours and not 8 days as in Küster et al, (2017).  
Despite these two differences, the concentration of tropinone used, growth 
room/ambient light conditions and temperature were all comparable Tropinone 
application was reduced to 48 hours to reduce the potential risk of bacterial 
contamination. Whilst the risk of this occurring was low, it was deemed appropriate 
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with using an unsterile environment, as well as samples being made up of multiple 
small leaf discs which allowed for maximum tropinone infiltration into the plant tissue. 
It can be speculated that accumulation of pseudotropine and tropine could have reached 
comparable levels to that reported in Küster et al, (2017) if left for the same amount of 
time. However, this was not tested.  
 
In tuber sprout assays, transgenic lines exhibited significant differences to the 
Désirée control. Tubers from the WstrI/nptII 47.1 contained elevated levels of both 
calystegines A3 and B2, whilst line WstrI/nptII 24.1 tubers exhibited a significant 
difference between the fed and unfed calystegine B2 content. This difference showed 
that there was an increase in calystegine B2 content within the tropinone fed lines.  
Petterson et al (2013) show the calystegine A3 and B2 content of cultivar Désirée 
sprouts are 15 and 21 µg/g (FW) respectively. In the unfed and fed sprouts of line 
WstrI/nptII 47.1 the A3 content was 32.4 ± 13.5 and 23.1 ± 14.1 µg/g (DW). The 
calystegine B2 content was 26.1 ± 7.7 in unfed sprouts and 28.6 ± 11.5 µg/g (DW) in 
fed sprouts. Whilst the concentration of the calystegine and other metabolites would be 
lower in a fresh weight sample (Petterson et al, 2013), the indication that calystegine 
content within this study is higher than the controls is an interesting point differing from 
previously published research. The levels of pseudotropine in WstrI/nptII 47.1 are not 
different to the levels in the controls.  One potential hypothesis to explain why there is 
greater accumulation of calystegines, but no change to pseudotropine levels within 
WstrI/nptII 47.1 could be that trII expression within tuber sprouts has been unaffected 
by the increase in trI expression. With both enzymes competing directly for tropinone, 
both arms of the tropane alkaloid biosynthesis pathway are not active.  
 
5.4.4.1 Use of elicitors to potentially enhance tropine production.  
 
In previous studies methyl jasmonate has been shown to upregulate the 
expression of genes along the tropane alkaloid biosynthesis pathway (Kang et al, 2004; 
Deng 2005; Kushwaha et al, 2013). Kushwaha et al, (2013) determined that the relative 
expression of trI within Withania leaf tissue exposed to methyl jasmonate for 6 hours 
was between 5 and 8-fold higher after application. However, following 48 hours of 
exposure, the transgenic and control plantlets did not show any differences in 
expression (Kushwaha et al, 2013). In this study the WstrI expression levels in 
transgenic potato plantlets grown in the presence of methyl jasmonate showed no 
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significant difference to controls. However, the expression of trII in transgenic lines 
showed between a 2 and 6-fold increase, with a 1-fold increase in cultivar Désirée. 
Deng, (2005) examined the effects of methyl jasmonate upon the formation of tropine 
and pseudotropine in Datura stromonium. Deng (2005) demonstrated the concentration 
of tropinone, tropine and pseudotropine was enhanced by addition of 1µM methyl 
jasmonate. The increase in these metabolites was between 1.2 and 1.4-fold change when 
compared to controls. It was also noted that the levels of pmt in the roots were also 
enhanced following methyl jasmonate addition, which was not investigated within this 
study. The reported effects on genes upstream of the tropinone branch point by the 
elicitor could indicate that that there is greater availability of tropinone. This was not 
tested within the assays conducted in this study, however, could be of interest to see if 
there is an increase in tropinone/pseudotropine or tropine accumulation within root or 
tuber sprouts from potato.  
 
Methyl jasmonate has been shown to increase hyoscyamine in Scopolia root 
cultures (Kang et al, 2004) as well a decrease in calystegine levels after 48 hours, with a 
predominant effect being seen on the tropane alkaloid pathway. Coupling the use of 
methyl jasmonate with manipulation to carbohydrate metabolism may enhance the 
effects to this pathway and although there does not appear to be a study which looks at 
both conditions it may provide further insights into the biosynthetic pathway within 
potato.  
 
5.4.5 Presence of high value tropane alkaloids 
 
In this study high valued tropane alkaloids have been detected within tuber 
sprout and methyl jasmonate feeding assays. The tropane alkaloids hyoscyamine, 
anisodamine and scopolamine were detected in tissues from both assays within 
transgenic and control lines. These alkaloids have not previously been detected within 
tissues of Solanum tuberosum and although the concentrations of these compounds are 
extremely low, the highly sensitive detection and quantification method which was 
developed in chapter 3 was sufficient to detect and accurately quantify them.  
 
Anisodamine was the only tropane alkaloid detected in the Désirée and 
WstrI/nptII 47.1 plantlets from methyl jasmonate assays. Whereas, tuber sprouts from 
the same lines contained detectable levels of hyoscyamine, anisodamine and 
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scopolamine. The WstrI/nptII transgenic lines contained between 2 and 135-fold higher 
levels than measured in the Désirée control line.  
 
The detection of these alkaloids is of interest as it suggests there is activity 
within the tropane alkaloid biosynthesis pathway, in the tuber sprout and young plantlet 
tissues. With higher levels of these metabolites being detected within tuber sprouts and 
is the site of the nortropane alkaloid biosynthesis pathway (Keiner and Dräger, 2000), it 
could be suggested that tuber sprouts are a candidate tissue to undergo further 
manipulation. This may enhance the production of tropane alkaloids, due to their ability 
to store these alkaloids at higher concentrations. From the work conducted in chapter 4, 
which suggests that the two annotated h6h genes within Solanum tuberosum genome 
database are non-functional, the development of WstrI/h6h transgenics using a bona-
fide h6h gene may elucidate greater accumulation of the commercially interesting 































In summary, transgenic potato lines over-expressing trI from Withania 
somnifera were generated and underwent analysis to determine if there was any change 
to the endogenous tropane alkaloid profile.  The transgenic lines showed a diversion in 
the pathway flux of the substrate tropinone, away from pseudotropine and towards 
tropine, which is a step in the production of downstream alkaloids and one of the 
primary objectives of this study. There was also a reduction of pseudotropine by almost 
80% in some lines, whilst no significant effect upon trII expression could be measured. 
This suggests that the enzyme produced from the WstrI transgene outcompetes trII for 
access to the substrate tropinone.  
 
Moving forward, it would be of scientific and commercial interest to further 
develop tools which can enhance the production of tropine within the highly efficient 
potato lines and then couple these with enhancements to the downstream genes. 
Previous discussion regarding carbohydrate metabolism enhancing the tropane alkaloid 
biosynthesis pathway more efficiently than methyl jasmonate and other elicitors opens 
further avenues of pursuit. The over-expression of invertase within potato (Richter et al, 
2007) and information published on the effects of additional sucrose over elicitors in 
Atropa belladonna upon tropane alkaloid biosynthesis (Rothe et al, 2001), suggest that 
changing multiple conditions to elicit the best enhancement may be of interest. If this 
approach was to be taken, there is potential to achieve enhancement across the whole 































Chapter 6: Effects of tropinone reductase II down-
regulation and the simultaneous effects of tropinone 
reductase II down-regulation and WstrI overexpression 























Tropinone reductase II (trII) is known to be active within potato tissues, and in 
particular sprouting tubers (Kaiser et al, 2006), which contain high levels of 
calystegines. trII expression and enzymatic activity has been shown to be higher than trI 
(331,000 pkat/mg compared to 530 pkat/mg protein, respectively (Kaiser et al, 2006)) in 
most tissues of potato plants. As tropinone does not accumulate Richter et al, (2007) 
concluded that it is the availability of tropinone and not trII activity which is the rate 












Figure 6.1.1: The tropinone branch point.                 
Schematic representation of the tropinone branch point, with the point of emphasis being trII catalysing 
the conversion of tropinone to pseudotropine.  
 
Calystegines are polyhydroxy alkaloids (shown through the structure of 
calystegine A3 within the biosynthetic pathway in Figure 1.2). As well as displaying 
glycosidase inhibiting activity, calystegines have also been investigated due to 
indications that they have antiviral and immunostimulatory activity (Molyneux et al, 
1993). Calystegines have been found within members of the Solanaceae, the 
Convolvulaceae, and the unrelated family, the Moraceae (Schimming et al, 2005). The 
Solanaceae and the Convolvulaceae are two plant families which belong to the 
Solanales.  Within the Solanaceae, Bekkouche et al, (2001) determined the distribution 
of eight nortropane alkaloids within eight different species, from seven genera. It was 
determined that from the calystegines being investigated there were differences to the 
overall profile exhibited. For example, the profile from aerial parts of Atropa 
belladonna and Hyoscyamus albus were identical (with A3, B1, B2, B3 and N1 being 




found), whereas, within Withania frutescens and Withania somnifera there were major 
differences with the profiles of calystegine found. Only B2 and C1 were detected in 
Withania somnifera and A3, B1, B2, B3, C1 and N1 were detected in Withania frutescens. 
It was also noted that calystegine B2 was found in seven of the eight genera studied, 
which aligns with the finding of Friedman et al, (2003) and Petersson et al, (2013) 
where calystegine B2 was the most abundant nortropane alkaloid within potato tuber.   
 
Keiner et al, (2000) demonstrated that in sprouting potato tubers, the highest 
calystegine content occurs five months after being kept in cold storage within the 
sprouting eyes of the tuber. The sprouting eyes are when there is < 1 mm of white shoot 
appearing from eyes. As sprout length increased over a further three months, calystegine 
content decreased by approximately 50 %. This decrease, as the authors state, is on a 
fresh mass basis and not solely due to the increase in water content within the sprouts. 
Other potato tissues have shown that calystegine content varies across developmental 
stage and tissue type. Primary aerial leaves and roots of emerging small plants contain 
approximately the same concentration and profile of calystegines (Keiner and Dräger, 
2000). The highest concentrations are seen when tuber initiation begins. As maturation 
and senescence occurs, calystegine content across all tissues decreases.  The role of 
calystegines is to attract root rhizobia to help promote growth in early plant 
development (Höke and Dräger, 2004). Thus, the requirements for nortropane alkaloids 
within plant tissues, particularly the roots decreases throughout plant development. 
 
The aim of this study is to inhibit the conversion of tropinone into the 
nortropane alkaloids providing a greater substrate concentration for conversion towards 
the tropane alkaloid biosynthesis pathway. This will be accomplished through the 
generation of independent antisense SttrII transgenic lines (AstrII), as well as transgenic 
lines which over-express WstrI whilst downregulating SttrII.  Within the SttrII down-
regulated lines, it is of interest to see if tropinone flux is diverted away from conversion 
to pseudotropine and if there is any endogenous trI activity resulting in tropine 
formation. With the co-transformed WstrI and AstrII lines it is of interest to investigate 
whether WstrI activity can disrupt the flux of tropinone towards pseudotropine more 
efficiently than the SttrII down-regulating lines, and whether there is a resultant increase 
in concentration of tropine.  
 
 




6.2 Materials and Methods 
 
6.2.1 Production of plasmid and trasngenics 
 
As in chapter 5, the vector was confirmed by restriction endonuclease digest and 
Sanger sequencing before being electroporated into Agrobacterium tumefaciens (section 
2.5.4.2). Agrobacterium mediated transformation into Solanum tuberosum cultivar 
Désirée (in the case of 3Ω1 Tnos:nptII:Pnos 35sCaMV:AstrII:Tnos and of 3Ω1 
Tnos:nptII:Pnos 35sCaMV:WstrI:Tnos to produce single AstrII lines and co-
transformed AstrII/WstrI lines) or in cultivar Bintje to produce single AstrII lines. 
Figures 6.2.1 through 6.2.3 show the same methodology for the production of 
transgenic lines as seen in Chapter 5, through the extraction of genomic DNA and 
testing for the presence of nptII (with ef-1α as a loading control). For the positive lines 
from this analysis, further PCR analysis was undertaken to the determine if the 
35sCaMV:AstrII:Tnos cassette was present in the single AstrII transgenic lines, and if 
both the 35sCaMV:AstrII:Tnos and 35sCaMV:WstrI:Tnos were present in the co-
transformed lines.  
 
6.2.2 Biological replication 
 
Within most assays, there were 4 biological replicates per line. The only 
deviation from this was for line WstrI/AstrII/nptII 3.2 in the exogeneous tropinone leaf 
assay where n = 2, and for WstrI/AstrII/nptII 3.1 and 3.2 in the exogeneous tropinone 
































Figure 6.2.1: Diagrammatic representation of vectors for production of transgenics.       
Top: Complete 3α2 destination vector containing the 35sCaMV:AstrII:Tnos gene cassette. Bottom: Final 
3Ω1 destination vector containing the transgenic selectable marker gene nptII as well as the 
35sCaMV:AstrII:Tnos gene cassette from the 3α2 vector. The vector diagram also includes the diagnostic 
restriction endonuclease cut sites for SspI, NheI and BsaI which will be used to determine if the 
recombinant ligation reaction has been successful. These two vectors were generated using the 
GoldenBraid cloning methodology detailed in chapter 1.11 and 2.5.3.4.3. Vector maps generated using 
SnapGene® Viewer 3.2.1 














Figure 6.2.2: Predicted and actual enzymatic digest of produced transformation vectors. 
Left: Predicted restriction digestion map for the finalised 3Ω1 Tnos:nptII:Pnos 35sCaMV:AstrII:Tnos 
transformation vector using BsaI in a single digestion reaction and  then double digestion reaction using 
SspI and NheI. Lane 1 - DNA ladder; Lane 2 - BsaI restriction digest (yielding band sizes of 6698/3731) 
Lane 3 – SspI and NheI restriction digest (yielding band sizes of 4771/4150/1752/5) .Right: Image of 
ethidium bromide stained electrophoresis gel showing the expected banding pattern of the complete 
transformation vector. The 5 bases band is too small to be resolved and imaged on the gel. There are two 
bands visible at the top of the image which represents the 4771/4150 fragments. Predicted digestion 











Figure 6.2.3: Electrophoresis gel of transgenic cassette.       
Image of ethidium bromide stained electrophoresis gel showing the results of a PCR using a primer pair 
designed for regions within the 35sCaMV promoter and Tnos terminator. This pair of primers was used, 
as it allowed for the differentiation of the two gene cassettes being used in a single reaction due to the 
200bp difference.  Lane 1 – 1kb DNA marker (Promega, UK), Lane 2 – Co-transformed transgenic line, 
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Figure 6.3.1: trII time course expression data from four tissues                                                     
RT-qPCR expression data for SttrII from four different tissues during seven stages of plant development. 
Each panel represents a different tissue, with A – root; B – tuber; C – stem and D – leaf. Developmental 
stages relate to the following with average height given as an indicator: V.G – Vegetative Growth (stage I 
(27.0 cm) to III (61.8 cm)), T.I – Tuber Initiation (stage I (93.2 cm) and II (109.5 cm)), T.B – Tuber 
Bulking (131.6 cm) and M – Maturation/Senescence (128.2 cm).  Growth stage definitions taken from 
Patil et al, (2016). Three replicates were used at each growth stage, with the standard error represented by 


























RT-qPCR analysis of trII from four tissues during the growth and development 
of potato can be seen in Figure 6.3.1. The levels of expression in the four tissues 
investigated indicate that trII is expressed at different levels when compared to the 
endogenous control, ef-1α. The highest expression levels are seen within the roots, with 
the lowest expression ratio being 2.4:1 (± 0.5) during V.G III and the highest 13.1:1 (± 
5.4) during T.B II. In other tissues levels also varied with developmental stage but were 
generally 1.8 and 14.8 fold lower than the levels seen in roots at V.G II and T.B II 
respectively.   
 
6.3.1 Transgene characterisation. 
 
            After initial characterisation for the presence of the transgene, lines found to be 
positive for the either the AstrII or AstrII/WstrI constructs, continued to be grown on 
MS20 kanamycin media. RNA was extracted from these lines with the same process 
followed as in Chapter 5 Figures 5.2.4 and Table 5.2.1. Once RNA was extracted cDNA 
was synthesised and RT-qPCR was used to check the relative expression ratios for StrII 
and WstrI against ef-1α. Initially 21 lines were tested, with two of these being positive 
for AstrII and WstrI in cultivar Désirée, two AstrII positive lines in cultivar Bintje and 
17 AstrII lines in cultivar Désirée. The results from this RT-qPCR analysis can be seen 
in Figure 6.3.2A (StrII/ef-1α expression ratio) and Figure 6.3.2B (WstrI/ef-1α 
expression ratio).  
 
           Figure 6.3.2 shows that there is variation in the SttrII/ef-1α and WstrI/ef-1α 
expression ratios for the down-regulating and the co-transformed transgenic lines 
produced. Expression of trII within the down-regulating (AstrII/nptII 26.1) and co-
transformed line (WstrI/AstrII/nptII 3.1), give a comparative expression level of  0.05 ± 
0.00 and 0.53 ± 0.06 respectively when compared to trII expression within the cultivar 
Désirée control. WstrI expression of the two co-transformed lines when compared to the 
constitutively expressed ef-1α is 0.22 ± 0.02 and 1.20 ± 0.06 for WstrI/AstrII/nptII 3.1 
and 3.2 respectively. This indicated that for line 3.1, WstrI expression is not as high as 
ef-1α, and that line 3.2 exhibits almost a 6 fold increase in expression compared to 3.1. 
The impact of these different expression levels on metabolite levels will be elucidated 
later in the study.  
 





Figure 6.3.2: Transgene expression data from characterisation of initial trasngenics.  
A: RT-qPCR expression ratios between SttrII and ef-1α from the nine transgenic lines which are being 
investigated further due to exhibiting the highest level of trII expression down-regulation. Expression 
levels from 21 plantlets were initially tested. The data from the other 12 plantlets is shown in appendix 
A.6.2.2. B: RT-qPCR expression ratios between WstrI and ef-1α from the co-transformed transgenic lines 
which are being investigated further due to exhibiting WstrI expression and SttrII down regulation. In 
both cases the error bars represent the standard error between technical replicates in the RT-qPCR 
analysis (n = 3). AstrII/nptII lines are in cultivar Désirée, AsB40 lines are in cultivar Bintje and the 






























    The lines in Figure 6.3.2 were grown in the glasshouse as detailed in Chapter 2.4 
during the summer months of 2017, in a randomised block design with four biological 
replicates alongside the trI over-expression transgenics discussed in Chapter 5. Height 
measurements were taken weekly for all plants grown during this period, with the 
average height of the transgenic lines grown seen in Figure 6.3.3. Of the down-
regulating transgenics, one of the seven lines exhibited stunting. This line AstrII/nptII 
6.3 reached a maximum height of 110.9 ± 7.3 cm. The co-transformed lines also 
experienced stunting in their growth, reaching 115.8 ± 11.7 and 127.5 ± 9.1 cm for 
WstrI/AstrII/nptII 3.1 and 3.2 respectively. This is compared to the Désirée and Empty 
Vector controls grown, which reached a height of 156.5 ± 5.2 for cultivar Désirée and 
149.5 ± 5.8 for the Empty Vector lines. 
 
The growth parameters measured in Figures 6.3.5 and 6.3.6 indicate that for 
AstrII/nptII 6.3 and the two co-transformed lines within this study, there were 
significant differences in the development of these plants. Across the four organs 
examined, the fresh weight for the tissues harvested from these three lines, was 
consistently and significantly lower than the other transgenics lines and controls. 
Whilst, there did not appear to be any difference in carotenoid or chlorophyll content 
between any of the transgenic lines compared to the controls, after exogenous tropinone 
leaf assays discussed in Figure 6.3.8, further analysis for AstrII/nptII 6.3 will not be 
shown, as interpretation of the results would be confounded by the general differences 

















6.3.2 Growth and phenotypic characterisation 
Figure 6.3.3: Height measurements during growth of AstrII and WstrI/AstrII transgenics 
Top: Average weekly plant height measurements for the seven AstrII/nptII transgenics lines within both 
cultivars and controls grown in glasshouse conditions. This indicates that six of the seven lines grown did 
not exhibit any adverse growth effects such as stunting when compared to the controls, whilst there was 
one line (AstrII/nptII 6.3) that only grew to an average height of 110.9 ± 14.5 cm. Bottom: Average 
weekly height measurements for the two WstrI/AstrII/nptII lines in cultivar Désirée. These are the 
average of the four biological replicates with the Standard Error being shown (n = 4). Cultivar Désirée, 
Bintje and an Empty Vector (EV) transgenic were grown as experimental controls.  











Figure 6.3.4: Growth characteristics.  
Chlorophyll and carotenoid levels from harvested leaves during week 12 of their growth, showing no 






















Figure 6.3.5: Biomass of tissues from harvested transgenic lines.  
Harvested potato organ fresh weight data from: A = root, B = stem, C = leaf, D = tuber mass, E = tuber 
number. AstrII/nptII 6.3 and the two co-transformed lines show a highly significant decrease in fresh 
weight when compared to the control lines, which correlates with the average height achieved across the 
replicates (Figure 6.3.4). * indicates a significant difference where P < 0.05 ** indicates a significance of 
P < 0.01 and *** indicates a significance of P < 0.001 (n = 4). AstrII/nptII lines are in cultivar Désirée, 
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Figure 6.3.6: Tuber tropane and nortropane alkaloid metabolite content.  
Metabolites associated with the tropane and nortropane alkaloids detected within tubers from AstrII/nptII 
transgenic lines compared to controls. Panel A = ornithine, B = calystegine A3 and C = calystegine B2. 
These were the only metabolites of the ten from along the tropane and nortropane alkaloid biosynthesis 
pathway detectable. Data was generated using the MRM developed in Chapter 3, and is the result of a 
single injection from each of the four replicates grown. * indicates a significant difference to control lines 
where P < 0.05 (n = 4). 
 
The tropane and nortropane alkaloid content of harvested tubers and roots can be 
seen in Figures 6.3.6 and 6.3.7. From the panel of ten tropane and nortropane alkaloids 
within the MRM developed in chapter 3, only three were detected in the tuber and five 
in the roots. Whilst the same three metabolites, ornithine and the two calystegines (A3 
and B2) were detected in both tissues, the detection of pseudotropine and importantly 
elevated levels of tropine within the root was an indication that through the addition of 
























The tubers from the WstrI/AstrII/nptII lines were not analysed due to poor 
tuberisation and development, as indicated from the tuber fresh weight and count in 
Figure 6.3.5 (panel D and E). There was a significant reduction in calystegine A3 
content in the two AstrII/nptII lines analysed with line 18.1 containing 0.42 ± 0.18 and 
26.1 having 0.28 ± 0.19 µg/g DW compared to 0.96 ± 0.17 and 0.98 ± 0.13 µg/g DW in 
the controls (P = 0.038). Although there is no significant difference in the calystegine 
B2 content within these lines (P = 0.45), there appears to be a slight reduction in 
AstrII/nptII 26.1. The roots of WstrI/AstrII/nptII 3.1 and AstrII/nptII 26.1 were 
analysed for their tropane and nortropane alkaloid profile along with controls. There 
was no significant difference in the levels of the precursor ornithine (P = 0.24 and 0.35 
respectivley), as well as no detectable level of the metabolites pseudotropine and tropine 
in AstrII/nptII 26.1 and cultivar Désirée, calystegine B2 in WstrI/AstrII/nptII 3.1 and 
tropine in the Empty Vector control. WstrI/AstrII/nptII 3.1 showed significant 
difference in the content of calystegine A3 (4.73 ± 1.14 µg/g DW, P = 0.00005) and 
tropine (0.87± 0.34 µg/g DW, P = 0.047) when compared to the controls used (cultivar 
Désirée contained 52.27 ± 6.01 µg/g DW calystegine A3 and no detectable tropine).  
 
The reduction in calystegine A3 and slight difference in B2 within tubers for 
AstrII/nptII 18.1 and 26.1, suggests that there has been manipulation in the synthesis 
and storage of calystegines within these down-regulating lines. Similarly, the reduced 
calystegine A3 and elevated tropine levels in the roots of WstrI/AstrII/nptII 3.1 suggests 
together there may have been a change in the tropane and nortropane alkaloid 
biosynthesis pathway at the tropinone reductase branch point.  













Figure 6.3.7: Root tropane and nortropane alkaloid metabolite content.  
Metabolites associated with the tropane and nortropane alkaloids which were detected within roots from 
AstrII/nptII and WstrI/AstrII/nptII transgenic lines where available compared to controls. Panel A = 
ornithine, B = pseudotropine, C = calystegine A3, D = calystegine B2 and E = tropine. These were the 
only metabolites of the ten from along the tropane and nortropane alkaloid biosynthesis pathway 
detectable. Data generated using the MRM method developed in Chapter 3, and is the result of a single 
injection from each of the four replicates grown. The error bars shown is the standard error, * indicates a 
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6.3.4 Exogeneous tropinone leaf disc assays 
 
Figure 6.3.8 and 6.3.10 show the results of leaf disc assays from two different 
developmental stages for the down-regulating, co-transformed transgenic and control 
lines in both cultivar Désirée and Bintje. As with the leaf disc assays described in 
Chapter 5, these time points were at weeks 5 and 7, which correspond to vegetative 
growth III and tuber initiation I. Exogenous tropinone was applied to the leaf discs, and 
across the two time points the conversion to pseudotropine is variable between the 
analysed lines. AstrII/nptII 26.1 (1.64 ± 0.27 µg/g and 2.43 ± 0.31 µg/g FW)  shows a 
significant difference (P = 0.0195) across the time points compared to the control lines 
(5.24 ± 0.44 µg/g and 4.47 ± 0.66 µg/g FW) for assays 1 and 2 respectively. 
WstrI/AstrII/nptII 3.1 and 3.2 exhibited similar levels of pseudotropine within the leaf 
disc assays. The highest level was seen within WstrI/AstrII/nptII 3.2 for leaf disc assay 
2, at 0.54 ± 0.01 µg/g FW (P = 0.0011). The was no significant difference in the 
conversion to tropine within the AstrII/nptII transgenic compared to controls (P = 0.28 
and 0.22 for AstrII/nptII 18.1 and 26.1 respectivley), whereas, the WstrI/AstrII/nptII 
lines showed elevated levels of tropine within the samples. The highest levels of tropine 
can be seen in the second disc assays for these lines, where it reaches 37.99 ± 11.95 and 
40.73 ± 6.90 µg/g FW respectively (P = 0.015), with the Désirée control in the same 
assays containing 0.63 ± 0.05 and 0.46 ± 0.04 µg/g FW. The Bintje down-regulated trII 
lines showed no significant difference in the concentration of pseudotropine and tropine 
between the control and transgenic lines assayed.   
 
RT-qPCR was used to determine the SttrII and WstrI relative expression levels 
of lines used in the leaf disc assays at the time points. Figure 6.3.9 and 6.3.11 shows 
that trII expression levels in the co-transformed lines were significantly different across 
the two time points analysed for the lines derived from cultivar Désirée, with P values 
given being <0.05 and <0.01 for WstrI/AstrII/nptII 3.1 and 3.2 respectively. Across the 
two assays of the AstrII/nptII lines there was no significant difference (P values varied 
between 0.19 amd 0.34) in the relative expression levels of trII when compared to ef-1α. 
Similarly, for the AstrII Bintje transgenic lines there was no significant difference 
between the SttrII/ef-1α expression ratios for the first two leaf disc assays (P values 
between 0.13 and 0.34). 
 
 








Figure 6.3.8: Pseudotropine and tropine content from Désirée transgenic leaf disc assays. 
Pseudotropine (top) and tropine (bottom) content of leaf discs from down-regulating and co-transformed 
transgenic and control lines during three separate assays, at three stages during plant development. 
Exogenous tropinone and KCl (as a control – data not shown) was applied to the leaf discs, before they 
were left for 48 hours.  Data was generated using the MRM method developed in Chapter 3, and is the 
result of a single injection from each of the four replicates grown. * indicates a significant difference 
where P < 0.05, ** indicates a significance of P < 0.01and *** indicates a significance of P < 0.001 when 














Figure 6.3.9: Tropinone reductase gene expression during Désirée leaf discs assays.  
RT-qPCR data showing the SttrII/ef-1α (top) and WstrI/ef-1α (bottom) expression ratios from the 
AstrI/nptII, and co-transformed transgenic lines and controls during the three separate leaf disc assays.. 
SttrII was tested to ensure there was no effect on this gene through the transformation process and to 
ensure that the gene was still expressed during this assay. The WstrI/ef-1α expression ratio shows WstrI is 
not expressed to the same levels as ef-1α within the leaf tissue, with the exception of leaf disc assay 1 for 
WstrI/AstrII/nptII 3.2. After leaf disc assay 1 the WstrI expression levels between the two co-transformed 
lines are comparable to each other. There is no significant difference in expression ratios between the 
WstrI/nptII transgenics for trII when compared to the controls.  * indicates a significant difference where 
P < 0.05 (n = 4).  
* 
SttrII/ef-1α expression ratio 
WstrI/ef-1α expression ratio 




For the co-transformed lines during the first assay seen in Figure 6.3.9, WstrI is 
expressed at twice the level seen in the latter two assays (P = 0.04). This follows what 
was seen with the WstrI relative expression pattern in the single WstrI over-expression 
lines discussed in Chapter 5. However, the overall expression ratio is lower than in the 
single over-expression transgenics. They exhibited a ratio of 0.54 ± 0.03 (for 
WstrI/AstrII/nptII 3.1) and 0.97 ± 0.04 (for WstrI/AstrII/nptII 3.2) to 1.00 when 
compared to ef-1α. Within leaf disc assay 2 and 3 the WstrI/ ef-1α expression ratios 
display the same pattern, with the lowest ratio being in leaf disc assay 3 at 0.09 ± 0.00 
and 0.10 ± 0.01 for the two lines. 
 
The lower expression levels of WstrI seen in the co-transformed transgenic lines 
when compared to the single WstrI over-expression lines in Chapter 5 could explain 
why the accumulation of tropine is not as high in the co-transformed lines. Whilst the 
expression of trII within these lines is significantly reduced, being coupled with the 
presence of the active WstrI, the changes in the metabolite flux away from 


























Figure 6.3.10:  Metabolite content from Bintje AstrII leaf disc assays. 
Pseudotropine (top) and tropine (bottom) content of leaf discs from down-regulating transgenic and 
control lines during three separate assays, at three stages during plant development in cultivar Bintje. 
Exogenous tropinone and KCl (as a control – data not shown) was applied to the leaf discs, before they 
were left for 48 hours. There was no significant difference between the controls and SttrII transgenic 
Bintje lines for the amount of pseudotropine and tropine detected by the MRM method developed in 































Figure 6.3.11: trII gene expression during Bintje leaf discs assays.  
RT-qPCR data showing the SttrII/ef-1α ratio of the AstrII cultivar Bintje lines. As with the cultivar 
Désirée lines, SttrII was tested to ensure there was no effect on this gene through the transformation 
process and to ensure that the gene was still expressed during this assay. There was no significant 
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6.3.5 Exogeneous tropinone tuber sprout feeding assays 
 
Tuber sprout feeding assays were used to determine if there was any 
manipulation to the tropinone branch point within this tissue, as it has been shown to 
have high calystegine content and is the site of nortropane biosynthesis (Keiner and 
Dräger, 2000). Exogenous tropinone and KCl was added to sprouts from transgenic and 
control lines, with these being kept under 16:8 hour light/dark conditions for 48 hours, 
before metabolite analysis. Figure 6.3.12 shows the tropinone fed lines exhibited 
significant differences when compared to the KCl fed controls. Detection of 
pseudotropine for the co-transformed line WstrI/AstrII/nptII 3.1 was significantly lower 
than that of the Désirée and Empty Vector lines when fed both tropinone and KCl (P = 
0.013). There was not a significant difference for the concentration of tropine detected 
in the co-transformed line WstrI/AstrII/nptII 3.1 (P = 0.54), although the levels of 
tropine detected within the tuber sprouts was 58.72 ± 37.10 ug/g DW. When the results 
for these two metabolites are analysed together they provide evidence that the 
metabolite flux has been diverted away from the nortropane alkaloid pathway and 
towards the tropane alkaloid biosynthesis pathway within these lines. There was also a 
significant increase in tropine formation within AstrII/nptII 26.1 compared to control 
lines. As this line did not undergo transformations which would affect trI, the increase 
in tropine seen within AstrII/nptII 26.1 is due to the action of the endogenous trI from 
potato converting tropinone. Within the two AstrII/nptII lines that had tuber sprouts 
tested, there was no significant difference in the pseudotropine accumulating in 
tropinone fed lines compared with controls (P = 0.11 and 0.06 for AstrII/nptII 18.1 and 
26.1 respectivley).     
                  
In the co-transformed and AstrII/nptII lines the accumulation of downstream 
tropane alkaloids can be seen within sprouts which were fed KCl and tropinone. 
Although the levels seen for the metabolites littorine, hyoscyamine, anisodamine and 
scopolamine within these lines are not as high as those detected for pseudotropine or 
tropine, their presence is of interest (P values in most cases were > 0.05, except for 
hyoscyamine in AstrII/nptII 18.1 where P = 0.007, and scopolamine in AstrII/nptII 26.1 
where P = 0.032).  










Figure 6.3.12: Alkaloid metabolite content in transgenic tuber sprouts during feeding assays.  
Detection of metabolites from the tropane and nortropane alkaloid biosynthesis pathway from sprouts 
which have been fed exogenous tropinone (■) and the KCl fed controls (□). Each panel represents a 
different metabolite with: A = ornithine, B = pseudotropine, C = calystegine A3, D = calystegine B2, E = 
tropine, F = littorine, G = hyoscyamine, H = anisodamine and I = scopolamine. * indicates a significant 
difference where P < 0.05, ** indicates a significant difference where P < 0.01 (n = 4, except for 
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6.3.6 Effects of methyl jasmonate on tropinone conversion 
 
Figure 6.3.13: Detected tropane alkaloids in transgenic plantlets grown in the presence of 
methyl jasmonate and tropinone.  
Detection of metabolites from a plantlet feeding assay, where plantlets were grown on MS20 media (□), 
MS20 + 5 mM tropinone (■) and MS20 + 5 mM tropinone + 1 mM methyl jasmonate (■). Data is shown 
for the metabolites which were detected within the samples. Each panel represents a different metabolite 
with: A = ornithine, B = pseudotropine, C = tropine, D = anisodamine. * indicates a significant difference 
where P < 0.05, ** indicates a significant difference where P < 0.01, *** indicates a significant difference 
where P < 0.001 (n = 4) 
 
Hyoscyamine, anisodamine and scopolamine are detected at 0.49, 1.62  and 3.34 
µg/g DW respectively in WstrI/AstrII/nptII 3.2 in the presence of KCl, surprisingly, the 
levels of these tropane alkaloids is not as high in sprouts which were fed tropinone. 
Although in the case of WstrI/AstrII/nptII 3.2 there was only one tuber sprout available 
for each experimental condition, due to the poor tuberisation and development of these 
lines, however the indication that these metabolites are present offers a potential avenue 
































As in Chapter 5, assays were conducted which involved feeding plantlets on 
three different media types to determine if methyl jasmonate can enhance tropinone 
conversion to tropine and how it affects the down-regulation of trII. Figure 6.3.13, 
indicates that the plantlets which were grown in the presence of tropinone and methyl 
jasmonate had higher levels of the four metabolites detected from the ten in the MRM 
developed.   
 
Figure 6.3.14: WstrI and trII expression data from AstrII and WstrI/AstrII methyl jasmonte 
application assays  
RT-qPCR data showing the SttrII/ef-1α (top) and WstrI/ef-1α (bottom) expression ratios from AstrII/nptII 
and WstrI/AstrII/nptII transgenic lines and controls for samples from the plantlet feeding assay. Plantlets 
grown on control (□), and tropinone + methyl jasmonate (■) media were tested to see if the addition of 
the methyl jasmonate elicitor had any effect upon the expression of WstrI and SttrII. 




The two co-transformed lines exhibited the greatest effect upon pseudotropine 
and tropine accumulation. WstrI/AstrII/nptII 3.1 showed a very significant decrease in 
the accumulation of pseudotropine and a significant increase in tropine accumulation. 
This pattern can be seen in both the tropinone and tropinone plus methyl jasmonate 
conditions. Interestingly AstrII/nptII 18.1 grown in the presence of tropinone and 
methyl jasmonate shows the highest accumulation of both pseudotropine and tropine 
amongst the down-regulating lines. Unfortunately for this line, the trII gene expression 
data is unavailable due to poor RNA quality.  
 
Gene expression analysis was conducted for the lines which were grown on the 
control and the tropinone plus methyl jasmonate media, for SttrII and WstrI (when 
applicable). As shown in Figure 6.3.14, for both SttrII and WstrI the expression levels 
appear to be higher in plantlets which were grown in the presence of the elicitor methyl 
jasmonate and this follows previous research concerned with the effects of methyl 
jasmonate upon pmt and h6h (Kang et al, 2004). This does however, appear to reverse 
the down-regulatory effects on trII. Although trII is expressed at a higher level, in the 
co-transformed lines, WstrI expression is also increased. This offers an explanation as to 
why there is not a greater accumulation of pseudotropine, with tropinone flux 























6.4.1 Expression patterns of trII 
 
The pattern of trII gene expression in the Solanaceae has previously been 
determined using northern blot analysis. Northern blot analysis can be used to visually 
investigate gene expression by detecting RNA using a hybridisation probe after 
separation by electrophoresis. Kaplan et al, (1995) have shown that qRT-PCR and 
Northern Blot analysis offer similar results in quantitifying gene expression levels, 
however, qRT-PCR offers a more direct means of quanitifcation, with fewer 
environmental impacts. Solanaceous tropane alkaloid producers exhibit the highest trII 
expression profiles within the roots, followed by leaves and stem tissue. This was 
demonstrated to be the case in Anisodus acutangulus (Kai et al, 2009). The study 
conducted by Kai et al, (2009) corroborated the earlier analysis by Keiner et al, (2002) 
which showed trII is expressed highest in the roots, with limited expression in stem and 
leaf tissues. As well as these three tissues, Keiner et al, (2002) also showed there was 
high trII expression in tuber sprouts seven months post-harvest. This supports the 
evidence described by Keiner and Dräger, (1999) that tuber sprouts are the sites of 
nortropane alkaloid biosynthesis.  
 
Whilst the studies conducted by Keiner et al, (2002) and Kai et al, (2009) do not 
give a numerical value for the expression profile, visually, the expression pattern is 
readily discernible. The expression profile described in Figure 6.3.1 shows that the trII 
expression ratio fluctuates from three to thirteen fold higher than the ubiquitous ef-1α in 
roots throughout the growth and development of the potato plants. Within the stem and 
leaf, the expression ratio is generally below 1 compared to ef-1α, however, it does peak 
at 1.8 during early plant growth. trII expression within tubers is consistently low at a 
ratio of 0.2:1. The expression patterns generated by northern blot analysis within 
Anisodus acutangulus and potato support the expression profile described in Figure 
6.3.1. This demonstrates that trII expression profiles within potato follow similar 
patterns to that seen within tropane alkaloid producing species.   
 
Transgenic lines generated were characterised by RT-qPCR for their trII 
expression levels within young leaves. Keiner et al, (2002) have shown that in young 
leaves, trII expression is low, so strong expression of trII is not to be expected. 




Comparison to untransformed cultivars Désirée and Bintje shows that generated 
transgenics displayed a varying degree of trII down-regulation relative to ef-1α. The 
levels seen in the untransformed controls correlate to the levels seen in the trII analysis 
within 6.2.1 during V.G. I. The strongest expression levels seen within this study also 
follow the pattern of reduction of trII transcript levels seen in Küster et al, (2017). In 
the roots and tuber sprouts examined by Küster et al, (2017) it was reported that trII 
expression when compared to controls was 4% and 0.4% respectively. Therefore, whilst 
the expression in the transgenics generated in this study were from leaf tissue, the 
similarity to effects seen in the Küster et al (2017) study was of interest.              
     
6.4.2 Phenotypic differences 
 
From the growth data shown in Figure 6.3.4 and the harvest data in Figure 6.3.5 
there were clear abnormalities in one of the down-regulating lines (AstrII/nptII 6.3) as 
well as the two co-transformed lines.  
 
The phenotype exhibited by these lines show similarities to phenotypes 
described in the review by Barrel et al, (2013). The phenotypes described were because 
of the transformation and re-generation process. As Solanum tuberosum is clonally 
propagated, sometimes unexpected mutagenic events may occur when transgenes are 
inserted. Within the review it was identified that the generation of these abnormal lines 
could be because of somaclonal variation. That is variation which occurs during the 
regeneration from cell culture. Although AstrII/nptII 6.3 underwent leaf feeding assays 
as shown in Figure 6.3.8, from further analysis was not conducted on this line so that 
any potential deleterious effects the phenotype may have caused were removed.  
 
6.4.3 The detectable endogenous nortropane and tropane alkaloid content 
 
The calystegine content of potato tubers has previously been determined by 
Friedman et al, (2003) and Petersson et al, (2013) who examined a variety of potato 
cultivars as shown in Figures 1.8 and 1.9. Reported levels of calystegines within the 
cultivar Désirée from Petersson et al, (2013) can not be directly compared to the levels 
seen within this study, due to differences in sample preparations. However, examining 
calystegine A3 and B2 ratios within Désirée it has been shown to be 1:1.40. In the 
control lines of this study the ratio is 1:1.54 for cultivar Désirée and 1:1.62 for the 




Empty Vector. While the ratio is slightly higher in controls from this study, they exhibit 
a similar trend when compared to the ratio in Petterson et al (2013). It can therefore be 
suggested that the results from the transgenics are comparable to calystegine levels in 
commercial cultivars.  
 
The tuber calystegine concentrations within AstrII/nptII 26.1 showed there was 
a reduction of 74% in A3 and 40% in B2 concentration compared to cultivar Désirée. 
Whilst this level of reduction was not seen in other transgenic lines, there was a 60% 
reduction in calystegine A3 concentration in AstrII/nptII 18.1. This represents a 
significant reduction in calystegine A3 accumulation across the two transgenic lines. 
This suggests there has been manipulation of the nortropane alkaloid biosynthetic 
pathway and to the storage of these metabolites within transgenic potato lines. The 
calystegine content in AstrII/nptII 26.1 roots was not significantly different to levels 
seen in the control lines. However, as accumulation within tubers is reduced it can be 
suggested that there has been manipulation to the nortropane alkaloid biosynthesis 
pathway within the roots.  
 
Detectable tropine within roots of WstrI/AstrII/nptII 3.1 indicates that the WstrI 
transgene is influencing the endogenous metabolite flux across the tropinone branch 
point. Tropine levels within the root medulla and bark of Withania somnifera, have been 
reported to be 2096.85 ± 10.98 and 1966.10 ± 8.87 µg/g DW respectively (Kushwaha et 
al, 2013). Whilst the levels of tropine within WstrI/AstrII/nptII 3.1 are not as high as 
those found within Withania, (0.87 ± 0.34 µg/g DW) the detection of tropine in a 
previously inactive producer is of interest. There is little information available with 
regards to the natural tropine levels found within potato tubers. Richter et al (2007) 
dissected the tuber into three different tissues and determined the levels of tropine 
accumulation after application of tropinone. They reported levels of approximately 30 
µmol/g DW, this equating to around 4.70 µg/g. This shows that when in the presence of 
exogenous tropinone, tropine levels in Désirée lines are approximately 5-fold higher 
than in WstrI/AstrII/nptII 3.1.  
 
There also appears to be a highly significant difference in calystegine A3 and B2 
content of line WstrI/AstrII/nptII 3.1. Calystegine A3 content is 4.73 ± 1.14 µg/g DW 
which is significantly lower than the levels detected within Désirée. Calystegine B2 was 
not detected within this line, which suggests that this was not accumulated. It is unclear 




as to why elevated levels of pseudotropine were detected within roots of 
WstrI/AstrII/nptII 3.1. This does indicate that reductions in calystegine content may be 
due to other factors as the precursor to these nortropane alkaloids is clearly present. It 
can be speculated that the defects which have been seen during the growth and 
development of this co-transformed line may be a cause for the differences in 
nortropane alkaloid content.  
 
6.4.4 Tropinone feeding assays 
 
Tropinone feeding assays have been used in this study to exacerbate the 
manipulation across the tropinone branch point within the transgenics.  
 
Single transgenic lines in the cultivar Désirée and Bintje exhibited different 
effects in levels of pseudotropine and tropine accumulated. Across the tropinone leaf 
feeding assays, the AstrII/nptII Désirée lines showed significant reduction in the levels 
of pseudotropine detected, whereas there was no difference in the levels within the 
Bintje background. Kuster et al, (2017) demonstrate in leaf assays that there was a 
highly significant difference in the accumulation of pseudotropine across the five SttrII 
down-regulating lines developed. The decrease they reported was from 600 µg/g in 
control lines to < 10 µg/g DW in the transgenics. They also describe that there was no 
change in tropine accumulation.  
 
Decreasing pseudotropine accumulation was seen in the AstrII/nptII Désirée 
transgenic lines generated in this study. However, the effects on accumulation were not 
as dramatic when compared to the results from Kuster et al, (2017). SttrII expression 
levels within the leaves from the assays in this study were analysed to elucidate 
potential differences. trII expression levels were shown to be the same as the respective 
control lines. This would explain why the expected effects at the tropinone branch point 
have not been seen within the single AstrII/nptII down-regulation lines.  
 
Co-transformed WstrI/AstrII/nptII lines displayed a decrease in pseudotropine 
and an increase in tropine accumulation through the two leaf assays. trII and WstrI gene 
expression in these lines was as hypothesised, with a 5-fold decrease in trII expression. 
Comparing the WstrI/AstrII/nptII lines to the single WstrI/nptII transgenics (from 
chapter 5), the accumulation of pseudotropine in the co-transformed lines is reduced by 




approximately 50%. However, the single WstrI/nptII lines display a 3 fold increase in 
tropine accumulation. Differences in WstrI gene expression between these single and 
co-transformed lines can explain these differences. The co-transformed lines exhibited 
lower trII and trI expression when compared to the single WstrI/nptII lines. This 
suggests that whilst the co-transformed lines displayed growth and phenotypic effects 
from the transformation process, they offer an insight into the simultaneous disruption 
of both arms of the tropane and nortropane biosynthesis pathway.  
 
The calystegine content of the tuber sprouts from WstrI/AstrII/nptII 3.1 indicates 
that in the unfed lines, there was a 150-fold difference in the concentration of B2 when 
compared to A3. The B2 content of this line was also significantly higher than that seen 
in the Désirée and Empty Vector. Whereas, in the presence of tropinone, pseudotropine 
and calystegine accumulation were significantly different to the Désirée and Empty 
Vector. There was a significant decrease in the build-up of pseudotropine in both 
WstrI/AstrII/nptII lines. However, there was an unexpected increase in the accumulation 
of calystegine A3 in line 3.1 as well as B2 across both lines. Pseudotropine and 
calystegine levels in the single AstrII/nptII lines did not exhibit any significant 
difference when compared to Désirée and untransformed controls.  
 
The levels of pseudotropine, and the two calystegines (A3 and B2) when related 
to reported levels within Küster et al (2017), suggest that the effects on the nortropane 
alkaloid arm are not as pronounced within this study. The total calystegine content seen 
within control sprouts from Küster et al (2017) is reported at 3000 µg/g, however the 
content is only 7 µg/g in the controls from this study. Total calystegine content reported 
by Küster et al (2017) are also supported by the levels reported by Keiner and Dräger 
(2000). The discrepancy in the total calystegine content could be due to the differences 
in storage conditions during dormancy. Whilst the lines in this study were stored at 4oC 
for 4 months before being left at room temperature for 5 weeks to sprout, Küster et al 
(2017) stored their tubers at 7oC for 5 months or at 7oC for 4 weeks then 2 months at 
room temperature.  
 
Keiner and Dräger (2000) demonstrated that the highest levels of calystegines 
can be found in tubers 5 months after harvest. Calystegine B2 levels were found to be 6 
to 7-fold higher at this point, than directly after harvest. They also showed that single 
sprouts appeared on tubers after 2 weeks at room temperature if the tubers were stored 




at 4oC for 3 months. The sprouting exhibited by tubers within this study developed 
slowly which may have impacted the accumulation of calystegines.  
 
6.4.4.1 The potential enhancement of transgene expression through the 
application of an elicitor  
 
Methyl jasmonate application has been shown to increase the expression of trI 
within W. somnifera 8-fold after 6 hours (Kushwaha et al, 2013), as well as having a 
weak effect on A. acutangulus trI expression in roots (Kai et al, 2009). Kai et al, (2009) 
reported that trII expression in A. acutangulus can also be enhanced when in the 
presence of methyl jasmonate. Zabetakis et al, (1999) demonstrated that in Datura 
stramonium root cultures there was an increase in tropine (4-fold), hyoscyamine (1.8-
fold) and scopolamine (2.5-fold) accumulation after 7 days of methyl jasmonate 
application, when compared to control cultures. This reported change in gene 
expression level and the increase in metabolite content suggested that methyl jasmonate 
may enhance changes to the transgenic lines developed within this study.  
 
Utilising the MRM method developed in chapter 3, only four metabolites were 
detected in plantlet samples when grown in the presence of tropinone and methyl 
jasmonate. In the AstrII/nptII lines, there was a significant difference in the 
accumulation of pseudotropine. AstrII/nptII 18.1 when grown in the presence of methyl 
jasmonate and tropinone showed an increase in pseudotropine accumulation compared 
to the control and tropinone fed plantlets. There was also significant difference in 
accumulation of tropine within all the AstrII/nptII lines, compared to the control 
plantlets. Tropine accumulation within Désirée controls indicate that endogenous SttrI 
displayed a degree of activity. As with pseudotropine, AstrII/nptII 18.1 showed an 
increase in tropine concentration within plantlets grown in the presence of methyl 
jasmonate. 
 
 SttrII RT-qPCR analysis for control and methyl jasmonate grown plantlets 
indicates there was up to a 4-fold increase in AstrII/nptII 28.1, and the Désirée control 
showing a 2-fold increase in trII expression. Kai et al, (2009) showed that trII 
expression increased in the presence of methyl jasmonate. Although there was an 
increase in trII expression in plantlets which were grown in the presence of methyl 
jamonate, there does not appear to be an increase in pseudotropine accumulation 




compared to plantlets grown in tropinone. The quality of extracted RNA from 
AstrII/nptII 18.1 which was grown in the presence of methyl jasmonate was unsuitable 
for analysis, so whilst it showed a 4-fold increase in pseudotropine accumulation, the 
underlying gene expression can not be determined. Although these lines showed low 
trII expression levels when they were initially characterised, it appears trII expression 
levels increased through-out plant development to that seen in controls.   
 
There was a decrease in pseudotropine and increase in tropine within co-
transformed transgenic plantlets grown in the presence of tropinone, when compared 
controls. The application of methyl jasmonate on these lines elicited no significant 
difference in the levels of pseudotropine and tropine accumulated. WstrI expression 
showed a non-significant increase within the methyl jasmonate grown plantlets. The 
expression levels seen within the lines exhibiting the highest levels of expression was 
less than a tenth of the ef-1α expression. There was also an increase in the trII 
expression levels within these co-transformed lines; however, the activity of WstrI 
appears to have been sufficient to drive metabolite flux towards tropine formation. 
Anisodamine detection in AstrII/nptII, WstrI/AstrII/nptII and control lines although at 
relatively small levels suggests that there may be limited functionality of the 
downstream pathway.  
 
6.4.5 The detectability of the high valued tropane alkaloids 
 
The detection of the downstream tropane alkaloids within tissues examined 
through various feeding assays is of particular note. These tropane alkaloids have not 
been previously reported within tissues of potato (Kaiser et al, 2006). The four tropane 
alkaloids which are synthesised downstream of tropine were all seen in tuber sprout 
samples analysed from both tropinone fed and unfed assays. Whilst these metabolites 
were detected, the total tropane alkaloid concentration within the tuber sprouts was 
0.066% of the level found within the current commercial source of these compounds 
Duboisia myoporoides (Kohnen et al, 2017). As the tropane alkaloids can be detected, it 
suggests that there is some limited functionality of the downstream biosynthesis 










Whilst it appears that the single trII down-regulating transgenic lines did not 
exhibit the hypothesised effect upon the tropinone branch point, the co-transformed 
transgenic lines could open potential avenues for further development. Taking into 
consideration potential plasmid manufacture issues which may explain the phenotypic 
characteristics displayed within the co-transformed lines shown in Figure 6.3.4 and 
6.3.5 and re-developing the strategy to utilise a single plasmid rather than two may lead 
to stronger plant growth and development.  
 
The characterisation of the endogenous metabolites within WstrI/AstrII/nptII 3.1 
roots has shown that there is manipulation across the tropinone branch point. Tropine 
levels were detected at 0.87 ± 0.37 μg/g DW and Calystegine A3 was detected at 4.73 ± 
1.14 μg/g DW. These levels are significantly differnet to the Désirée controls used. 
Coupled with the exogeneous tropinone assay which showed that there was a decrease 
in pseudotropine in all lines in these studies, whereas in the co-transformed lines there 
was an increase in detectable tropine levels. 
 
This approach may develop robust adaptations and manipulation to the 
tropinone branch point and it is an avenue of pursuit worth following. With the 
detection of economically important tropane alkaloids, the potential enhancement to 
tropine accumulation and introduction of genes which display higher functionality to 
this region of the pathway could lead to a better platform for the production of these 























































7.1 General discussion 
 
Whilst tropane alkaloids have been used within medicine for almost 5000 years 
(Griffin and Lin, 2000), the improvement and commercialisation of these plant natural 
products has only been studied since the early 1950’s (Bernard, 1952). Because of this, 
the tropane alkaloid biosynthesis pathway has been elucidated in members of the 
solanaceae, (Nakajima et al, 1993; Kaiser et al, 2006; Kohnen et al, 2017) but how the 
pathway is regulated in potato is poorly understood. Previous research conducted by 
Kaiser et al, (2006) and Richter et al, (2007) have shown that trII is more active than trI 
in potato tissues. Limited trI activity therefore represents a lesion in the tropane alkaloid 
biosynthesis pathway in potato preventing the formation and accumulation of TA’s 
formed downstream.  
 
The main aims of the study can be summarised into three different areas. Firstly 
a robust detection method for tropane alkaloids and associated metabolites employing 
the Agilent QqQ-LC-MS/MS was developed. Secondly, a transgenic approach was used 
to manipulate the tropinone flux towards tropine biosynthesis. Finally, using 
recombinant protein assays, determine the functionality of annotated tropane alkaloid 
biosynthesis genes present downstream of the known pathway lesion points within the 
potato genome.  
 
A robust quantification detection method was developed using a combination of 
the ThermoFischer Orbitrap™ and Agilent QqQ-LC-MS/MS systems. The 
fragmentation patterns of the tropane and nortropane alkaloids as well as associated 
metabolites have not been extensively reported in the literature. The development of a 
targeted quantification method for metabolites along the tropane alkaloid biosynthetic 
pathway using the QqQ-LC-MS/MS was pivotal to discerning metabolite variability 
between the transgenic lines and for the recombinant protein assays. The fragmentation 
pattern for the three high value tropane alkaloids, hyoscyamine, anisodamine and 
scopolamine have been reported by Chen et al, (2017) and Zhou et al, (2017) and can be 
seen in Table 3.1.1. The fragmentation products detected for these alkaloids in this 
study are in agreement with results previously reported in earlier studies; however, there 
are slight differences in the number of fragments produced. These differences could be 
attributed to variability in machine, separation column matricies and chromatography 
conditions. Previously reported studies detected a greater number of fragments for the 
 




tropane alkaloids atropine (racemic hyoscyamine) and scopolamine (Chen et al, 2017; 
Zhou et al, 2017). The overlap displayed between fragments produced for these 
metabolites in the development of the method in this study was important. The 
similarities in fragmentation patterns for these metabolites, gives confidence in the 
fragments produced for the other metabolites along the pathway as well as the overall 
MRM which has been used in associated assays.   
 
Using a transgenic approach, this study has shown it is possible to influence the 
partitioning of substrate within the biosynthetic pathways at the tropinone branch point. 
The introduction of a known active trI gene from Withania somnifera has potential 
significantly enhanced endogenous tropine accumulation in the roots of transgenic 
potato lines. 
 
In previous studies, manipulation of the tropinone branch point in potato has 
been studied to try and reduce the accumulation of calystegines and promote the 
accumulation of tropine within tissues (Keiner and Dräger, 2000; Richter et al, 2007). 
These studies were primarily concerned with the trII (nortropane alkaloid) arm of the 
pathway and through a transgenic approach and mechanical wounding assays, attempted 
to understand the distribution and mechanisms behind calystegine formation. Building 
on these studies, Küster et al, (2017) generated transgenic lines which impacted both 
arms of the pathway independently. In this study, transgenic lines were developed 
disrupting the endogenous tropinone reductase activity and any metabolite changes 
quantified. This study also demonstrated that the endogenous potato trI gene catalysed 
the conversion of tropinone to tropine, and by down-regulating trII reducing the 
concentration of the calystegines. Whilst Küster et al (2017) enhanced the accumulation 
of tropine through over-expression of the endogenous trI gene the pseudotropine 
concentration in all transgenic lines bar one showed no significant variation. 
 
Within this study, the introduction of an active trI gene from Withania somnifera 
resulted in an almost two fold increase in tropine accumulation compared to the SttrI 
lines overexpressing the endogenous potato SttrI lines reported in the Küster et al 
(2017) study. Therefore, the introduction of the WstrI gene into the potato genome 
enhances the ability of potato to produce and accumulate tropine compared to the 
endogenous gene. Conversely, in the WstrI overexpression lines from this study, the 
pseudotropine levels in leaf disc assays were reduced by ca. 50 % suggesting that whilst 




the endogenous potato trI catalyses the conversion of tropinone to tropine the 
accumulation compared to an exogenous trI within potato is lower. 
 
Transgenic lines down-regulating the potato gene, SttrII, used in this study did 
not exhibit the same degree of manipulation on the formation of pseudotropine as 
shown in Küster et al, (2017). In that study, pseudotropine levels in the generated 
transgenics were < 10 µg/g (FW) compared to 600 µg/g (FW) seen in the control lines. 
Here, AstrII/nptII transgenic line which showed greatest manipulation to the tropane 
alkaloid biosynthesis pathway, showed pseudotropine levels of 1.6 µg/g (FW), whereas 
the Désirée controls contained 5 µg/g (FW) when exogenous tropinone was applied in 
leaf feeding assays. Single AstrII/nptII transgenic lines did exhibit a reduction in 
endogenous tuber calystegine content, but there was no significant reduction in content 
within the roots. Pseudotropine accumulation in the presence of exogenous tropinone 
within these AstrII/nptII lines was reduced, but this was not as dramatic as the levels 
seen in the transgenics developed by Küster et al (2017).  
 
Metabolite results from the Désirée AstrII/nptII lines indicate that trII activity 
was disrupted. However, trII expression levels within the leaf disc assays were not 
significantly different compared to the controls although a reduction in levels of 
pseudotropine across these lines indicates a reduction in enzyme activity. The 
WstrI/AstrII/nptII co-transformed lines, which have not previously been generated in 
previous studies manipulating the TA biosynthetic pathway, demonstrated that both 
arms of the pathway can be manipulated simultaneously. Although these lines did not 
accumulate tropine to the levels comparable with single WstrI/nptII lines, the co-
transformed lines exhibited a greater reduction in pseudotropine accumulation. The 
generated co-transformed lines offer a different point of view compared to the single 
transgenics for the overall enhancement of the tropinone branch point within the 
pathway. These WstrI/AstrII/nptII transgenic lines also exhibited a phenotype which 
was detrimental to the growth of the plants, but still allowed for metabolite effects along 
the pathway to be measured. If future investigation of this pathway were to be 
undertaken, it would be best practice to re-manufacture a single transformation vector 
which can manipulate both arms of the pathway and re-transform Solanum tuberosum.  
 
The use of elicitors, such as methyl jasmonate, in an attempt to upregulate the 
genes at the tropinone branch point of the pathway and enhance gene expression did not 
have the hypothesised effects nor replicated the effects described in Zabetakis et al, 




(1999) and Kai et al, (2009). Previously methyl jasmonate has been shown to increase 
the expression of pmt and h6h which led to an increase in the associated metabolites 
around these areas of the tropane alkaloid biosynthesis pathway (Kang et al, 2004; Ryan 
et al, 2015).  This avenue of investigation, whilst not giving the anticipated results may 
still be enhanced through the manipulation of carbohydrate metabolism (Richter et al, 
2007), however this would require the generation of further transgenic lines. Transgenic 
lines which have had their carbohydrate metabolism manipulated have been shown to 
have a 2 to 3-fold increase in tropine accumulation (Richter et al, 2007). The increase in 
tropine present, coupled with the methyl jasmonate enhancement of downstream 
tropane alkaloid biosynthesis genes could further increase the accumulation of the 
economically important tropane akaloids.   
 
Due to the economic importance of the tropane alkaloids, alternative methods 
for the manufacture of these compounds are of commercial interest. Recent advances 
have used S. cerevisiae in the manufacture of intermediates of benzylisoquinoline 
alkaloids (these are plant-secondary metabolites which include codeine and morphine) 
(DeLoache et al, 2015). This approach offers an interesting avenue for overcoming 
yield and alkaloid variability in the current commercial production platform. Although 
the recombinant protein assays, expressing the native h6h genes from potato did not 
show any conversion of hyoscyamine to scopolamine, the biotransformation of 
hyoscyamine in E. coli using h6h from Datura, would be of interest to move into a 
yeast system. Using a microbial system to produce these metabolites would allow for an 
increase in efficiency and yield with each step being able to be strictly regulated, 
maximising output. This would allow large scale fermentation to occur and could be a 
potential platform to generate the whole pathway in a cell culture system which 
industrially produces tropane alkaloids.  
 
As well as regulating reaction conditions, moving to a yeast or microbial system 
has advantages over a transgenic approach, as food sources are not being removed from 
the food chain. This can have similar conotations to the usage of food sources in the 
manufacture of first generation biofuels. These ethical implications aside, through this 
project the accumulation of downstream tropane alkaloids has been shown within the 
tubers of transgenic lines. Although the main site of accumulation is the leaves, the 
detection of these drugs within the tubers of transgenic lines, which are the parts of 
Solanum tuberosum which are consumed can be problematic if levels of tropane 




alkaloids are enhanced. Therefore, if any further enhancement of the tropane alkaloid 
pathway in Solanum tuberosum was to be undertaken this issue would need to be 
overcome.  
 
Results of this study have shown that through the introduction of a functional trI 
gene the utilisation of the substrate, tropinone, can be diverted towards tropane alkaloid 
biosynthesis and away from the nortropane alkaloids. However, conversion of tropine to 
the economically important tropane alkaloids hyoscyamine and scopolamine is limited 
within potato.  Whilst a relatively small concentration of tropane alkaloids is detected 
within tuber sprout and plantlet tissues, for potato to be considered a viable platform to 
produce tropane alkaloids, further research would need to be conducted to overcome 
lesions identified within this study such as the h6h lesion as well develop an 
understanding of any potential lesions between trI and h6h. Recent advances in the 
genome editing technology CRISPR and particularly the potential time and accuracy 
benefits it offers would be of interest. CRISPR coupled with the development of high 
throughput spectrophotmetirc techniques can increase the understanding and knowledge 
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Table A.3.1: Average relative abundance and Standard deviation of compounds used in the early development of the MRM method 
 



































Table A.3.2: Data for metabolites associated with the tropane and nortropane alkaloid biosynthesis 




Standard Product Ions Collision Energy Abundance Buffer Ratio (A/B) 
Ornithine 
70.1 16 6770 
100/0 116.1 4 4132 
115.1 4 1501 
Tropinone 
98.1 20 78750 
100/0 
57.1 36 44868 
56.1 48 25199 
82.1 20 26010 
Pseudotropine 
96.1 21 79234 
100/0 
67.1 29 25817 
124.1 17 49742 
42.2 45 14532 
Calystegine A3 
142.1 8 22080 
100/0 
79.1 20 8928 
77.1 36 5790 
98.1 16 5115 
Calystegine B2 
140.1 8 19553 
100/0 
158.1 4 9235 
Tropine 
98.1 24 35960 
100/0 
58.2 28 27963 
57.1 36 28898 
56.1 52 16787 
Phenylalanine 
120.1 8 132080 
65/35 
77.1 44 45788 
103.1 28 43711 
51.1 72 24069 
Littorine 
142.1 28 153128 
50/50 
93.1 32 197007 
77.1 60 122601 
124.1 24 404892 
Hyoscyamine 
124.1 24 494919 
50/50 
93.1 32 252103 
77.1 68 174560 
91.1 48 119048 
Anisodamine 
140.1 24 477875 
50/50 
77.1 80 76020 
91.1 44 68738 
58.2 44 47005 
Scopolamine 
138.1 12 396847 
50/50 
156.1 12 408702 
77.1 72 207672 
103.1 4 233802 





Datura Leaf Potato Sprout 
Metabolite ng/mg DW st.dev ng/mg DW st.dev 
Ornithine 0.01731815 0.000717269 0.484461236 0.017539583 
Tropinone 0.000584393 0.000312652 0.000626943 0.000144902 
Calystegine A3 0.005797557 0.000735296 0.03095444 0.005437381 
Tropine 0.000937892 0.00053239 0.000190937 1.03666E-05 
Phenylalanine 0.023147082 0.000769118 0.289143578 0.001754108 
Littorine 0.032198174 0.000390754 -0.003076015 8.24471E-06 
Hyoscyamine 0.013527441 0.000329121 -0.001562105 1.88645E-05 
Anisodamine 0.078729797 0.001208632 -0.003233839 0.000306518 
Scopolamine 0.149712454 0.002380208 -0.004312895 0.000153176 
 
 
Table A.3.3: Numerical representation of the metabolites being detected in the samples from Figure 
3.3.8 showing that although in minute quantities, metabolites of interest are able to be detected within 
the Datura leaf sample and that the metabolites up to the tropinone branch point and associated with the 



















Table A.4.2.1: Primers used in the synthesis and sequencing of recombinant protein vectors, as well 
as RT-qPCR analysis for the two annotated h6h sequences within potato. GenBank Accession numbers 




Primer Sequence (5'-3') UPL Probe Gene I.D
pET-Dsh6h-NheI_F GCT AGC ATG GCT ACT TTT GTC TCA AA Dsh6h KR006982.1
pET-Dsh6h-EcoRI_R GAA TTC TTA ACA GAA GAA CCA ACA CA Sth6h_u743 XM_006352681.2 
pET-Sth6h-NdeI_F CAT ATG ATG GCA TCA CTA GTT TCA AG Sth6h XM_006340300.2 
pET-Sth6h-BamHI_R GGA TCC TTA GAG CTT ATA TGG TTT CA
pET-Sth6h_u743-NdeI_F CAT ATG GAT GGA AAA TAA TTT AGT GTC
pET-Sth6h_u743-BamHI_R GGA TCC TTA GAG CTT GTA AGA CTG AAG
pET-T7_ter GCT AGT TAT TGC TCA GCG G
Sth6h_qPCR_F TGG TGA CCC ATC ACT ACC C 122
Sth6h_qPCR_R GCA CCA TCA CAA TGT TCA CC 122
Sth6h-u743_qPCR_F GCC TGA AAG TTA CAT ATT CCC AGA 80
Sth6h-u743_qPCR_R TGG ACT GCT ACC ACT TAA AGG AA 80




















Table A.5.2.1: Primer sequences and location of primer binding upon WstrI coding sequence used in 
this study.  
 
 
Figure A.5.2.1: WstrI/ef-1α expression ratios for all plant lines characterised prior to the best 





Primer Sequence (5'-3') UPL Probe Gene I.D
Ws_trI-syn-F GCG GGT CTC GAA TGG ATG AAT CAA G Ws_trI KF360055.1
Ws_trI-syn-R GCG CGG TCT CGA AGC TTA AAA TCC A
Ws_trI-F CGA ATG GAT GAA TCA AGC GTT T
Ws_trI-R AGC TTA AAA TCC ACC ATT AGC T
Ws_trI-Trans-F CCA TGG AAG ATC TAG ATG GAG TC
Ws_trI-Trans-R TTG CAC CTT TGG AAG CAG AAT AA
Ws_trI_Tnos_Seq_F TCA ATT CAG TTG CTC CAG GA
Ws_trI_35s_Seq_R AGT TCA TTT TCA TTA CGT GAA C
Ws_trI_qPCR-F CGA AGA AGT CGC TGC AGT AAT 18
Ws_trI_qPCR-R TAT AAT CTG GCC CGT TAC ATA AGA                18
Primer Sequence (5'-3') UPL Probe Gene I.D
Ws_trI-syn-F GCG GGT CTC GAA TGG ATG AAT CAA G Ws_trI KF360055.1
Ws_trI-syn-R GCG CGG TCT CGA AGC TTA AAA TCC A
Ws_trI-F CGA ATG GAT GAA TCA AGC GTT T
Ws_trI-R AGC TTA AAA TCC ACC ATT AGC T
Ws_trI-Trans-F CCA TGG AAG ATC TAG ATG GAG TC
Ws_trI-Trans-R TTG CAC CTT TGG AAG CAG AAT AA
Ws_trI_Tnos_Seq_F TCA ATT CAG TTG CTC CAG GA
Ws_trI_35s_Seq_R AGT TCA TTT TCA TTA CGT GAA C
Ws_trI_qPCR-F CGA AGA AGT CGC TGC AGT AAT 18
Ws_trI_qPCR-R TAT AAT CTG GCC CGT TAC ATA AGA                18























Table A.6.2.1: Primers used in the production of down-regulation vector, sequencing and 
characterisation of transgenics within this study  
 
 
Figure A.6.2.1: RT-qPCR analysis for all SttrII down-regulating lines prior to the best lines being 




Primer Sequence (5'-3') UPL Probe Gene I.D
As_trII-672-F GCG CCG TCT CGC TCG AAT GGA AGC AGC AGG AAA ACA A St_trII AJ292343.1
As_trII-672-R GCG CCG TCT CGC TCG AAG CTT AAG GCA TTG GGT ATG GGA T
trII-5UTR-F AAA TCA ATT GGA GGC TTC ATT
trII-5UTR-R GCA GCC TTC AAG ATT CC
35s-AS-Trans-R GGG TCT TGC GAA GGA TAG TG
As-35stoNPTII-R TAG ATC GTC TTG ATC AGA CC
As_trII_35s_Seq_R TCT ACA TAG AAT GGG TGA GC
As_trII_Tnos_Seq_F TGA TTA CGT GAA CAT GTA TA
qPCR-trII-5U_74F CCC ATT TTT CAA GTC TTG TGC 74
qPCR-trII-5U_74R GCA GCC TTC AAG ATT CCA TC 74
qPCR-As_trII-138_F TGC TGC TTC ATA TGT CAC TGG 138
qPCR-As_trII-138_R TGA TTA AAA GCC ACC ATT AGC C 138
Primer Sequence (5'-3') UPL Probe Gene I.D
As_trII-672-F GCG CCG TCT CGC TCG AAT GGA AGC AGC AGG AAA ACA A St_trII AJ292343.1
As_trII-672-R GCG CCG TCT CGC TCG AAG CTT AAG GCA TTG GGT ATG GGA T
trII-5UTR-F AAA TCA ATT GGA GGC TTC ATT
trII-5UTR-R GCA GCC TTC AAG ATT CC
35s-AS-Trans-R GGG TCT TGC GAA GGA TAG TG
As-35stoNPTII-R TAG ATC GTC TTG ATC AGA CC
As_trII_35s_Seq_R TCT ACA TAG AAT GGG TGA GC
As_trII_Tnos_Seq_F TGA TTA CGT GAA CAT GTA TA
qPCR-trII-5U_74F CCC ATT TTT CAA GTC TTG TGC 74
qPCR-trII-5U_74R GCA GCC TTC AAG ATT CCA TC 74
qPCR-As_trII-138_F TGC TGC TTC ATA TGT CAC TGG 138
qPCR-As_trII-138_R TGA TTA AAA GCC ACC ATT AGC C 138
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